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This study explored the genetic influence of susceptibility genes on brain 
volumes in psychosis. More specifically, I explored whether certain allelic 
variations are associated with global brain volumes in subjects with psychosis, 
their relatives and in healthy controls. To increase the statistical power, I 
combined three different MRI scan datasets since a calibration study showed 
high intra-class correlations (ICC above 0.9) between MRI protocols (Chapter 
3). I therefore included 535 participants (225 patients with psychosis, 130 
relatives and 180 healthy volunteers).  
 
In the first analysis I compared grey, white and whole brain volumes between 
patients and healthy controls (Chapter 5). Patients with schizophrenia 
spectrum psychoses showed smaller grey matter and larger white matter 
volume, and smaller whole brain volume than healthy controls. They also 
showed smaller grey matter volume than patients with bipolar disorder, who 
also had smaller white matter volume than healthy controls. In the second 
analysis, I estimated differences in brain volumes between relatives and 
patients and healthy controls (Chapter 6). Only patients with bipolar disorder 
showed smaller whole brain volume than their relatives. There were no 
significant differences in brain volumes between the relatives of patients with 
bipolar disorder or schizophrenia and the healthy volunteers. Finally, I 
evaluated the role of familiarity on these volumes (Chapter 6). In families with 
schizophrenia the family clusters accounted for 48% of the total variance in 
grey matter volume, for 27% of the total variance in white matter volume, and 
for 35% of the total variance in whole brain volume. In families with bipolar 
disorder the family clusters accounted for 48% of the total variance in grey 
matter volume, for 43% of the variance in white matter volume, and 22% of 
the total variance in whole brain volume.  
 
In the second part of the thesis I explored genetic influence of 20 SNPs 
previously reported to influence brain morphometry in psychosis and in 
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healthy individuals, on these volumes (Chapter 7). I found evidence for an 
association between OLIG2_rs762178, MCPH_rs930557 and 
DTNBP1_rs1047631 and grey, white or whole brain volumes. However, this 
association did not survive multiple comparison corrections. 
 
In conclusion, despite strong evidence of high heritability and familial influence 
on volumetric measures, I found not evidence of association between the 
selected candidate genes and these brain regions. These findings highlight 
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Chapter 1 Introduction 
 
1.1 Introduction 
Despite advances in neuroimaging and genetic research, the neurobiology of 
the two major functional psychotic illnesses; schizophrenia and bipolar 
affective disorder is little understood. This thesis describes my work analyzing 
magnetic resonance images (MRI) of the brain of patients, their unaffected 
relatives and healthy volunteers to determine the volumetric changes for grey 
and white matter associated with this illness and their relationship to an 
underlying genetic susceptibility. 
 
1.2 Psychosis  
Psychosis from the Greek ψυχή "psyche", for mind/soul, and -ωσις "-osis", for 
abnormal condition, means an abnormal condition of the mind.  The first 
attempts to classify the illness were made by Kraepelin. He described 
dementia praecox where thought disorder, delusions and hallucinations were 
the prominent symptoms, in contrast with manic-depressive illness where 
mood changes were the prominent symptoms. Importantly, he also described 
that psychotic illnesses aggregate in families. Later on, this was further 
demonstrated in family studies of psychosis. In fact, family studies have 
estimated that the familiality of schizophrenia is between 41% and 87% 
(Gottesman and Shields 1982; Kendler et al, 1983; Cannon et al., 1998b; 
Cardno et al, 1999), while in bipolar disorder is between 73% and 87% 
(Cardno et al, 1999; Kendler et al, 1995, McGuffin et al, 2003). Nevertheless, 
the clinical distinction between these two major psychoses has always been 
less apparent. In the sections that follow, I will outline the classification of 
psychoses, the deviations in brain volume that have been described in these 
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1.3 Evolution of the classification of psychosis 
From the first descriptions of psychotic symptoms, the definition of psychosis 
has been controversial. One of the first categorical classifications of the 
psychotic symptomatology was done by Kraepelin (Kraepelin; 1919). 
Kraepelin‘s dichotomous classification was based on evidence derived from 
the development of symptoms and clinical outcomes. He provided a 
description of ―dementia praecox‖, in which thought disorder, delusions and 
hallucinations were the most prominent symptoms. He provided a second 
definition for manic-depressive illness, where mood changes were the most 
prominent symptoms. Later on, Bleuler reviewed Kraepelin‘s concepts and 
proposed the term schizophrenia, ―split-mind‖ as it reflected better the clinical 
presentation and illness progress of patients suffering what it was called 
dementia precox (Bleuler, 1950). 
Both Kraepelin and Bleuler subdivided schizophrenia into categories, based 
on differences in the most prominent symptoms and in prognoses. These 
classifications have been the basis for current categorical classification 
systems such as the Diagnostic and statistical manual of mental disorders 4th 
edition criteria, (DSM-IV, APA, 2000) and the International Statistical 
Classification of Diseases and Health Related Problems (ICD-10, WHO, 
1992). In these systems these syndromes have been defined mainly into two 
major categories as schizophrenia and bipolar disorder with psychotic 
symptoms.  
 
1.4 Current classification 
In the ICD-10, the classification of psychosis as a syndrome falls into two 
major categories (and a similar classification is described in the DSM-IV), 
each including a number of other diagnoses: 
1.4.1 Schizophrenia  
F20 Schizophrenia: The main characteristics are distortions of thinking and 
perception, and affects that are inappropriate or blunted. These distortions are 
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accompanied by clear consciousness and intellectual capacity. The typical 
psychopathological phenomena include thought echo; thought insertion or 
withdrawal; thought broadcasting; delusional perception and delusions of 
control; influence or passivity; hallucinatory voices commenting or discussing 
the person‘s actions.  
 
Schizophrenia presents with a sub classification depending on the presence of 
prominent symptoms and prognosis:  
F20.0 Paranoid schizophrenia  
F20.1 Hebephrenic schizophrenia  
F20.2 Catatonic schizophrenia  
F20.3 Undifferentiated schizophrenia:  
 
F21 Schizotypal disorder Patients present with eccentric behaviour and 
anomalies of thinking and affect which resemble those seen in schizophrenia, 
though no definite and characteristic schizophrenic anomalies occur at any 
stage. An important characteristic is that there is no definite onset and course 
is usually those of a personality disorder. 
 
F22 Persistent delusional disorders Includes a variety of disorders in which 
long-standing delusions constitute the only, or the most conspicuous, clinical 
characteristic.  
 
F23 Acute and transient psychotic disorders This is a heterogeneous 
group of disorders characterized by the acute onset of psychotic symptoms 
with severe disruption of ordinary behaviour. Acute onset is defined as 
development of symptoms in two weeks or less. For these disorders there is 
no evidence of organic causation.  
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F24 Induced delusional disorder A delusional disorder where only one of 
the people suffers from a genuine psychotic disorder; the delusions are 
induced in the other(s) and usually disappear when the people are separated. 
 
F25 Schizoaffective disorders In this category both affective and 
schizophrenic symptoms are prominent; therefore, do not justify a diagnosis of 
either schizophrenia or depressive or manic episodes.  
 
F28 Other nonorganic psychotic disorders Delusional or hallucinatory 
disorders that do not justify a diagnosis of other disorder 
 
F29 Schizphrenia Unspecified nonorganic psychosis 
1.4.2 Mood Affective Disorders 
F30 Manic episode The prominent symptoms are persistent elevation of 
mood, increased energy and activity, and usually marked feelings of well-
being and both physical and mental efficiency. Additionally they could present 
with talkativeness, over-familiarity, increased sexual energy, and a decreased 
need for sleep. Irritability, conceit, and boorish behaviour may take the place 
of the more usual euphoric sociability. The disturbances of mood and 
behaviour might be accompanied by the presence of hallucinations or 
delusions. 
F31 Bipolar affective disorder This category includes patients with two or 
more episodes of mood and activity levels with significant disturbance. These 
episodes have to include occasions of an elevation of mood, increased energy 
and activity (hypomania or mania) and on others of a lowering of mood and 
decreased energy and activity (depression). However, repeated episodes of 
hypomania or mania only are also classified as bipolar. Additionally, in order 
to be classified under the psychosis category they should present with 
psychotic symtoms i.e. hallucinations, delusions. 
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F32.3 Severe depressive episode with psychotic symptoms In this 
category, symptoms of depression should be present with hallucinations, 
delusions, psychomotor retardation, or stupor so severe that ordinary social 
activities are impossible. 
Although over the years there have been attempts to classify psychotic 
illnesses based on their symptoms and prognosis, this has proven to be a 
difficult challenge. Although the two illnesses appear clinically distinguishable 
in the categorical classifications, the clinical boundaries between them often 
remain blurred because of a lack of pathognomonic symptoms. There is a 
clear overlap of symptoms in both illnesses, as demonstrated by studies using 
factor analysis of symptoms (Dikeos et al 2006, Demjaha et al., 2009) 
However, Dikeos and colleagues study (2006) reported mania as the best  
factor to distinguish between the two major psychotic disorders (Dikeos et al 
2006). This finding supports the use of this approach when trying to 
distinguish schizophrenia from bipolar disorders. 
With advances in research, several studies have been suggesting that both 
illnesses share some characteristics in terms of epidemiological and 
neurobiological risk factors (Murray et al., 2004; Craddock et al., 2005b). For 
instance, a small excess in winter birth has been shown to occur in both 
illnesses (Takei et al, 1992).  Additionally, poor premorbid adjustment has 
been shown to be impaired during childhood in subjects who later on develop 
these illnesses but this is more noticeable in schizophrenia. This has been 
demonstrated by Cannon and colleagues in both retrospective (Cannon et al 
1997) and prospective studies (Cannon et al 2002a). Interestingly, there is 
also a cross-over in risk, where for example a familial risk for schizophrenia 
increases the risk of developing an affective psychosis and vice versa 
(Kendler at al., 1993a,b; Valles et al., 2000; Cardno et al., 2002; Arajarvi et al., 
2006). 
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Moreover, there are a number of genetic and clinical phenotypes such as 
sustained attention and working memory that overlap in patients with bipolar 
disorder and schizophrenia and their relatives, and these have been 
described in a recent meta-analysis and a review (Arts et al 2008, Ivleva et al., 
2010). Furthermore, there is also evidence of an overlap in linkage and 
susceptibility genes between the two disorders (Bramon and Sham, 2001; 
Sklar et al., 2002; Craddock et al, 2005a; Lake, 2007).  
In conclusion, findings from epidemiological and genetic studies show that 
there is an important overlap between the disorders described in classical 
dichotomous classifications of psychotic illnesses. However, more recently an 
effort has been made to find markers that could help distinguishing between 
these disorders. I will describe these in more detail in the following sections. 
1.5 Brain development and its heritability 
The focus of my thesis is the evaluation of brain volume differences in patients 
with psychosis, their healthy relatives and in healthy controls, and the 
evaluation of genetic contribution for these differences. During the past 
decade, new developments in schizophrenia research have led to understand 
psychosis as a brain disease. Moreover, changes in brain volumes have been 
reported to be present at the onset of the illness (Chua et al., 2007; 
Jayakumar et al., 2005). These findings suggest abnormalities during the 
brain development of patients with psychosis. Therefore, in order to 
understand how psychosis deviates from a trajectory of normality, it is 
important to understand first where differences between affected and 
unaffected individuals might lie. In the next section I will briefly describe the 
normal development of the brain in order to make inferences on its heritability, 
and on the genetic influence that might be implicated in the development of 
brain morphometric deviations in psychosis. 
 
1.6 Normal brain development and heritability 
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Brain development and growth start in the pre-natal period and continue 
during childhood until early adulthood. There have been several studies 
describing the normal development of the brain and genetic influence on this 
process. By the age of 6 years, the human brain reaches 95% of the adult 
human brain volume (Giedd et al., 1999a) with grey and white matter volume 
increasing until early adolescence. After this period, grey matter volume 
(except temporal lobe area) starts to decrease while white matter volume 
continues to increase (Giedd et al., 1999a; Paus et al., 1999). Moreover, 
normal brain development follows different regional trajectories as shown by 
the work done by Giedd and colleagues (1996; 1999a). The authors described 
that the anatomic development of subcortical structures has been reported to 
be almost complete by late childhood while cortical regions having 
substantially longer development. In addition, some studies show that grey 
matter volume increases in late childhood and decreases during puberty 
following a consistent parietal-temporal-frontal lobe pattern (Giedd et al., 
1999a,b). Furthermore, in longitudinal studies, white matter has been shown 
to increase until age 45 and to start decreasing after that age (Bartzokis et al., 
2001). These findings are consistent with descriptions of brain volume 
changes in adulthood, when the whole brain volume decreases at the 
expenses of grey matter volume loss (Raz et al., 2004; Allen et al., 2005). 
 
A number of studies have also described a dynamic variation in brain volume 
in adolescents in areas such as the frontal and temporal cortex, amygdala and 
hippocampus which seem to reduce their volume during this period (Sowell 
and Jernigan, 1998; Thompson et al., 2000). A well formulated theory explains 
this decline in volume as secondary to synaptic pruning (Huttenlocher 1979; 
Huttenlocher and Dabholkar, 1997). This theory describes brain volume 
changes as part of an adaptive process by which irrelevant connections are 
eliminated. Additionally, during adolescence there seems to be an increase in 
myelination in the limbic system pathways. During adolescence, when 
cognitive functions are enhanced, this change seems accompanied by 
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changes in brain activity in the frontal lobe, as seen with functional 
neuroimaging (Casey et al., 2000; Rubia et al., 2000).  
 
Given that brain volumes are phenotypic expressions of genes, research in 
brain development in healthy people has looked at brain volume as a 
quantitative trait with high heritability (Thompson et al 2001a). In order to 
understand the expression of a certain phenotype, it is important to 
understand the concept of heritability as dependent on genes and 
environment. This can be expressed in the following formula (Fisher, 1918; 
Visscher et al., 2008): 
 
Phenotype (P) = Genotype (G) + Environment (E).  
The variance in the phenotype – Var (P) – is the sum of genetic effects as 
follows: 
Var(P) = Var(G) + Var(E) + 2 Cov(G,E).  
In a controlled experiment where environment can be fully controlled thus, 
Cov(G,E) can be held at 0. Therefore, heritability is defined as: 
H2 =Var (G)/Var(P) 
This heritability would reflect all the genetic contributions to the phenotypic 
variance of a certain population. In order to estimate the heritability of certain 
phenotypes, familiality models take into account the variability of certain traits 
or phenotypes, such as brain volume, within families in comparison to the 
variability of the trait under study in not related individuals. In this model, both 
genetic and environmental factors are measured together. However, a more 
specific approach used in family and twins studies aims to assess the 
contribution of genetic and environmental factors separately. Here the 
heritability is described as the proportion of genetic variability over the total 
variance in a particular phenotype. Twins provide strong models to assess 
this. When using this approach, the heritability of brain volumes is estimated 
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by comparing the variation between monozygotic (MZ) pairs and dizygotics 
(DZ) pairs. It is argued that if the MZ pairs are more similar that the DZ pairs 
the trait measured (in this case, brain volumes) is due to genetic influence.  
The heritability of whole grey matter and white matter volumes has been 
estimated to be around 82% and 87% respectively (Posthuma et al. 2002). 
More recent studies have corroborated evidence of a high heritability in brain 
volumes, finding that the whole brain volume heritability is estimated around 
70 %, while global grey and white matter volumes heritability is between 70 
and 77% (Kremen at al., 2010).  
Finally, it has been shown that the observed morphometric changes are likely 
to be due to changes in gene expression during human brain development as 
shown by Webster and colleagues (2002, 2006). The authors described 
changes in BDNF expression during neurodevelopment changes expression 
along the maturation of the prefrontal cortex, hyppocampus and temporal 
lobes. This finding further supports the theory of genetic influence in brain 
development and the need to investigate this further in psychosis.  
 
1.7 Brain development in psychosis 
There is increased evidence from MRI studies of brain structural abnormalities 
in psychosis (Wright et al 2000; Shenton et al 2001; Farrow et al 2005; Steen 
et al., 2006;, McDonald et al 2004; Kemptom et al 2008; Segall et al., 2009; 
Ellison-Wright and Bullmore 2010) and this will be discussed in the sections 
below. Moreover, there is strong evidence that these morphometric brain 
changes might be due to aberrant neurodevelopment as a result of 
interactions between genetic and environmental factors (Rapoport et al., 
2005). This is also based on the view that schizophrenia is the behavioral 
expression of an abnormal neurodevelopmental course which begins before 
the clinical onset and is caused by a combination of environmental and 
genetic factors (Cardno et al., 1999a; Sigh et al., 2004). Keshavan and 
colleagues (1999a, 1999b) have proposed a model in which the brain 
development might be affected in subjects that later on develop 
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schizophrenia. This model suggests that environmental insults such as 
maternal viral infection in utero (Brown and Begg, 2005) could affect a crucial 
period of normal brain development and lead to the formation of abnormal 
neural networks (Keshavan, 1999a). Another crucial neurodevelopmental 
period, as described in the previous section, is during childhood and 
adolescence. In this period, the brain undergoes important developmental 
changes as shown in healthy adolescents (Giedd et al., 1999a) and it seems 
to be greatly controlled by genetic loading (Lenroot and Giedd, 2008). It has 
been proposed that genetic factor and/or environmental insults in this period 
might lead to loss of synapses (synaptic pruning) and brain plasticity 
(Keshavan et al., 1999b; Keshavan et al., 2005) underpinning the 
morphometric changes observed in psychosis. Studies on brain volumes in 
patients with childhood onset of schizophrenia (COS) have become of great 
value when trying to understand brain development in psychosis during this 
crucial time. Several studies in COS have shown significant grey matter 
volume loss and enlarged ventricles in comparison to healthy controls (Frazier 
et al., 1996; Rapoport 1997, 1999). Moreover, longitudinal studies have 
demonstrated that, in early onset schizophrenia (EOS), there are similar but 
more striking grey matter loss pattern than the ones found in healthy control 
(Gogtay 2004). One of the studies showed that in very EOS the initial deficit 
was significant parietal grey matter loss, which then progresses anteriorally 
into the temporal lobes towards the prefrontal cortices (Thompson et al., 
2001b). These changes appear to be exaggerations of normal cortical 
development (Ropoport et al., 2005). In addition, the parallelism in brain 
changes over time between patients with schizophrenia and healthy controls 
in adult population was also shown in a recent study by Sun et al (2009). The 
authors showed that cortical brain reductions in patients and healthy controls 
have similar anatomical patterns albeit more significant in patient.  
 
The neurodevelopmemtal theory for patients with bipolar disorder has been 
investigated but it has reached less conclusive results so far. There is some 
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evidence for possible abnormal brain maturation in bipolar patients from 
clinical pre-morbid neurobehavioral impairment. Cannon et al., (1997) 
reported a significant pre-morbid social impairment in bipolar patients in 
comparison to healthy controls. Moreover, a prospectively study from a British 
birth cohort study (van Os et al., 1997) found that patients that later on 
developed affective disorder presented with higher rate of speech defects; 
decreased psychomotor alertness and an excess of twitching and grimacing 
motor behaviors during childhood and adolescence. These findings suggest 
impairment in neurological development in bipolar disorder. From structural 
brain neuroimaging, increased amygdala volume in adult patients with bipolar 
disorder is one of the most consistently reported findings (Strakowski et al., 
1999; Altshuler et al., 1998). However, reduction in amygdala volume has 
been found in adolescents (DelBello et al., 2004) and both adolescent and 
adult (Blumberg et al., 2003; 2004) patients with bipolar disorder. Therefore, 
emphasis has been put to evaluate the amygdala development in bipolar 
disorder. A study evaluated brain volume differences in adolescents with 
bipolar disorder (Chen at al., 2004). Although the differences were no 
statistically significant, the authors found a correlation between left amygdala 
volumes and age in bipolar patients which was not present in matched healthy 
controls. The authors suggest that this difference might reflect abnormal 
developmental pathway in bipolar disorder. However, there is still lack of 
evidence of progressive structural brain morphological changes from 
longitudinal studies which has very much supported the neurodevelopmental 
theory in schizophrenia. A recent comprehensive critical appraisal by Sanches 
et al., (2008) reviewed the evidence for the theory of neurodevelopmental 
disorder in bipolar disorder. The authors suggested that the evidence is weak 
and that the lack of positive findings might be related to use of medications as 
this has been shown to affect grey matter and whole brain volumes (Sassi et 
al., 2002). The authors concluded that abnormal neurodevelopment as a 
causal factor in bipolar disorder remains unclear and more research is 
needed.  




In conclusion, the brain volume differences and the accelerated progressive 
reductions seen in patients with schizophrenia in comparison to healthy 
volunteers may be due to genetic factors leading to increased synaptic 
pruning, and supports the neurodevelopmental hypothesis of the illness. As 
for the bipolar disorders, the evidence for a neurodevelopmental theory still 
remians unconvincing. 
 
1.8 Brain volume in psychosis 
Starting in the last century, there has been much effort in trying to identify 
brain abnormalities as biological markers for psychosis. The initial approaches 
used in psychosis were either included post-mortem studies (Crichton-
Browne, 1979; Southard 1910 and 1915; Jacobi and Winkler, 1928) or the 
application of invasive methods such as pneumonencephalography 
techniques (Haug et al., 1962; Jacobi and Winkler, 1928). Both these methods 
found enlarged lateral ventricles in individuals with schizophrenia. With the 
appearance of less invasive techniques such as X-rays and the development 
of Computer Tomography (CT), and later on Magnetic Resonance Imaging 
(MRI) the study of brain structure has progressed immensely. There is 
increased evidence from MRI studies of brain structural abnormalities in 
psychosis (Wright et al 2000; Shenton et al 2001; Farrow et al 2005; Steen et 
al., 2006; McDonald et al 2004; Kemptom et al 2008; Segall et al., 2009; 
Ellison-Wright and Bullmore 2010) and this will be discussed in the sections 
below. However, despite the technological progress, the identification of a 
reliable biomarker in psychosis has remained elusive. These could be partly 
due to the use of different MRI acquisition parameters across studies, 
including for example slide thickness (Filippi et al., 1998) or in methods used 
in measurements with variability in inter-rater and intra-rater reliability (Filippi 
et al., 1995). Nonetheless, recent automated computational methods based 
on Voxel Based Morphometry (VBM) have allowed a more reliable and faster 
estimation of structural brain differences (Ashburner and Friston, 2000) 
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among different patient populations such as schizophrenia (Wright et al., 
1999; Meda et al., 2008), unipolar disorder (Du et al., 2012), autism (Abell et 
al., 1999), epilepsy (review by Keller and Roberts 2008) and healthy young 
people (Sowell et al., 1999).  In the sections that follow, I will describe the 
most recent and consistent findings in structural neuroimaging MRI in 
schizophrenia and bipolar disorder. 
 
1.8.1 Schizophrenia 
Although there are limitations in the reliability of neuroimaging findings, due to 
heterogeneity of the samples evaluated and the variation in the methods 
used, a number of subtle volumetric changes have been consistently 
described in patients with schizophrenia when compared to healthy 
volunteers. One of the most consistent findings has been the observation of a 
reduction in whole brain volume and grey matter volume, as well as evidence 
of an enlargement of ventricular volumes in patients with schizophrenia 
(Wright et al 2000; Steen et al., 2006).  A detailed literature review of studies 
that used region of interest approaches by Shenton et al. (2001) examined 
evidence provided for structural brain changes described in about a decade of 
research in schizophrenia. The most reliable findings identified with this 
approach have been enlarged lateral ventricles, reduced hyppocampal and 
amygdala volumes, and hemispheric asymmetries. Additionally, 
parahippocampal gyrus, superior temporal gyrus, prefrontal cortex, insula and 
cingulate gyrus have also been found to be reduced in volume in patients with 
schizophrenia when compared to healthy controls (Mc Carley et al., 1999; 
Hornea et al., 2005; Wright 1999 and 2000). These volumetric changes have 
been replicated in patients at their first episode of psychosis, when it is 
assumed that exposure to antipsychotic drugs would have been none or 
limited (Keshavan et al., 2005; Steen et al., 2006; Kuroki et al., 2006).  
A meta-analysis also conducted in studies that used a region of interest 
approach concluded that there is a 2% reduction in whole brain volume (grey 
and white matter) in patients with schizophrenia when compared to healthy 
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controls (Wright et al., 2001). Several studies have found evidence of 
reduction in cortical grey matter volume in patients with schizophrenia when 
compared to controls (Wright et al 1999, Ananth et al 2002, Farrow et al 2005, 
Segall et al., 2009). Moreover, reductions in global gray matter volume have 
also been observed at the time of illness onset in medication naïve subjects 
(Salgado-Pineda et al., 2003; Jayakumar et al., 2005; Chua et al., 2007). 
These findings suggest that the loss of whole brain matter volume might be 
particularly due to grey matter loss (Vita et al. 2006).  A more recent meta-
analysis by Ellison-Wright and Bullmore (2010) concluded that there are 
increased basal ganglia and reduced thalamus volume. However, changes in 
the basal ganglia should be consider carefully as might be related to the 
medication effects as described by a systematic review carried out by Novaris 
and Dazzan (2009). The authors reported that antipsychotics seem to act 
more regionally in the basal ganglia rather than globally in the brain. 
Moreover, typical antipsychotics seem to be more responsible than with 
atypical antipsychotic in increasing the volume of the basal ganglia. They also 
reported that the data on differential effects of antipsychotic type on the cortex 
and thalamus still remains uncertain.  
The evidence for structural neuroimaging and white matter volume has been 
less consistent. Reduction of whole white matter (Buchanan et al., 1998) and 
bilateral white matter reduction in frontal lobes (Buchanan et al., 1998; 
Paillere-Martinot et al., 2001) have been reported. The whole brain white 
matter volume decrease of about 1% of in schizophrenia patients in 
comparison to healthy controls have been reported by a meta-analysis (Wright 
et al., 2000). However these findings have not been consistently replicated for 
the whole white matter volume (Ananth et al 2002) or the frontal lobes (Baaré 
et al., 1999, Hirayasu et al., 2001 and Staal et al., 2000).  
More recently evidence from VBM studies has been examined in the search of 
reliable marker for schizophrenia. A meta-analysis by Honea and collegaues 
in 2005 a described the reduction in left temporal lobe gyrus and left medial 
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temporal lobe as the most consistent finding in patients with schizophrenia 
when compared to healthy controls (Honea et al., 2005).  Ellison-Wright and 
colleagues (2008) conducted a meta-analysis of VBM structural brain volumes 
in patients with schizphrenia. They reported reduction in grey matter in the 
basal ganglia-thalamo-cortical circuit (Ellison-Wright et al., 2008). In addition, 
these authors compared brain changes in first episode versus chronic 
schizophrenia patients. They found that cortical grey matter volume reductions 
seem more prominent in the chronic stages of the illness. Another meta-
analysis by Chan et al. (2009) reviewed subjects with schizophrenia in their 
first episode and in their chronic stages. The authors described progressive 
brain volume changes in schizophrenia in the cortico-striato-thalamic circuit 
and showed that structural abnormalities in the fronto-temporal area are also 
evident in nonpsychotic individuals at high risk of developing schizophrenia. In 
addition, smaller gray matter volumes in the chronic group were more 
extensive. Taken together with the other evidence, these findings suggest that 
gray matter abnormalities become more extensive through first-episode and 
chronic illness. These progressive changes are important to consider when 
pooling together neuroimaging findings from first-episode and chronic patients 
with schizophrenia in multicentre studies.  
Despite the report of some relatively consistent findings across studies of 
patients with schizophrenia, all studies comment on the heterogeneity of the 
methods used to evaluate structural brain volume differences. To advance 
evidence, it is therefore important to further investigate these findings in larger 
samples, with a consistent method that would limit the presence of 
methodological confounders.  
 
1.8.2 Bipolar disorder 
There is less consistent evidence of the brain alterations that are present in 
bipolar disorder. The studies carried out to date have often included 
heterogeneous samples of patients with affective symptoms, and either with 
or without psychotic symptom. In addition, many studies have included 
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patients with unipolar as well as bipolar disorder with psychotic symptoms. 
However, the studies that have narrowed their inclusion criteria for Bipolar 
Disorder I and II are still small in number when compared to the number of 
studies conducted in schizophrenia. One of the most consistent finding 
reported in bipolar disorder has been ventricular volume enlargement in 
patients when compared to healthy volunteers (McDonald et al 2004a, 
Kemptom et al 2008). Another frequently reported finding has been the 
presence of white matter abnormalities. Some of these appear to be 
qualitative rather than volumetric differences, and include an increase in 
periventricular and deep white matter hyperintensities (Altshuter et al 1995, 
Bearden et al 2001, Kempton et al 2008). Importantly, this has not been found 
at first onset of the illness (Strakowski et al 1993; Zanetti et al., 2008) but has 
been reported as in children and adolescents with the bipolar disorder 
compared to healthy volunteers (Pillai et al., 2002; Beyer et al 2009). In terms 
of structural white matter volume evaluations, smaller white matter volumes 
have been found in patients at their first episode of a bipolar illness in 
comparison to healthy volunteers (Vita et al 2009, Arnone et al 2010) 
 
Deviations of regional brain volumes have been even more contradictory. 
Some studies have reported increased amygdala volumes as the most 
consistent finding (Altshuler et al., 1998; Strakowski et al 1999, Frodl et al 
2002). There is no surprise that a brain structure involved in coding emotions 
would be affected in mood disorders. However, amygdala volume in 
adolescents with bipolar disorder has been reported as reduced in 
comparison to healthy volunteers (Chang et al 2005). Furthermore, these 
changes in the amygdale and subgenual prefrontal cortex have been 
supported by more recent studies in medication-free patients with major 
depression (Tang et al 2007) and at first-episode presentation of bipolar 
patients (Rosso et al 2007; Koo et al 2008). 
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This variability in findings has been attributed to factors such as sample 
characteristics, medication use and methodological heterogeneity. In recent 
years there have been a number of meta-analyses that have tried to aid 
researchers to narrow the brain deviations into the most consistent findings in 
affective psychosis. The clearest association has been reported for lateral 
ventricular enlargements (McDonald et al 2005, Kempton et al 2008, Arnone 
et al 2009), with less agreement for other brain structures. In the meta-
analysis by McDonald et al. (2005), the authors found considerable 
heterogeneity in the volumetric deviations of the amygdala, thalamus and 
subgenual prefrontal cortex. Another area with inconsistent finding is the 
volume of the whole brain matter and the temporal lobe volumes and these 
deviations have been reported as possibly related to the duration of illness 
and the use of medication (Arnone et al., 2009). Also, the reduction in whole 
brain volume has not been found in first episode bipolar illness (Vita et al 
2009), and this has been suggested to represent a marker of illness 
progression rather than of the illness itself. 
 
In conclusion, it is not surprising that the critical appraisal carried out by 
Sanches et al. (2008) describes there is little evidence of consistent brain 
changes among patients with bipolar disorder.  
 
1.8.3 Schizophrenia and bipolar disorder 
There is still less evidence for brain volume differences between subjects with 
schizophrenia and those with bipolar disorder. Previous studies have found 
differences in volumes when comparing both groups; patients with 
schizophrenia showed statistically signifficant smaller grey matter volumes 
when compared to bipolar patients (McDonald et al., 2005; Yuksel et al., 
2012).  
 
Kempton and colleagues‘ (2008) meta-analysis of MRI studies in bipolar 
disorder attempted an additional analysis comparing brain findings in these 
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disorders. However, the authors found that there was a significant publication 
bias and therefore no conclusion could be drawn in this respect (Kempton et 
al 2008). In another meta-analysis, Arnone et al. (2009) showed that patients 
with schizophrenia present with smaller right amygdala volume and larger 
lateral ventricles bilaterally when compared to patients with bipolar disorder 
(Arnone et al., 2009). It is worth noting that studies using VBM were excluded 
from this analysis. Another meta-analysis by Ellison-Wright and Bullmore 
(2010) looked at the VBM method comparing both groups. The authors 
reported grey matter volume reductions in the anterior cingulate as 
characteristic of bipolar disorder, and volume reductions in the limbic system 
and neocortical structures as more specific to schizophrenia. However, there 
was substantial overlapping in the reduction of the insular volumes (Ellison-
Wright and Bullmore, 2010). Moreover, patients with schizophrenia have been 
found to share the endophenotypes such as enlarged ventricles and P50 and 
the P300 auditory evoked potentials with subgroups of patients with bipolar 
disorder who also experience psychotic symptoms (Strasser et al., 2005; 
Potash et al., 2006). These findings support the concept that these disorders 
not only share common genes (Craddock et al. 2006, Potash et al., 2006; 
Craddock et al., 2009) and clinical presentation (Ivleva et al., 2008; Craddock 
and Owen 2010), but also the intermediate stage, brain deviations (Ivleva 
2010). 
 
1.8.4 Influence of medications on brain volume 
Brain volume alterations in patients with schizophrenia have been described 
as present already from the first illness presentation (Keshavan et al., 2005; 
Kuroki et al., 2006; Steen et al., 2006; Vita et al., 2006). This has given rise to 
the notion that these alterations are not simply related to the influence of 
psychotropic medications such as antipsychotics, antidepressants or mood 
stabilizers, which have been reported to affect brain structure. The most 
common medications used in psychosis are antipsychotics. These mostly act 
on dopamine type 2 (D2) receptors, and are thought to achieve their 
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antipsychotic therapeutic effect by virtue of this blockade. A variety of studies 
has shown that antipsychotic drugs have direct effects on brain structure, and 
grey matter volumes in particular (Navari & Dazzan, 2009; Leung et al., 2011). 
One of the areas with highest density of D2 receptors are the basal ganglia 
which has been reported as increased in patients with schizophrenia exposed 
to neuroleptic medication, particularly first generation antipsychotics (Lang et 
al., 2004; Navari & Dazzan, 2009). When cortical grey matter volume is 
assessed, first generation antipsychotic medication seems also having an 
effect. Reduction of the pre-frontal cortex and medial temporal lobe has been 
shown to be affected more by first than second generation antipsychotic 
medication (Lieberman et al., 2005). In patients with bipolar disorder, Lithium 
is associated with increase grey matter volumes (Sassi et al., 2002; Bearden 
et al., 2007; Lyoo et al., 2010; Hallahan et al., 2011). A recent meta-analysis 
suggested associations between lithium treatment in patients with bipolar 
disorder and grey matter volume increases (Kempton et al, 2008).  
 
1.9 Endophenotype approach to understand psychosis 
One of the greatest challenges for psychiatry has always been to measure its 
illnesses in a reliable and valid manner. The aim has always been to 
categorize the symptoms to reach a diagnosis. One approach to try and 
identify biological markers that could be used to classify different illnesses has 
been the use of endophenotypes. The concept of endophenotype was 
introduced by Gottesman and Shields (Gottesman & Shields, 1973) as a 
theory to understand genetic concepts in schizophrenia. It is conceptualized 
as an internal phenotype evaluable by biological or microscopic tests.   
 
A biological marker can be regarded as an endophenotype when it fulfills 
certain criteria as described by Gottesman and Gould (2003):  
1)  the endophenotype is associated with the  illness in the population;  
2)  the endophenotype is heritable;  
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3) the endophenotype is primarily state-independent (independent of the 
illness activity);  
4)  the endophenotype co-segregate within families and 
5) the endophenotype found in affected family members is found in non-
affected family members at a higher rate than in the general population.  
 
One of the difficulties in identifying endophenotypes in psychosis is the 
heterogeneity of the illness.  There is evidence that schizophrenia and bipolar 
disorders share symptoms, susceptibility genes and biological markers 
(Craddock and Owen 2005a; Fischer and Carpenter 2009). Furthermore, 
there a number of endophenotypes that have been considered in psychosis 
such as neurocognitive deficits, whole brain volume, P50 and P300 event-
related potential (Ivleva et al., 2010). Unfortunately, the study of these 
biomarkers has reported contradictory findings and no marker, so far, has 
been sensitive enough to be used to differentiate healthy controls from 
affected subjects. In the next section, I will describe the brain volume 
abnormalities that have been proposed as endophenotypes in order to help 
identify genes involved in a putative pathophysiology. 
 
1.10 Brain volumes and unaffected relatives of patients with psychosis: 
The inheritance of whole brain volume in schizophrenia has been described 
as between 66% and 97% (Peper et al., 2007; Rijsdijk et al., 2005). This has 
been further investigated in elderly twins by Pfefferbaum et al (2004) to 
additionally assess genetic influence on brain changes over time 
schizophrenia. The authors showed that the genetic influence in whole brain 
volume is still high, at around 80% in later life (Pfefferbaum et al., 2000). 
These results suggest that brain volume differences found in psychosis are 
under great genetic influence, making them appealing biomarker to be 
explored. However, in order to fulfil criteria as a biomarkers, the trait should be 
present in family members more than in the general population (Gottesman 
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and Gould, 2003). In this section I will highlight relevant findings on brain 
volumes in the unaffected relatives of patients with psychosis. 
 
Some of the changes reported in schizophrenia such as, grey matter and 
ventricular volume differences, are shared by unaffected relatives of patients 
with schizophrenia, although to a lesser degree (Cannon et al 1998a; 
McDonald et al, 2002 and 2006). The comparison of offspring and siblings of 
patients with schizophrenia with healthy controls has shown reductions in the 
hippocampus volume (Kashavan et al 1997, Lawrie et al 1999; Johnstone et 
al., 2002). However, others have failed to replicate this finding (Schulze et al., 
2003). A meta-analysis carried out by Boos and colleagues (2007) included 
different types of first-degree relatives; namely, siblings, monozygotic twins, 
dizygotic twins, parents, offspring and unspecified first-degree relatives. The 
authors‘ results support the initial findings on hippocampal volume reductions 
in healthy relatives of patients with schizophrenia in comparison to healthy 
controls. In addition, the authors reported significant whole grey matter 
reductions and enlarged third ventricles in the relatives group. Although 
ventricle volumes enlargement has been found in schizophrenia and their 
healthy relatives and proposed as an endophenotype (Mc Donald et al., 
2002), more recently, the use of ventricular volume as an endophenotype in 
schizophrenia has been argued against, in view of its high vulnerability to 
environmental influences (Rijsdijk et al., 2005) and the high level of 
contradictory reports (Kremen et al., 2012). Regional differences between 
unaffected relatives of schizophrenia and healthy controls have been recently 
reported in brain volumes and grey matter thickness by Goghari and 
colleagues (2007). The authors reported volume and surface area reductions 
in the right cingulate gyrus; surface area decrease in the superior temporal 
lobe and, bilateral decrease in cingulate thickness. They also found relatives 
to have slight increase in gray matter volume in the left hemisphere, bilaterally 
in the parahippocampal gyri, and in the left middle temporal lobe (Goghari et 
al. 2007). Moreover, prefrontal cortex grey matter volume reductions has also 
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been found in relatives at high risk of developing schizophrenia in VBM 
studies (Job et al., 2003; Diwadkar et al, 2006). Additionally, although less 
prominently, areas such as medial temporal lobe have also been described to 
be reduced in healthy relatives of patients with schizophrenia (Lawrie et al., 
1999; Keshavan et al., 1997; Job et a., 2003; Boos et al., 2007). However, a 
recent study by Boss and colleagues (2012) found no differences in grey or 
white matter volumes and cortical thickness between healthy siblings of 
patients with schizophrenia and healthy controls.  
 
Twin studies have shown that co-twins with schizophrenia have about 2% 
smaller whole brain volumes than their non-schizophrenic co-twins; the latter, 
showed around 1% smaller brains than healthy control twins (Baare et al., 
2001). In addition, a more recent twin study by van Haren and colleagues 
(2004) concluded that similarities for whole brain volume reductions were 
greater as pair members were more closely genetically related i.e. 
monozygotic twins > siblings > unrelated control subjects. Furthermore, the 
progressive brain change such as grey matter reductions, described in 
patients with schizophrenia has also been shown in their healthy co-twins and 
seem to be greatly influenced by a genetic component (Brans et al., 2008).  
 
The evidence on structural brain changes in relatives of bipolar has been less 
extensively reported. Both bipolar patients and their first-degree relatives 
share a reduction in the anterior thalamic gray matter when compared to 
healthy colunteers (McIntosh et al., 2004). Other studies have shown 
reduction in pituitary volumes in bipolar patients and in their relatives when 
compared to healthy controls (Mondelli et al., 2008). However, in a study by 
McDonald et al (2006) relatives of patients with bipolar disorder showed no 
morphometric differences in comparison to healthy controls.  
 
A study by McDonald et al., (2004) on structural brain endophenotypes and 
measures of genetic liability in families of patients with schizophrenia or 
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bipolar disorder, evaluated the genetic risks for brain volumes. The authors 
described a genetic risk for schizophrenia associated with bilateral fronto-
striato-thalamic and left lateral temporal regions, while for bipolar disorder the 
risk was specifically associated with gray matter deficits in the right anterior 
cingulate gyrus and ventral striatum. White matter volume reduction in the left 
frontal and temporoparietal regions was present in both diseases and 
therefore, regarded as a generic endophenotypes. 
 
All these findings suggest a genetic risk for psychosis is strongly related to 
brain structural alterations. 
 
1.11 Brain volumes as endophenotypes in psychosis 
Given the brain volume heritability in healthy people, its changes in the 
psychotic disease, and its reduction in unaffected relatives of patients with 
schizophrenia likely to be gene carriers, such as first-degree relatives or co-
twins (Glahn et al., 2007), brain volume measures have become an appealing 
endophenotype in the study of psychosis. As reviewed earlier, structural MRI 
studies have proposed several brain structure variations that could be used as 
endophenotypes for psychosis. These have included for example, reductions 
in the whole brain and grey matter volumes, enlargement of cerebral 
ventricles and reduction of hippocampal volume (Prasad and Keshavan, 
2008).  
 
Despite strong evidence for brain volume changes in psychosis, there is still a 
poor understanding of the meaning and role of these findings in the 
development of psychosis. Although endophenotypes are a promising starting 
point, there are still difficulties in linking these abnormalities to the illness 
behavior. This difficulty lies in a number of factors, such as the heterogeneity 
of the clinical presentation of psychosis, the different methodologies used to 
assess different phenotypes, and the argument that psychosis is an illness 
with common genetic variants such as ZNF804A and CACNA1C (O‘Donnovan 
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et al., 2009), each of weak effect as assessed in genome-wide association 
studies, in schizophrenia (O‘Donovan et al., 2008) and bipolar disorder (Sklar 
et al., 2008; Ferreria et al., 2008). One additional major limitation lies in the 
power needed to detect subtle differences for each of these phenotypic or 
genetic variants.  
 
Therefore, despite evidence from neuroimaging studies in psychosis, the 
question of finding biological markers that distinguish schizophrenia from 
bipolar disorder and healthy controls remains unanswered. Recently, more 
effort has been put in strategies that combine neuroimaging data acquired in 
different centers to address this pitfall and to increase the statistical power 
required for association studies. This approach will be described in the 
sections below. 
 
1.12 Multicentre neuroimaging studies  
Despite advances in MRI technology, there is still little understanding of the 
role of genes in brain volume. The main argument to explain this has been the 
small sample size and the lack of statistical power necessary to show a 
relationship, if one exists, between brain changes and genes. One obvious 
way to increase the statistical power of neuroimaging and genetic studies is to 
increase the sample size. While it is not difficult to pull data from different 
studies for genetic analysis, neuroimaging measures are more susceptible to 
variability in scanner properties and parameters settings during acquisition 
stages. In any neuroimaging study acquisition errors may occur by both 
technical issues such as spatial inhomogeneities (non-uniformity of the main 
magnetic field that can affect intensities and therefore tissue segmentation) or 
introduced by participants (different subjects position in the scanner). Some of 
these issues can affect the intensity of the single voxel, and hence affect the 
segmentation process for brain volume measurements. Some of these errors 
can be corrected for example by calibrating the scanner, or by following a 
particular protocol when positioning patients in the scanners. Even when 
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these precautions are taken, most sources of variability cannot be completely 
eliminated (Jovicich et al 2006). Nevertheless, many studies looked at the 
validity and reliability of using multi-centre neuroimaging data. There is 
evidence that the validity of combining neuroimaging data can be measured in 
a phantom (an artificial object of known dimensions and properties that is 
used to test or monitor an MRI systems homogeneity, imaging performance 
and orientation aspects). However, the introduction of humans into the 
scanner adds a ―dynamic‖ variable (due to internal fluid movements and 
human movements) creating more image distortions than phantoms which 
needs to be assessed by test-retest and possibly corrected (Jovicich et al 
2006). Therefore, the reliability of multi-centre neuroimaging data needs to be 
measured in repeated measurements in a phantom and in humans (Tofts et al 
1998, VanHaren et al 2003, Jovicich et al 2006). Moreover, studies that use a 
small number of healthy volunteers repeatedly scanned on different scanners 
or after upgrades are also recommended to test reliability (Tofts, 1998; Han et 
al., 2006; Jovicich et al., 2006). These studies have assessed the reliability of 
multi-scanner data and given a solid base to understand the methods to 
reliably and accurately measure brain volumes when combining neuroimaging 
in muti-center studies. 
 
In recent years, Voxel Based Morphometry (VBM) has become the leading 
method for analyzing large neuroimaging datasets. This method has the 
advantage of being almost fully automated, hence reducing the bias 
introduced by researcher variability (Ashburner and Friston 2000; 2005). On 
the other hand, to reliably apply this method, researchers still need to obtain 
good quality images that need to be successfully aligned in the initial step of 
this analysis method. In addition, the method is sensitive to differences in MRI 
scanners (Moorhead et al 2009).These can be corrected by using scanner 
specific priors (template images added in the neuroimaging pipeline to 
increase segmentation accuracy), but these do not solve the problems related 
to between-scanner differences in image characteristics and quality 
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(Ashburner and Friston 2000; 2005, Moorhead et al 2009). Therefore, when 
using VBM approaches such as Statistical Parametric Mapping (SPM) 
(Ashburner and Friston 2005), one of the most commonly used semi-
automated methods for the analysis of brain structure based on VBM method, 
it is recommended that images should be obtained from the same scanner, so 
that variability in image quality is reduced.  
 
There are only a handful of studies that have combined multiple neuroimaging 
datasets from patient samples. Most of them have looked at the reliability of 
combining neuroimaging data obtained from different scanners. However, 
they have all used different methods to process the neuroimaging and obtain 
brain volumes. One study looking at grey matter reductions in a cohort of 
patients with Alzheimer‘s disease using support vector machine (SVM) is an 
example of a supervised multivariate classification method (Vapnik, 1998; 
Bishop, 2006). The SVM method is highly dependant on spatial normalization 
pre-processing and therefore; the authors found that automated VBM 
methods can actually help overcome the errors introduced by the variability 
established when preprocessing a large neuroimaging sample from multiple 
scans (Kloppel et al 2008). However, it is important to mention that 
Alzheimer‘s disease tends to have more homogenous clinical populations 
than psychotic disorders.  
 
In psychosis, a multi-centre study by Van Haren and colleagues (2003) 
evaluated brain volumes as predictors of outcome in a fist episode of 
psychosis. In order to assess the validity and reliability of the findings five 
healthy volunteers and a phantom were scanned at the three sites. They used 
a fully automatic methods based in histogram analysis (Schnack et al., 2001a 
and Schnack et al., 2004) followed by mathematical corrections depending on 
a calibration factor. The calibration factor is a constant for a fixed acquisition 
protocol, but which can differ for different protocols on different scanners. The 
authors found over and underestimations on grey and white matter separation 
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between scanners. However, by applying a linear scaling procedure on the 
histogram improved comparability between volume measurements of 
neuroimaging from the different scanners. In conclusion, this study also 
emphasizes the need of carrying out a calibration to ensure the test reliability 
on multicentre studies.  
More recently a case control study conducted by Meda et al (2008) evaluated 
brain volume differences using VBM in SPM2. The brain scans were collected 
at four different sites. Therefore, to ensure reliability, authors created a study 
specific template. In this way, normalization of grey matter segments to a 
study-specific template ensures to better reflect grey matter distribution found 
within the study as it accounts for example any data inhomogeneities due to 
scanner differences. In addition, this approach ensures a minimal warping is 
required for coregistration as described in the optimized VBM method 
described by Good et al (2001). Moreover, scanner differences were tested by 
accessing a main effect of site to look at any grey matter differences that 
existed across scanners and using conjunction analysis to verify homogeneity 
of grey matter differences across sites. With this method, the authors 
replicated previous studies findings of decreased frontal, parietal, temporal 
grey matter volumes in schizophrenia. In addition, by increasing the sample 
size (400 participants) and therefore the statistical power to detect differences 
they also found reduced grey matter volume in areas such as the superior 
parietal lobule, caudate, rectal gyrus, and transverse temporal gyrus. 
However, they did not report whole grey, white or whole brain matter volume 
evaluation in this study.  Their results suggest that VBM analyses of brain 
volume in psychosis can be improved by using larger samples. 
 
In conclusion, despite the variety of neuroimaging processing methods, all the 
studies regarded the MRI multi-centre scan approach as a valid strategy to 
increase the power for neuroimaging studies in psychotic populations. To my 
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knowledge, there is no multicentre MRI study that has been conducted in 
bipolar disorder or in bipolar disorder and schizophrenia together using VBM.  
 
1.13 Psychosis and genetics 
Both schizophrenia and bipolar disorders have been reported to run in families 
by Kraepealin since the beginning of the 20th Century. Family, twin and 
adoption studies have addressed (described below) the familial segregation of 
schizophrenia and attempted to estimate the proportion of variance in 
vulnerability attributed to genetic and environmental factors. Heritability 
estimates for both disorders, schizophrenia and bipolar disorders, approach 
80%. Therefore, large efforts have been put to identify the specific genes 
involved. During the last few years, advances in genetic technologies (e.g. 
dense genome-wide SNPs platforms and next generation sequencing), have 
enabled the parallel genotyping and sequencing of large number of individuals 
at a rate that was previously unconceivable. These advances have allowed 
the hypothesis-free search of genetic factors mediating vulnerability to 
psychosis by performing genome-wide association studies in large cases-
controls samples including thousands of participants collected via international 
consortia.  . 
 
In this section I will describe the different genetic approaches that have been 
used to investigate the genetic influence in psychosis. Some studies have 
been based on the gene-environment interaction model, in which those 
psychotic illnesses are considered consequence of the combination of 
environmental and genetic factors. In order to explore the genetic influence in 
this interaction, genetic epidemiology has tried to answer main four questions 
as introduced by Faraone and Tsuang: 
 
1- Is psychosis heritable? 
2- What are the relative contributions of genes and environment? 
3- What is the mode of transmission? 
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4- Which are the specific genes involved? 
 
The first and second questions have been addressed by twin, family and 
adoption studies. Family studies have estimated the familiality of 
schizophrenia to be between 41% and 87% (Cardno et al, 1999; Kendler et al, 
1983) while for bipolar disorder to be between 73% and 87% (Cardno et al, 
1999; Kendler et al, 1995, McGuffin et al, 2003). Interestingly, there is also 
seem to be a cross-over, so that having a relative with schizophrenia 
increases the risk of developing bipolar disorder (Kendler et al, 1993a,b,c; 
Maier et al., 1993, 2002).   
 
1.13.1 Family studies 
These studies investigate the risk of developing the disorder of interest in 
relatives of patients as compared to the general population. However, the 
family study design is unable to disentangle genetic factors from 
environmental risk factors that are shared by members of the same family. 
Gottersman et al. (1991) showed that relatives of patients with schizophrenia 
have an increase risk of developing the illness. Moreover, the closer the 
relative the higher the risk is. In bipolar disorder, the risk of developing the 
disorder in the first degree relatives has been reported to be ten times higher 
in comparison to the general population. This evidence has found support in 
The Irish Roscommon Family Study. This study has shown that probands of 
several schizophrenia spectrum disorders and bipolar disorder segregate in 
families when compared with healthy controls and their relatives (Kendler et 
al, 1993a,b,c).  Moreover, these findings have been recently replicated in a 
large Swedish study. In this study, it was reported that first degree relatives of 
patients with schizophrenia have a ninefold increased risk in comparison to 
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1.13.2 Twin studies 
Twin studies have addressed the difficult question of how much is the 
contribution of either genetic or environmental factors in the development of 
psychotic disorders. Broadly speaking twin study models have been 
developed in order to explained genetic influence in the development of 
psychosis. In this way, if the disorder is driven by genetic factors the 
concordance rate in monozygotic twins should be higher than in dizygotic 
twins. These studies are designed on the rational that monozygotic twins 
should share 100% of their genes while dizygotic twins share approximately 
50%. These give an estimated 2:1 ratio of genetic likeness to calculate the 
proportion of genetic risk of a given trait. Additionally, co-twins tend to share 
the same birth and nurture environment. The concordance rate of 
monozygotic twins is used to estimate the contribution of environmental 
factors, as they share the same genetic loading; while the difference between 
dizygotic twins is used to estimate the heritability as well as the environmental 
factors. In this way, if the familiar clustering is solely genetic, the concordance 
in the development of psychotic disorders should be near 100% in 
monozygotic twins. However, there are factors such as different genetic 
penetrance that affect the proportion of individuals who express a specific 
phenotype and environmental factors that also shape gene expression. All 
these additional factors that have an impact of gene expression make the 
assessment of genetic influence in psychosis very challenging. The 
concordance rate of monozygotic twins has been described in the range of 40 
to 50% (Cardno and Gottesman, 2000; Sullivan et al., 2003).  
 
Many studies have looked at the heritability of psychosis. In the Finnish 
national twin cohort study, described that the genetic factors that accounted 
for the disorder was 83% while the shared environmental factors were 
responsible for the remaining 17% (Cannon et al., 1998b) Similar results were 
found in the review of European twin studies by Cardno and Gottesman 
(Cardno and Gottesman, 2000). Interestingly, similar results were shown with 
the based on the Maudsley Twin Register with twins with schizophrenia 
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heritability of 83% and bipolar disorder heritability between 82% and 85% 
(Cardno et al., 1999). A recent meta-analysis by Sullivan and colleagues 
(2003) described the heritability of schizophrenia as 81%. Moreover, offspring 
of unaffected monozygotic co-twins carry the same risk of developing 
schizophrenia as the offspring of the affected co-twin (Gottesman and 
Bertelsen, 1989; Kringlen and Cramer, 1989). The heritability for bipolar 
disorder has been less often reported. However, it is estimated to be around 
85% (McGuffin et al., 2003). These studies concur in suggesting that the 
genetic factors play a mayor role in the development of schizophrenia and 
affective psychosis. 
 
1.13.3 Adoption studies 
The aim of these studies is to assess the differences in risk between adoptive 
and biological relatives. There are mainly two methodological designs that are 
used to disentangle the effect of sharing the genetic predisposition and the 
nurturing environment.  
a) The adoptees family method, which looks at the risk of developing the 
disorder in the adoptee individual. The most influential study has been the 
Danish Adoption Study (Kety et al., 1994). This study found that the risk of 
schizophrenia spectrum disorder was higher in the biological relatives of 
adoptees, who shared part of the genetic background but not the family 
environment, than in the relatives of control adoptees.  
b) The adoptees method, in which the parent with schizophrenia is the 
proband. With this approach, The Finnish Adoptive Study of Schizophrenia re-
examination of earlier work by Tienari et al., (1994) reported a 5.3% relative 
risk of schizophrenia in adoptees who had biological mothers with the illness 
(defined as high risk). In the low risk adoptees (defined as those whose 
biological mothers had either a non-schizophrenia-spectrum diagnosis or no 
lifetime psychiatric diagnosis) the relative risk was described at 1.7%. 
However, when comparing the risk with that of a broadly defined 
schizophrenia spectrum disorder in the mothers, the relative risk increased to 
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22.4% compared to those with low risk with 4.3% of morbid risk. In this study, 
there was not difference when comparing affective psychosis (Tienari et al., 
2003).  
 
In summary, adoption studies, using either of these approaches, provide 
evidence for the importance of genetic factors in the development of psychotic 
disorders.  
 
1.13.4 Mode of transmission 
Although its mode of transmission is still unknown, psychosis appears to be a 
complex multifactorial disorder related to a number of environmental factors 
and/or genes, which interact or co-act in causing the illness (Sullivan et al, 
2003). This third question has been explored by segregation analysis. This is 
a preliminary method in genetic epidemiology to determine whether there is 
evidence that a major gene underlies the distribution of a given phenotypic 
trait. This analysis provides initial evidence whether a single gene has a major 
effect on a particular phenotypic trait only based on phenotypic information. 
Although these studies can show that a particular phenotype is related to the 
illness, they can not definitively prove that the trait is under the control of a 
single gene. The advantage of segregation analysis is to establish an 
association between a gene and trait which gives support to further 
investigate more in-depth studies such as linkage analysis.  
 
It is now well establish that mode the of transmission of psychosis follows a 
multifactorial polygenic model (Gottesman and Shields, 1982) in which there 
is a large number of genes with small effect that in combination with 
environmental factors cause psychotic illnesses. The polygenetic component 
might explain the heterogeneity and overlap of symptoms we often encounter 
in clinical practice. 
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 As discussed above, there is also increasing evidence that both 
schizophrenia and bipolar disorder co-segregate in families (Van Snellenberg 
2009, Lichtenstein 2009) and share susceptibility genes (Craddock, 
O‘Donnovan and Owen, 2005a, 2006; 2009; Moskvina et al., 2009; Schulze et 
al., 2012)..  
 
Finally the fourth question is investigated by linkage and association genetic 
studies 
 
1.13.5 Molecular genetic analysis  
1.13.5.1 Linkage studies 
Linkage studies are based on the theory that families affected with multiple 
affected individuals will show areas of the chromosomes that are affected. 
These studies serve as a base for exploring candidate genes in the region of 
the linkage signal and carry out association studies on alleles in the candidate 
genes There are a number of susceptibility loci that have been described as 
shared by schizophrenia and bipolar disorder including 13q32, 18p11 and 
22q11-13 (Badner and Gershon, 2002; Levinson, 2003; Lewis et al; 2003). 
Chromosome 8 has been of great interest in the study of schizophrenia with a 
number of studies finding 8p23.1 and 8p21.3 to be in linkage disequilibrium 
(Blouin et al., 1998; Garver et al., 2001; Gurling et al., 2001; Suarez et al., 
2006 Walss-Bass et al., 2006). More recently the advance for linkage studies 
is that it can be done in larger scale by genome wide linkage studies. A study 
carried out in 409 European and American ancestry families found showed 
evidence of possible linkage for schizophrenia in 8p23.3-p21.2 and 11p13.1-
q14.1 in both populations and 4p16.1-p15.32 in the American ancestry 
population and 5p14.3-q11.2 European one (Suarez et al., 2006). As per 
bipolar disorders, chromosome 16p and 20 regions have been described to be 
implicated in the disease (Ross et al., 2008; Byelrley at al., 2011). In recent 
reviews, chromosomes 6q, 8q, 12q, 13q, 16p, 18p, 18q, and 22q have been 
also described in European families (Craddock et al., 2005a; Serretti and 
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Mandelli, 2008). Moreover, current data suggest strong association of the 
3p21.1 locus and bipolar disorders (Vassos et al., 2012)  
 
1.13.5.2 Association analysis of candidate genes 
These studies evaluate the differences in allele frequencies between cases 
and controls at specific loci that are believed to be implicated in the aetio-
pathogenesis of the disorders by previous knowledge. The hypothesis is that if 
the studied allele is involved in causing the disease, it should be 
overrepresented in cases. In this way, a specific gene and allele can be 
hypothesized to play a potential causal role in the disease. Additionally, these 
studies are design based in a specific phenotype or illness marker. Knowing 
the phenotype and the putative function of the candidate gene that plays a 
role in the selected phenotype, the association is calculated. Therefore, this 
study design tends to be in theory more powerful than linkage studies to 
detect differences as they based on a priori evidence of potential 
endophenotypes.  
 
The selection of a specific endophenotype has proven difficult in psychosis 
due to the poor understanding of its ethiopathogenesis. However, association 
studies have focused to evaluate candidate genes either because they have 
implication in neurocircuits implicated in the disease (dopamine, serotonin, 
glutamate, and acetylcholine) or genes that are located in the previously 
identified areas of chromosomes by linkage studies.  
 
In my study I included well established candidate genes as well as novel ones 
that could be implicated in brain volumes and psychosis. Some of the putative 
susceptibility genes identified for psychosis are thought to cause subtle 
structural variations in the brains of affected individuals, and might also 
influence brain structure in normal subjects (McIntosh et al, 2006). During the 
last few years, there has been remarkable progress in identifying risk genes 
for psychosis (reviewed in Kirov, O`Donovan and Owen, 2005, Craddock et 
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al., 2009). These include neuregulin 1 (NRG1) (Stefansson et al 2002), which 
has been replicated in Scotland (Stefansson et al., 2003), China (Tang et al., 
2004) and other populations; dysbindin (DTNBP1) (Straub et al, 2002 and 
Kirov et al 2004); and disrupted in schizophrenia (DISC1) (Miller, KJ, et al, 
2000) as susceptibility genes. Other genes such as catecholamine-O-methyl 
transferase (COMT) (Egan et al., 2001; Prata et al., 2009; Wirgenes et al., 
2010); Oligodendrocyte Linage Transcription Factor 2 (Olig2) (Georgieva et 
al., 2006), Reelin (RELN) (Shifman et al., 2008; Liu et al., 2010), have also 
been associated with psychosis. In bipolar disorder, the consistency of 
candidate genes findings have been less as demonstrated in recent meta-
analysis by Seifuddin et al. (2012). 
 
Interestingly, although many of these genes were first identified as 
schizophrenia susceptibility genes, several studies have also shown an 
association with bipolar disorder, thus supporting suggestions that 
schizophrenia and bipolar disorder may share a common etiology (Bramon 
and Sham, 2001; Cardno et al., 2002; Murray et al., 2004; Craddock et al., 
2006, 2009; Maier, 2006). Indeed, this is also supported by evidence that both 
schizophrenia and bipolar disorder share common underlying brain variations 
in white matter volumes (McDonald C., et al 2004). This would suggest that 
some genes and brain variations may be common to all psychotic disorders. It 
is therefore important to include all type of psychosis while investigating 
genetic influence on these illnesses.  
 
1.13.5.3 Genomewide association 
More recently, Genome Wide Association Studies (GWAS) have used a 
different approach. In candidate gene studies the loci of interest are chosen a 
priori, in contrast in GWAS the entire genome is interrogated in a hypothesis-
free fashion by using panel of genetic markers that cover the entire genome. 
In this way GWAS enable the genome-wide study of the impact of common 
variants as defined for Minor Allele Frequency present by more than 5% 
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(MAF>5%). GWAS performed so far cannot explore the effect of rare variants 
(MAF<5%) that are not represented in the GWAS platform (Hardy et al., 
2009).  
 
In GWAS studies, this allele frequency of the genome-wide markers is 
compared between cases and controls. Genome-wide SNPs array commonly 
used include up to 1 millon SNPs. Additionally, GWAS focus on associations 
between single-nucleotide polymorphisms (SNPs) plus those proxy SNPs or 
markers in linkage disequilibrium (non-random associations of SNPs) and 
traits of illnesses such as psychosis in a systematic and more unbiased way. 
As in the candidate gene studies approach, if the allelic variant is more 
frequent in people with the illness, that specific allele is considered 
"associated" with the illness. The strength or effect size of the association is 
usually measured with Odds Ratio (OR) for ―discrete trait‖ such as diagnosis 
or as proportion of variance explained for ―quantitative trait‖ such as brain 
volume. Therefore, the identified SNPs are considered to mark a region of the 
human genome that increases the risk for the illness (Pearson and Manolio, 
2008). 
 
The advantages of the GWAS over candidate gene association studies lies in 
the possibility of looking at the entire genome at once rather than testing only 
one or few genetic regions. In addition, the quality control that these studies 
undergo is much more restrictive than candidate gene approach. For example 
population stratification can be adjusted using information from the genetic 
markers that enable the fine estimation of ethnic stratification. In this way, 
ancestral genetic heterogeneity can be better controlled for. However, GWAS 
approach brings the disadvantages of multiple testing with the risk of finding 
an association just by chance. For this reason the statistical threshold of 
significance is established at 5X10-8 and very large samples are needed to 
achieve enough statistical power (Hirschhorn and Daly 2005). Moreover, 
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given the need of such large samples, replication of findings is more difficult to 
obtain (Pearson and Manolio, 2008). 
 
Therefore, larger samples achieved by international collaboration and more 
strict significant thresholds have been proposed by the Wellcome Trust Case 
Control Consortium to overcome these problems (WTCCC, Nature 2007).  
Although GWAS approach is not driven by a specific candidate gene, once 
the polymorphism is identified, it leads to studies to specify which genes are 
causal. Some previous GWAS studies looking at associations in psychosis 
had not consistently identified a genetic marker for these illnesses (WTCCC, 
2007; Sullivan et al., 2008; O‘Donovan et al., 2008; International 
Schizophrenia Consortium, 2009; Baum et al., 2008).  
 
More recently, meta-analyses of Genome-wide association studies (GWAS) 
have shown the advantage of combining the results of independent studies to 
obtain a pooled effect estimate). Once a genome-wide association signals is 
performed the region is sequenced to identify the ―causal‖ variant/variants and 
association is tested in the population. The meta-analysis carried out by Shi et 
al., found a significant association with schizophrenia in a region of linkage 
disequilibrium on chromosome 6p22.1 which includes genes related to 
immune system and chromatin modification gene (Shi et al., 2009). 
Additionally, other associations with genome-wide significance have been 
found with neurogranin (NRGN) that encodes a protein involved with the 
function of N-methyl-d-aspartate receptor (NMDA) and transcription factor 4 
(TCF4) involved in brain development (Stefansson et al., 2009). It is worth 
mentioning that Stefansson et al. significant results are based on a 
combination of 3 European GWAS. Meta-analysis of GWAS in bipolar 
disorders have consistently reported association of the illness and 
chromosomal region 3q21 (Scott et al., 2009; McMahon et al., 2010; Vassos 
et al., 2012) 
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1.14 The issue of power analysis in genetic studies 
The power of a statistical test represents the possibility  that the study will be 
successful in detecting a true effect and is dependent on a number of factors, 
including the magnitude of the effect, the sample size and study design, and 
the specified false-positive rate. Power analysis is appropriate when the 
concern is with the correct rejection, or not, of a null hypothesis. In this way, if 
the study is well powered, a statistically significant result would correctly reject 
the null hypothesis (i.e. no differences between the comparison groups). 
Therefore, power calculations are usually carried out during the planning 
stages of a study, most typically in determining the sample size required.  
There are mainly four parameters that affect the statistical significance of a 
test:   
1- the effect size 
2- the sample size (N) 
3- the alpha significance criterion (α) 
4- statistical power, or the chosen or implied beta (β) 
 
Traditionally, for many small-scale studies (small N), investigators have, by 
convention, adopted values such as α = 0.05 and β = 0.20 (80% power) as 
representing a realistic and adequate trade-off. However, for larger studies 
(lager N), and more specifically in genetic analysis, the issue is less about 
determining a difference between samples but rather with the estimate of the 
effect size. The effect size is an estimated measurement of the strength of the 
relationship between variables in a sample. Although the effect size cannot 
make any claim about whether the apparent relationship in this particular 
sample reflects a true relationship in the population, the larger the effect size, 
the more likely that it is a more accurate representation of the population. 
 
In order to increase the statistical significance of a test, the sample size can be 
clearly increased adding more subjects to the sample while  the effect size can 
also be increased; for example, by reducing the measurement error with more 
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accurate phenotyping, or through genotyping a region of interest more 
densely.  
With the increasing advantages in genetics technology, today‘s genetic studies 
carry the possibility of looking at the multiple genome SNPs at once rather 
than testing only one or few genetic regions. However, any statistical analysis 
involving multiple hypotheses carries the risk of the type I error (false positive) 
if appropriate measures are not taken. Therefore, measures such as applying 
a higher threshold of stringency to reject a hypothesis in order to compensate 
for the multiple comparisons being made (e.g. as in the Bonferroni method) 
should be used. In this situation, the power analysis should reflect the multiple 
testing approaches to be used. For this reason the statistical threshold of 
significance is established at 5X10-8 and very large samples are needed to 
achieve enough statistical power (Hirschhorn and Daly 2005) in genetic 
analysis.  
 
1.15 Genes under unvestigation 
As described so far in this chapter, there is the vast evidence of plausible 
genetic influence in brain abnormalities described in psychosis as well as 
genetic association between genes and psychotic illness. Therefore, in order 
to evaluate these factors in my thesis, I have carried out a literature review of 
candidate genes for brain volumes in psychosis to be tested. The selection 
process for the candidate genes is explained in chapter 2: Methods. In the 
next section I will describe the relevant genes that I have included in my 
thesis. 
 
1.15.1 SBNO1 and Hight Mobility Group AT hook-2 (HMGA2) 
The latest GWAS studies have described new common variants that regulate 
brain size (Taal et al., 2012; Stain et al., 2012; Ikram et al., 2012) in healthy 
population. These reports came from two multinational consortia: Cohorts for 
Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium 
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and Enhancing Neuro Imaging Genetics Through Meta-Analysis (ENIGMA). 
Each consortium investigated its participants‘ genomes for single nucleotide 
polymorphisms (SNPs) associating with brain measures on magnetic 
resonance imaging (MRI) scans. For validation they then sent their top hits to 
the other consortium, and additional researchers. Although there were no 
SNPs associated with total brain volume a number of gene variants were 
associated with hippocampal size or intracranial volume (this was measures 
total space within the skull, regardless of brain size). These new findings offer 
an opportunity to explore these variances in relation to putative 
endophenotypes such as hypocampus and brain volumes in psychiatric 
diseases such as psychosis. SBNO1 showed an effect on brain growth in 
early life (Taal et al., 2012) while HMGA2 gene, that encodes for protein that 
during development regulates stem cell renewal (Nishino et al., 2008), was 
associated with development of intracranial volumes in adults (Stein et al., 
2012). These findings give a solid base for further investigations on the 
genetic effects on neurodevelopment in early and later life of psychiatric 
illnesses like psychosis. I have evaluated these genes in my thesis. To my 
knowledge, in my thesis is the first time that SBNO1 and HMGA2 genes are 
assessed in a sample of patients with psychosis.  
 
1.15.2 Catechol-O-Methyl Transferase ( COMT) 
The gene for catechol-O-methyl transferase (COMT) codes for the enzyme 
catechol-O-methyl transferase involved in the synthesis and degradation of 
catecholamines. It is functionally polymorphic, with a variable amino acid, 
Val158Met. Some studies of the COMT gene have tested for association with 
the low activity (Met) allele (Akil et al 2003; Bray et al 2003) and psychiatric 
disorders (Shifman et al 2004; Hoth et al., 2006). Evidence suggests that the 
high activity (Val) allele, through increased catabolism of dopamine in the 
prefrontal cortex, may slightly increase the risk for schizophrenia and may 
explain some of the differences observed differences in cognitive performance 
and prefrontal cortical functioning between cases and controls (Egan et al., 
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2001). Two previous meta-analyses testing for association between COMT 
and schizophrenia have provided contradictory results. One study showed 
association only in cases of European descent (Glatt et al., 2003). However, 
Fan et al (2005) meta-analysis did not confirm either association or the 
presence of ethnic differences (Fan et al., 2005).  A large-scale European 
study involving patients with schizophrenia and controls and relatives tested 
positive markers and haplotypes identified in studies, but they found no 
significant association despite generous power (Williams et al., 2005). A study 
by Ohnishi and colleagues (2006) has shown that individuals homozygous for 
the Val-COMT allele have significant reduction of volumes in the left anterior 
cingulate cortex (ACC) and the right middle temporal gyrus (MTG) compared 
to Met-COMT carriers. In addition, significant genotype-diagnosis interaction 
effects on brain morphology were noted in the left ACC, the left 
parahippocampal gyrus and the left amygdala-uncus. Interestingly, genotype 
effect on brain morphology was not significant in the control group. 
Schizophrenics homozygous for the Val-COMT showed a significant reduction 
of volumes in the bilateral ACC, left amygdala-uncus, right MTG and left 
thalamus compared to Met-COMT schizophrenics. These findings suggest 
that the Val158Met polymorphism of the COMT gene might contribute to 
morphological abnormalities in schizophrenia (Ohnishi T. et al, 2006).  
 
1.15.3 Brain-derived neurotophic factor (BDNF) and BDNF receptor 
neurotrophic tyrosine kinase receptor type 2 (NTRK2) 
The BDNF/NTRK2 signaling pathway plays a critical role in regulating the 
survival and differentiation of neuronal populations. Moreover, this complex is 
also implicated during synaptic transmission (Huang and Reichardt, 2001) and 
neuroplasticity (Lu, 2003). BDNF is a trophic protein involved in 
neurodevelopment and also in modulating activity-dependent synaptic 
plasticity among mature neurons arborization (Binder and Scharfman, 2004; 
Angelucci et al., 2005). Furthermore, it decreases dendritic growth, particularly 
in the hippocampus and neocortex (Gorski et al.,2003; Lu et al.,2003). The 
Genetic influence in brain volumes in psychosis                                        PhD Ana Miorelli 
55 
 
single nucleotide polymorphism (rs6265), valine (Val) to methionine (Met) 
substitution at codon 66 in the proBDNF protein produces, inefficient BDNF 
trafficking, reduced activity-dependent BDNF release, and poorer 
hippocampus-mediated memory (Egan et al.,2003; Dempster et al.,2005; Tan 
et al.,2005). Additionally, the BDNF-Met variant has been associated in 
healthy volunteers with a decrease in volume of hippocampal and frontal lobe 
(Pezawas et al., 2004; Bueller et al., 2006). There are some theories that 
have been put forward to explain in which ways BDNF-Met variant may 
decrease gray matter volumes. For example, it has been suggested that in a 
relatively BDNF-deficient environment during embryogenesis, fewer neurons 
survive, and surviving neurons have smaller soma size diminishing dendritic 
growth (Gorski et al.,2003). These findings suggest the need of BDNF for their 
normal development. Another theory is that the functional complex of the 
BDNF-Met variant and its receptor (NTRK2) might influence gray matter 
volumes beyond neurodevelopment through modulating neuroplasticity in 
mature neurons (Xu et al, 2000). In psychosis studies, there is evidence for an 
increased risk for psychosis with the Val-Met (66) polymorphism (Neves-
Pereira et al., 2002, 2005; Rosa et al., 2006). Moreover, in schizophrenia, 
previous cross-sectional MRI studies have found that Met allele carriers with 
schizophrenia showed smaller brain volume in areas such as the frontal and 
temporal gray matter (Ho et al., 2006), hippocampus (Szeszko et al., 2005) 
and temporal grey matter (Ho et al., 2006).  
 
1.15.4 Neuregulin (NRG1) 
NRG1 is part of the neuregulin family of factors involved in growth and in 
neural migration and axon guidance (Mei and Xiong, 2008). Therefore, NRG1 
has become a strong candidate gene when looking for genetic and 
endohenotype associations in psychosis.  Furthermore, studies in childhood 
onset schizophrenia have described a crucial role of NRG1 SNP8NRG221533 
in the grey and white matter volume changes observed in carriers of the risk 
allele as well as for other NRG1 SNPs (Addington et al., 2007). This evidence 
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further supports the role of NRG1 as one of the candidates for the 
neurodevelopmental theory of psychosis.  
 
Some candidate genes are argued to regulate proliferation, migration and 
differentiation during the neurodevelopmental process including Neuregulin 
(NRG1) maps in chromosome 8q12. Neuregulin was firstly described in a 
genome-wide linkage scan of Icelandic families (Stefansson et al., 2002). The 
risk haplotypes are described as sharing a ―common core haplotype‖ 
(HapICE). This consists of five SNPs (SNP8NRG221132, SNP8NRG221533, 
SNP8NRG241930, SNP8NRG243177 and SNP8NRG433E1006) and two 
microsatellites (478B14-848 and 420M9-1395). For NRG1, SNP8NRG243177 
T allele (Stefansson et al., 2002; Rousos et al., 2010) and SNP8NRG241930 
G allele (Stefansson et al., 2002) and in Iranian populations (Sheriati et al., 
2011) have been described as the risk alleles for schizophrenia. In both 
polymorphisms T allele has been shown to be the minor allele frequency.  
 
The HapICE association has been replicated in other populations such as 
Scottish (Stefansson et al., 2003), Irish/UK (Williams et al., 2003), Japanese 
(Iwata et al., 2004), Japanese individuals (Fukui et al., 2006) and Chinese 
(Tang et al., 2004; Li et al., 2004). However, other studies in Causcasian 
population (Thieselton et al.; 2004, Duan et al., 2005; Ingason et al., 2006; 
Rosa et al., 2007) have not replicated this association and no susceptibility 
variant has yet been identified. Replication studies looking at specific 
polymorphisms have not always been consistent with the original association 
studies. For instance, with SNP8NRG221533, Stefansson et al (2002) 
reported the A allele as the risk allele for schizophrenia. However, other 
studies have found the T allele to be the risk allele in adults samples (Bakker 
et al., 2004) as well as in childhood onset schizophrenia (Addington et al., 
2007). These inconsistencies might be related in ethnic heterogeneity 
(Gardner et al., 2006) and to the genetic heterogeneity of the psychotic 
disorders.  




SNP8NRG241930 G alleles and SNP8NRG243177 T allele has been found in 
association with other endophenotypes like slower prepulse inhibitions in 
patients with schizophrenia (Rousos et al., 2010). Additionally 
SNP8NRG243177 T allele has also been associated with brain deviations in 
healthy volunteers (McIntosh, et al., 2008; Barnes et al., 2012), in patients 
with psychosis (Mata et al., 2009) and abnormal function in functional 
neuroimagings in individuals at high risk for schizophrenia (Hall et al., 2006). 
These findings support the notion of a possible role for these polymorphisms 
in the structural brain changes associated with schizophrenia.   
 
1.15.5 Dysbindin (DTNBP1)  
DTNBP1, otherwise known as dysbindin, binds to α- and β-dystrobrevin in 
muscle and brain. It is present in muscles and axon terminals in the 
cerebellum and hippocampus of the adult mouse brain (Benson et al., 2001). 
A plausible function in glutaminergic synapses has been described by Benson 
et al. (Benson et al., 2001). Glutamate 2/3 (mGlu2/3) receptor agonistic drug 
was the first drug developed not acting as a dopamine antagonist based on 
the glutamatergic hypothesis of schizophrenia (Patil et al., 2007; Chaki and 
Hikich, 2011). DTNBP1 mRNA is widespread in the brain. Reduced mRNA 
expression in dorsolateral prefrontal cortex has been described in patients 
with schizophrenia in comparison to healthy controls (Weickert et al., 2004). 
Moreover, this is also true for the hippocampal formation in patients with 
schizophrenia, who have been reported to show reduced protein expression in 
the brain (Weickert et al., 2008). Reduced DTNBP1 mRNA expression in 
cerebral cortex has also been associated with risk haplotypes for 
schizophrenia (Bray et al., 2005).   
 
Dysbindin was firstly described as associated with schizophrenia in linkage 
studies, which identified the 6p24-p22 as a region of high schizophrenia 
susceptibility (Moises et al., 1995; Straub et al., 1995; Wang et al., 1995). 
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Later investigations showed a genetic association for a susceptibility locus on 
chromosome 6p22.3 in Irish pedigrees with several single nucleotide 
polymorphisms (SNPs) (Straub et al., 2002). Associations with six of these 
polymorphisms were replicated in sib-pair and triad families (Schwab et al., 
2003). Association analysis of the 6p22.3 region has shown strong 
association with schizophrenia in Caucasian, Hispanic (Funke et al., 2004) 
and Chinese populations (Tang et al., 2003). However, there is conflicting 
evidence for an association with schizophrenia, with some studies failing to 
identify an association of the originally described DTNBP1 SNPs and 
schizophrenia (Li et al., 2005; Datta et al., 2007; Morris et al., 2003; Peters et 
al., 2008; Sanders et al., 2008). A meta-analysis identified a weak association 
of a DTNBP1 SNP with schizophrenia, which was not significant after multiple 
testing (Li et al., 2007).  Despite failing to replicate the original SNPs 
described in the Scottish population, Li et al. (2005) showed a significant 
association between DTNBP1 P1320 and P1757 and schizophrenia in the 
Chinese one. This provides support for DTNBP1 as a susceptibility gene for 
schizophrenia in the Chinese population, albeit with haplotypes different from 
those of the original study. 
 
Finally, in order to understand possible causal factors for the reported 
differences in brain volumes in psychosis, some studies have investigated 
genes involved in normal brain development such as Reelin (RELN), 
Microcephaline (MCPH, ASPM) and Oligodendrocyte lineage transcription 
factor 2 (OLIG2) in patients with psychosis. In this study, I have also explored 
the genetic influence of several neurodevelopmental genes that have been 
described as candidate gene to influence brain volume in patients with 
psychosis and in healthy populations.  
 
1.15.6 Microcephalin (MCPH) and (ASPM)  
Human brain volume is correlated with general intelligence, working memory, 
perceptual organization and processing speed (Postuma et al., 2003; 
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McDaniel 2005). Studies looking at possible genes modulating brain size have 
recently focused their attention on primary microcephaly. This condition is 
inherited as an autosomal recessive trait defined by no other significant 
neurological deficits than mild-to-moderate mental retardation. Subjects with 
primary microcephaly, show a well preserved gyral pattern, with no major 
abnormality in cortical architecture despite this marked reduction in size 
(Mochida and Walsh 2001; Bond et al., 2002). In situ hybridization 
demonstrates that microcephalin is expressed in particular around the lateral 
ventricles of the developing forebrain, suggesting that the gene has a role in 
regulating the size of the cerebral cortex (Jackson et al 2002).  
 
Jackson et al (1998) mapped the candidate region for the MCPH1 in 
chromosome 8p22. Subsequently, four more loci for primary microcephaly 
have been identified: MCPH2 on chromosome 19q13×1–13×2 (Roberts et al., 
1999) and MCPH3 on chromosome 9q34 (Moynihan et al 2000) mapped in 
families from the northern region of Pakistan; MCPH4 on chromosome 15q 
(Jamieson et al 1999) in families from Morocco; and MCPH5 on chromosome 
1q25–q32 mapped in families from Turkey (Jamieson et al., 2000) and Multan 
in Pakistan (Pattison et al., 2000). To date, there are four genes have been 
reported as responsible for primary microcephaly, these include microcephalin 
(MCPH1, MIM 607117), abnormal spindle-like microcephaly-associated 
(ASPM=MCPH5, MIM 605481), cyclin-dependent kinase 5 regulatory 
associated protein 2 (CDK5RAP2=MCPH3, MIM 608201) and centromere-
associated protein J (CENPJ=MCPH6, MIM 609279) (Bond et al., 2002, 2005; 
Jackson et al., 2002).  Of these, the ASPM=MCPH5 mutation has been 
described to account for about 43% of the total autonomic recessive primary 
microcephaly (Roberts et al., 1999; Bond et al., 2003).  
 
Studies looking at the influence of MCPH genes influence on brain volume 
outside primary microcephaly have shown contradictory results. While some 
have found positive associations of the homozygous males containing the 
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derived alleles of rs1057090 with larger cranial volumes in Chinese population 
(Wang et al 2008), others have not found an association between brain 
volume and MCPH and ASPM (Woods et al., 2006; Dobson et al., 2007).  
 
As in primary microcephaly, patients with schizophrenia show a well 
preserved gyral pattern, with no major abnormality in cortical architecture but 
a small reduction in brain size when compared to healthy controls (Wright et 
al., 2000). Additionally, general intelligence, working memory, perceptual 
organization and processing speed, shown to be affected in primary 
microcephaly have also been extensively reported in patients with psychosis 
(Kalkstein et al., 2010). Therefore, this gene has been studied in patients with 
schizophrenia, although so far with negative results (Rivero et al., 2006). 
Despite these initial negative results, genes linked to this condition can offer 
potential insights into the development and evolution of the cerebral cortex in 
patients with psychosis. 
 
1.15.7 Oligodendrocyte lineage transcription factor 2 (OLIG2) 
Oligodendrocyte lineage transcription factor 2 (OLIG2) maps to the 
chromosome 21q22.11. It is expressed throughout the brain during brain 
development and adulthood, and it is also involved in the formation of glial 
scar after brain injury (Ono et al 2009). The main function is that of a 
transcription factor that regulates the differentiation of motor neurones and 
oligodendrocytes (Ono et al 2009). Genes associated to myelination and 
oligodendrocyte functions have been associated with schizophrenia 
(Gerogieva et al 2006).  OLIG2 expression has been shown to be reduced in 
patients with schizophrenia (Gerogieva et al 2006; Mitkus et al., 2008). 
Particularly, the OLIG2 SNP rs10590004 allele A has been associated to 
schizophrenia (Gerogieva et al 2006), and seems to be associated with 
altered white matter integrity in healthy volunteers (Prata et al., 2012) and in 
patients with obsessive-compulsive disorder with psychotic symptoms 
(Stewart et al., 2007). Interestingly, other polymorphisms have been 
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associated with psychosis in patients with Alzheimer‘s disease (Sims et al. 
2009). So far, no study has investigated OLIG2 in affective psychoses.  
 
1.15.8 Reelin (RELN),  
RELN gene encodes the Reelin protein encoded. It was first described as the 
gene mutated in mice with an anomalous reeling gait (De Arcangelo et al., 
1996). Reelin is an extracellular matrix-associated glycoprotein expressed in 
the developing brain. It has been described to be involved in neuronal 
migration and synaptic plasticity, learning and memory (Beffert et al., 2005) 
and mostly present in GABAergic neurons (Pesold et al., 1998). Given its 
involvement in the brain development, it has been a gene of interest in relation 
to psychosis. Studies of postmortem brain tissues from patients with 
schizophrenia have shown a reduction of RELN mRNA and Reelin up to 50% 
(Impagnatiello et al., 1998, Eastwood et al., 2003 and 2006). Although 
reductions of RELN mRNA in brain tissue have been described in different 
regions of the brain using diverse techniques, they have been one of the most 
consistent molecular findings in RELN and psychosis (Knable et al., 2001). 
Nonetheless, a study evaluating RELN mRNA in brain tissue by Oviada and 
Shifman (2011) failed to replicate this reduction in schizophrenia samples. 
However, the authors described a significant reduction of the amount of the 
short RELN isoform in bipolar disorder patients. 
 
A genome-wide association study in schizophrenia in an Ashkenazi Jewish 
(AJ) population has revealed a sex-specific association between intronic 
single nucleotide polymorphism (SNP) in the reelin RELN gene and 
schizophrenia (Shifman et al., 2008). In addition, RELN SNP (rs7341475) was 
also shown to have a female-specific association (Shifman et al., 2008, Liu et 
al. 2010). Moreover, a meta-analysis evaluating four GWAS conducted in 
schizophrenia and the excluding sample described by Shifman et al (2008) 
confirmed the association with rs7341475 in women with schizophrenia with a 
calculated odds ratio of 1.11 (Ben-David et al., 2010). Despite the described 
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associations, when looking at intermediate phenotype such as measures of 
brain structure, brain function, and gene expression; some studies did not find 
a significant association with rs7341475 genotypes (Tost et al., 2010). 
However, other studies have reported association between working memory 
and other regions of RELN gene in patients with schizophrenia (Wedenoja et 
al., 2009). Interestingly, association of Reelin gene and patients with bipolar 
disorder has also been found (Fatemi et al., 2000; Guidotti et al., 2000). More 
recently, RELN SNP rs362719 was described to be associated with risk to 
bipolar disorder in women (Goes et al., 2010). These findings continue to 
support the hypothesis that RELN is implicated in the pathway of the 
development of psychosis. 
1.15.9 Corticotropin-Releasing Hormone Receptor 1 (CRHR1)  
CRHR1 has been associated in animal models with brain development in 
young mice (Hsuchou et al., 2010). Additionally, Corticotrophin-releasing 
factor (CRF) is a stress hormone that acts as a neuromodulator binding to 
CRHR1 in the hypothalamic-pituitary-adrenocortical (HPA) axis, playing an 
important role in the development of major depression (Arborelius et al., 1999; 
Hsu et al., 2012). Postmortem studies have shown decreased levels of 
CRHR1 mRNA in the frontal cortex in patients with major depression, 
suggesting that CRHR1 plays a role in the pathophysiology of the disorder 
(Nemeroff et al., 1988; Merali et al., 2004). In addition, it has been argued that 
corticotrophin-release hormone, released during stress, might change the 
synaptic spines stability leading to brain cortical malfunctioning and involved 
in the development of depression and psychoses (Bennett, 2008). A recent 
GWAS study described an association between CRHR1 and brain volume in 
healthy population (Ikram et al., 2012). These findings combined with previous 
reports in human studies describing elevated levels of CRF in the 
cerebrospinal fluid of patients with post-traumatic stress disorder with 
psychotic symptoms (Sautter et al., 2003) make CRHR1 gene a suitable 
candidate gene for brain volume changes in psychosis. 





Neuroimaging studies give a good insight into the neurodevelopmental theory 
of psychosis.  Structural MRI studies have consistently shown the presence of 
reductions of grey matter volumes and of ventricular enlargement in 
individuals with psychosis. Furthermore, longitudinal studies on early onset 
schizophrenia suggest the presence of an exaggeration of the normal cortical 
development in affected individuals. Finally, evidence that relatives of 
individuals with psychosis may share some of these brain alterations implies a 
role for an underlying genetic vulnerability to these alterations. These findings 
suggest that during the adolescent and early adulthood there may be a 
combination of factors such as genetic loading, brain maturation and 
environmental factors that take place and potentially underlie the onset of 
psychosis. In this study, I will investigate the relationship between genes that 
have been proposed as associated with neurodevelopment and psychosis, 
and their influence on global brain volume deviations. I will achieve this by 
comparing a large sample of patients with psychosis, their unaffected relatives 
and healthy controls. 
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Chapter 2: Aims and general methodology 
 
2.1 Aims of the thesis 
One of the difficulties with genetic and neuroimaging analyses is that large 
numbers of subjects are needed to test specific hypotheses.  
 
In this Thesis, I aimed to examine the role of recently identified susceptibility 
genes for psychosis and of genes involved in neurodevelopment in influencing 
brain volumes in subjects with psychosis, their relatives and in healthy 
controls. In order to achieve this, I have proceeded with two main steps: 
 
-First, I conducted a calibration study to explore whether MRI scans acquired 
with different neuroimaging protocols used in 3 different studies, the Aetiology 
and Ethnicity in Schizophrenia and Other Psychosis (AESOP) study, The 
Maudsley Family study and The Maudsley Twin study, could be combined to 
reliably estimate global brain volumes (grey matter, white matter, and whole 
brain volumes). These studies all acquired a three-dimensional Fourier-
transformed spoiled-gradient-recalled acquisition in the steady state (SPGR), 
with the same GE Sigma 1.5-T system (GE Medical Systems, Milwaukee), at 
the Maudsley Hospital. This first step was conducted in a sample of 12 
healthy individuals, each undergoing an MRI scan with the different protocols. 
 
-Second, I identified, gathered, genotyped where necessary (i.e if new 
samples were collected), and analyzed subjects in whom both DNA and MRI 
structural brain data were available from the above studies (AESOP, 
Maudsley Family study, Maudsley Twin study). Subjects included: individuals 
with psychosis, their relatives, and healthy individuals.  
  
2.2 Hypotheses to be tested 
I tested the following hypotheses: 
Genetic influence in brain volumes in psychosis                                        PhD Ana Miorelli 
65 
 
2.2.1 Brain volumes (MRI analysis): 
a. Smaller grey, white and total matter volumes would be present in 
subjects with psychoses compared to their relatives and to healthy controls;  
and  
b. These volume differences would be more marked in patients with 
schizophrenia than in bipolar patients in comparison to healthy volunteers;  
c.  The relatives of patients with psychosis will show volumetric brain 
changes intermediate between those of patients and healthy individuals;  
 
2.2.2 Genetic analysis: 
My analysis of the genetic data was restricted to the genes already genotyped 
for the three different studies. Among those, I chose to focus my attention in 
exploring genes that have been described as: 
 
- Candidate genes for psychosis such as: COMT, BDNF, NRG1 and 
DTNBP1. I predicted that carriers of COMT (rs4680 )-val allele, BDNF 
(rs6265)-Met allele and certain polymorphisms of NRG1 (SNP8NRG241930, 
SNP8NRG221533, rs6994992), DTNBP1 (rs1047631, rs875462), RELN 
(rs7341475) would be associated with smaller grey matter volume in the risk 
allele carriers 
 
- Genes that have been described to influence brain volume in normal 
populations but have not been explored in psychosis: I hypothesized that 
specific polymorphysms of MCPH (rs2305022, rs930557, rs1057090, 
rs2912016, rs3762271), SBNO1 (rs7980687), HMGA2 (rs1042725) and 
CRHR1 (rs11655470) would be associated with show smaller total brain 
volume in the risk allele carriers  
 
- Genes that have been described to influence white matter structure, 
such as OLIG2 (rs1059004), would be associated with smaller white matter 
volumes in the risk allele carriers  




2.3 Study samples 
Subjects included in this Thesis were recruited and evaluated as part of 3 
large studies that have been conducted within the Institute of Psychiatry, 
King‘s College London. These are: the Aetiology and Ethnicity in 
Schizophrenia and Other Psychosis (AESOP) study, The Maudsley Family 
study and The Maudsley Twin study. These were all approved by the London 
and Maudsley NHS Trust and Institute of Psychiatry Research Ethics 
Committee.  All subjects included in the studies gave their informed consent to 
participate. In the following sections I will describe the characteristics of each 
study in turn, and specify the respective inclusion and exclusion criteria. 
 
2.3.1 The Aetiology and Ethnicity in Schizophrenia and other Psychosis 
(AESOP) study 
The Aetiology and Ethnicity in Schizophrenia and other Psychosis (AESOP) 
study was an incidence study of functional psychosis carried out over a two-
year period, between 1st September 1997 and the 31st August 1999. A sample 
of first episode psychosis patients was recruited from secondary psychiatric 
in-patient and out-patient services of the South London and Maudsley NHS 
Trust, serving a large area of South London encompassing the boroughs of 
Lambeth, Southwark and Croydon. Cases were recruited from the at risk 
population that included all people between 16 and 64 years old, presenting to 
psychiatric services with first-in-lifetime functional psychosis.  
 
In addition, a sample of healthy individuals was recruited from the same 
catchment area. The sample of control subjects was selected randomly from 
the population, using the same sampling frame as that used by the Office of 
Population and Census Statistics (OPCS) Psychiatric Morbidity Survey, 
namely the postal address file (PAF) (Jenkins R. et al, 1995). This method 
was chosen to ensure comparability between cases and controls. With this 
approach, a random sample of ten target addresses was generated for each 
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case for which controls were recruited. Subjects selected were contacted 
three times (morning, afternoon, evening) to find an eligible control subject 
aged between 16 and 65 years willing to participate. This method broadly 
matched cases and controls by area of residence. 
 
Inclusion and exclusion criteria  
Patients with psychosis identified for the study were first screened for the 
presence of psychotic symptoms with the ―Screening Schedule for Psychosis‖ 
based on the Psychosis Screening Questionnaire (Appendix 1) (Bebbington 
and Nayani 1995). This questionnaire explores the presence of a broad range 
of psychotic experiences. Subjects positive for the questionnaire who gave 
written consent were assessed with a diagnostic tool, the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN 2.0) (WHO, 1992a). The 
SCAN is a tool designed to enable the formulation of psychiatric diagnosis 
(Janca at al, 1994). Using the data obtained with the SCAN, consensus 
diagnoses were agreed for all subjects. Those subjects who did not meet ICD-
10 (1992) criteria for a diagnosis of functional psychosis were excluded from 
the study. The cases identified were the entered into further assessments if 
they satisfied the following inclusion criteria: 
-Age 16-64 years 
-Resident within the area of the study 
-Absence of moderate or severe learning disability as defined by the ICD-10 
(WHO, 1992b) 
-Presence of a functional psychosis (ICD-10 F10-19, excluding coding F1x.0 
for acute intoxication; F20-29 and F30-39, psychotic codings). 
-No previous contact with psychiatric services for psychotic symptoms. 
-Agreement to undergo an MRI scan and provide DNA sample. 
 
Healthy individuals were included if they satisfied the following inclusion 
criteria: 
  - Age 16-64 years 
Genetic influence in brain volumes in psychosis                                        PhD Ana Miorelli 
68 
 
- Resident within the catchment area of the study 
- Absence of positive scores in the PSQ 
- Absence of moderate or severe learning disability as defined by the ICD-10 
(WHO, 1992b) 
- Agreement to undergo an MRI scan and provide DNA sample. 
 
In addition, both patients and healthy controls were excluded if they had: 
- History of neurological disorder or head trauma resulting in loss of 
consciousness for more than 1 hour 
- Poor English language skills 
- History of psychotic symptoms in the past. 
 
2.3.2 The Maudsley Family study 
The Maudsley Family Study is a large study that started in 1992 with the aim 
to investigate genetic liability to schizophrenia and bipolar disorder with 
psychotic symptoms and proceeded with several phases of recruitment. The 
recruitment of the sample I included in my Thesis was carried out over a 
period of 6 years (1997 to 2003). The families with at least one member 
affected by psychosis were invited to participate in the study. For 
schizophrenia, the study increased the variation of probable genetic liability by 
recruiting families who were either ―familial‖, where the index patient had other 
first- and/or second-degree relatives affected with a psychotic disorder, or 
―non-familial,‖ where the index patient had no known relatives with a psychotic 
disorder. For bipolar disorder, all subjects included in the study had a family 
history of bipolar disorder or another functional psychosis in the first or second 
degree relatives. Families were recruited by voluntary support groups such as 
the National Schizophrenia Fellowship (Rethink) and the Manic Depressive 
Fellowship. Additionally, direct referrals by the patient‘s treating physician 
were made to the research team. The majority of the families recruited lived in 
southeast England.  
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A group of control subjects was recruited from the community through 
advertisements in local newspapers or from staff, and were group-matched by 
age, gender, social classes, level of education and handedness. None of the 
control subjects had a life-time or family history of psychosis, and no relatives 
had a life-time history of psychosis.  
 
Inclusion and exclusion criteria  
For the whole sample, the inclusion criteria were: 
-  Age 16–69 years 
- First language English  
-Agreement to undergo an MRI scan and provide a DNA sample. 
 
Exclusion criteria were: 
- Current or previous organic brain disease, history of head trauma resulting in 
loss of consciousness for more than 5 minutes 
-Fulfilled criteria for DSM-IV substance or alcohol dependence in the 12 
months before the assessment.  
 
2.3.3 Maudsley Twin study 
The Maudsley Twin study aimed to investigate the role of genetic liability to 
schizophrenia and consisted of pairs of monozygotic (MZ) twins concordant 
for schizophrenia or schizoaffective disorder, and pairs of MZ and dizygotic 
(DZ) twins discordant for schizophrenia; in this group the co-twin was free of 
any psychotic illness. The patients were referred by the responsible 
psychiatrist from the whole of the UK. The study also included a control group 
consisting of pairs of MZ and DZ twins. This group was recruited from the 
Institute of Psychiatry Volunteer Twin Register and also with the help of 
advertisements in the media.  
The subjects in the schizophrenia group were clinically stable at the time of 
assessment and had undergone no recent changes to their medication.  
 




- Aged 16 to 65 years old 
- Patients fulfilled criteria for a diagnosis of schizophrenia in all the sub-types 
according to DSM-IV  
- Healthy volunteers had not had personal or family history up to second 
degree relative, of a psychotic or schizophrenia spectrum disorder. 
 
Exclusion criteria 
- History of neurologic complications or severe head injury with loss of 
consciousness. 
- Fulfilled criteria for substances misuse at the time of assessment based on 
DSM-IV. 
 
2.4 Socio demographic and Clinical assessments 
The same socio-demographic variables were evaluated across the 3 samples. 
In the AESOP study, general demographic information were obtained for the 
patients with a schedule specifically designed for the study were they self-
reported their date and place of birth, self-asserted ethnicity, years of 
education and employment. For the Family and Twin Studies socio-economic 
status was based on details of parental occupation at birth and derived from 
the Office of Population Censuses and Surveys Standard Occupational 
Classification (office of population censuses and surveys, 1991). 
 
2.4.1 Handedness 
This was assessed with the Annett scale (Annett 1970). This scale assesses 
the subject hand preferences for 12 actions (appendix 2). Based on these 
preferences subjects are classified into right, left or mixed handedness.  
 
2.4.2 Cognitive function 
In the AESOP and Maudsley Family Study IQ was estimated with the 
Wechsler Adult Intelligence Scale – Revised (WAIS–R) (Wechsler, 1981). The 
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Maudsley Twin Study used Wechsler Adult Intelligence Scale-III (Wechsler, 
1997). 
 
2.4.3 Family history of mental disorders 
Across all studies the Family and Genetic Questionnaire for Genetic Studies 
(FIGS) (appendix 3) was used to gather information about family history of 
psychiatric disorders. The questionnaire is based on a structured interview 
that assesses the presence of psychiatric symptoms and illnesses in relatives.  
 
2.4.4 Clinical assessment of affected subjects 
Structural diagnostic interviews were performed in the 3 studies. Diagnostic 
interviews were complemented by medical notes, and collateral history from 
relatives or informants to confirm diagnosis.  
 
In the AESOP study, subjects were interviewed with the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) carried out by trained raters. When a 
SCAN interview was not completed, symptoms information was entered in the 
Item Group Checklist (IGC) section of the SCAN alongside the case notes and 
informants‘ information. Consensus diagnoses were then reached according 
to the criteria of both the DSM-IV and the ICD-10 for a functional psychosis. 
As part of this study, inter-rater reliability for diagnosis was estimated for 20 
cases and was judged satisfactory, with kappa scores ranging between 0.63 
and 0.75. 
 
The Maudsley Family and Twin studies used the Schedule for Affective 
Disorder and Schizophrenia - Lifetime Version (SADS-L) by Endicott J, Spitzer 
RL (1978). This questionnaire assesses and rates subject's symptoms and 
level of functioning in order to make a diagnosis compatible with Diagnostic 
and Statistical Manual of mental disorders 4th edition (DSM-IV) criteria 
(American Psychiatric Association. DSM-IV, 1994). In the Maudsley Family 
Study diagnoses were made by two independent senior psychiatrists, blind to 
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family structures, who made a consensus diagnosis to give best-estimate 
lifetime diagnoses according to DSM-IV criteria. As for the Maudsley Twin 
study, patients were diagnosed by one independent psychiatrist to improve 
consistency, blind to family structures, who made a diagnosis to give best-
estimate lifetime diagnoses according to DSM-IV criteria. 
 
2.4.5 Exposure to antipsychotics 
Data on type, dose and length of exposure to antipsychotic drugs were 
recorded at the time of the MRI scan across all studies. This information was 
used to compute the total number of days of exposure to antipsychotic 
treatment up to the time of the MRI scan. 
 
2.4.6 Assessments of healthy volunteers 
The socio-demographic characteristics of healthy controls were obtained as 
those of patients in each study. In addition, the Psychosis Screening 
Questionnaire (Appendix 2) was used across all studies to exclude the 
presence of a psychotic disorder.  
 
2.4.7 Neuroimaging evaluation 
Images were processed using a Sun workstation (Sun Microsystems, 
Mountain View, USA) on a MAT-LAB (MathWorks, Natick, MA) platform, using 
Statistical Parametric Mapping (SPM) 




2.5.1 MRI acquisition protocols  
All three studies acquired a three-dimensional Fourier-transformed spoiled-
gradient-recalled acquisition in the steady state (SPGR), with the same GE 
Signa 1.5-T system (GE Medical Systems, Milwaukee), at the Maudsley 
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Hospital. All the images at the Institute of psychiatry were obtained in UNC 
format and stored in a Unix account.  
 
The acquisition parameters in the AESOP study were: 1.5-mm-thick 
contiguous coronal T1-weighted MRI images extending through the entire 
brain acquired with TE = 5msec, TR = 13.8msec, TI= 450 msec, field-of-view 
= 20cm, acquisition matrix=256×256×123 and Flip-angle = 20o. 
 
From the Maudsley Family I included the MRI scans obtained in the period 
between 1999 and January 2002. The acquisition parameters were: 1.5-mm-
thick contiguous coronal T1-weighted MRI images extending through the 
entire brain was acquired with TE=5.8 msec, TR=13.1 msec, TI= 450 msec, 
number of excitations=1, flip angle=20°, acquisition matrix=256×256×124. 
 
The Maudsley Twin study used a number of neuroimaging protocols along the 
years. The study has collected MRI scans using the same SPGR sequence in 
2 different scanners: a 1.5T GE scanner at the Maudsley Hospital and a 1.5T 
scanner at St Georges Hospital (Owens et al., 2012). In some cases, the 
same subject was scanned in both scanners. For compatibility reasons 
detailed below, in the Section on the calibration study (Chapter 2), I included 
in my study only images that were obtained in the 1.5T GE scanner based at 
the Maudsley Hospital. This is in fact where images for the other two studies 
included in this Thesis were also acquired. These images had identical 
acquisition parameters to those of the Maudsley Family study. For these 
reasons, thereon I will refer to this protocol as the ―Maudsley Family-Twin 
protocol‖. These acquisition parameters are described in Table 1. I did not 
include MRIs obtained at St George‘s Hospital as they proved to be markedly 
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3_F 7_T 3_F 4_A 
Orientation Coronal Coronal Coronal Coronal 
TR 13.1 35 13.1 13.8 
TE 5.8 5 5.8 5 
TI 450 0 450 450 
Flip angle 20 35 20 20 
xdim 0.859375 0.78125 0.859375 0.9375 
ydim 0.859375 0.78125 0.859375 0.9375 
zdim 1.5 1.5 1.5 1.5 
 
2.5.2 MRI processing 
Images from each study had been stored in separate Unix accounts at the 
Institute of Psychiatry. I first identified the correct MRIs for my project, 
ensuring, using an ad-hoc script, that only those with the exact scanning 
acquisition parameters were identified. Once identified, images were stored in 
a personal Unix account for pre-processing and analysis.   
 
As a first step, all images were converted to UNC format, allowing for the 
application of an algorithm that applies intensity correction (see below).  
 
All images then underwent quality control. This was done visually by me on all 
images to increase consistency. Quality control aimed to ensure full brain 
coverage, identification of wrap around artifacts, motion artifacts, presence of 
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intensity inhomogeneities, adequate grey/white matter contrast throughout the 
images, and identification of gross abnormalities.  
 
2.5.2.1 Intensity non-uniformity correction  
Intensity non-uniformity correction was applied to all MRI images to ensure 
optimal segmentation of the data into the correct tissue compartments. 
Magnetic resonance signal intensity from homogenous tissue should be 
uniform. However, due to artifacts introduced by a variety of sources which 
can lead to variations in signal intensity across the MRI image, this is hardly 
ever the case. There are in fact a number of reasons why this intensity non-
uniformity may occur, such as differences in the sensitivity of the scanner 
reception coil, induced eddy currents, and non-uniform excitation (Sled et al 
1998). Attention to such artifacts is particularly important in multi-study 
investigations, as changes in scanner signal may occur between serial time-
points. An iterative non-parametric method for intensity non-uniformity 
correction on MRI volumes (N3) was applied prior to the segmentation stage 
of processing (Sled et al 1998). The application of the N3 was fully automated 
and applied to all images. This method has been shown to improve the 
sensitivity of voxel based morphometry (VBM) methods of analysis, if used 
prior to the SPM analysis (Acosta-Cabronera et al. 2008). The N3 algorithm 
was applied using a specific script. This script corrects intensity non-
uniformities and also converts the images from coronal to axial orientation, 
and also to UNC to analyze format. Therefore, all the images obtained after 




To increase the accuracy of the segmentation, I realigned all the images to an 
image that I selected as a good quality image. As changes in scanner signal 
will occur between serial time-points, I selected for this purpose an image 
collected in the year 2001. This year was chosen as it was the mid-point in 
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time when the MRI for the 3 studies were obtained (between 1997 and 2003). 
I manually reoriented the selected image along the AC-PC line using the key 
landmarks of the Talairach and Tournoux atlas (1988). In their description, the 
midpoint of the anterior commissure (AC) is located first, serving as the origin 
of Talairach space. The brain is then rotated around the new origin (AC) so 
that the posterior commissure (PC) appears in the same axial plane as the 
anterior commissure. The connection of AC and PC in the middle of the brain 
forms the y-axis of the Talairach coordinate system. The x-axis runs from the 
left to the right hemisphere through AC. The z-axis runs from the inferior part 
of the brain to the superior part through AC. In order to further specify the x 
and z-axes, a y-z plane is rotated around the y (AC-PC) axis until it separates 
the left and right hemisphere (mid-sagittal plane). The reorientation was done 
using the reorientation tool of SPM, where the image can be reoriented by 
manually manipulating the parameters along the 3 main axes. Once I was 
satisfied with this re-orientation, I saved this to be used as the representative 
scan (Figure 1). All the images were then realigned against this representative 
scan. From this point on, the realignment was a fully automated process that 
is applied with SPM. This method ensures that all images are realigned and 
corrected to the same parameters as the ―representative scan‖ before 
segmentation.  
 
SPM8 before segmentation, the images undergo spatial normalization to the 
same stereotactic space by registering them to the same template image. In 
this way SPM8 spatially normalizes the images by matching and estimating 
each image to the optimum 12 parameters affine transformation (Ashburner et 
al., 1997). This is done within a Bayesian framework whereby the Maximum a 
Posteriori (MAP) estimates the spatial transformation using a priori knowledge 
of normal variability of brain size.  After this process, the affined transformed 
images are corrected for non-linear shape differences (from the template) by a 
linear combination of smooth spatial basis functions (Ashburne and Friston 
1999). 





Figure 2.1 Image re-orientation using the key landmarks of the Talairach and 
Tournoux atlas. This image was used as the representative scan. 
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The realigned and spatially normalized images were then used for tissue 
classification and segmentation. For the segmentation, SPM uses a mixed 
model cluster analysis to identify voxel intensities matching grey, white tissue 
and Cerebrospinal Fluid (CSF), using a priori knowledge of these tissue 
distributions from probability maps. As the segmentation step done with SPM 
also includes correction of intensities (Ashburner and Friston, 2000); in order 
to avoid duplicating the correction of intensity when applied the N3 algorithm 
to the images, the parameters were set as: for the ―bias regularization‖: 
extremely heavy regularization (10) and for the ―Bias FWHM‖: 150mm cut off 
as recommended in the SPM manual. The remaining parameters were the 
SPM8 default ones.  
From the probability maps obtained, volumes of grey and white matters and 
Whole Brain Volume (WBV) were calculated in both voxels and litres.  WBV 
was calculated summing the grey and white matter volumes.  
2.5.2.3 Volume extraction 
The volumes were obtained by using a script specifically designed for this 
purpose. This script runs in the pre-processed and segmented images. It 
calculates the volume of the different tissues in each voxel. The final whole 
tissue volume in each image was obtained in litres. 
 
2.6 Genetic data 
2.6.1 Genetic data collection 
DNA in the Family and Twin studies had been extracted from both blood 
samples and cheek swabs. During the baseline assessment of the AESOP 
study very few samples for genetic analysis had been collected. However, 
since patients were being re-contacted for a follow up evaluation, during this 
period I coordinated and collected additional DNA samples. For the AESOP 
study genetic samples were also collected from both blood samples and 
cheek swabs.  
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Blood samples were collected into an EDTA tube by a trained phlebotomist or 
medical professionals (including myself). The samples were stored in a -80oC 
before DNA extraction. When the sample was collected with a cheek swab, 
subjects were asked to swab their inner cheeks with 10 sterile cotton swabs. 
These were stored at room temperature as advised by manufacturer until 
processed for DNA extraction. 
 
2.6.2 Genotyping 
2.6.2.1 DNA extraction  
This step was carried out by colleagues at the Social Genetic Developmental 
Psychiatry centre (SGDP). The DNA was extracted with two different 
methods, depending on how the samples were collected. DNA was extracted 
from blood samples using a standard phenol chloroform extraction protocol. 
As for DNA extraction from cheek swab, this was done by an in house method 
(Freeman et al., 2003) 
 
2.6.2.2 DNA storage  
All samples were bar-coded, entered in the SADMAN database system and 
stored at -80oC in freezer at the SGDP centre. Barcodes were created in 
sequence in order to identify each individual sample. Barcodes are made of 
letters and numbers and were matched to progressive numbers on original 
folders stored at the main building of the IoP in order to facilitate tracking. This 
numbers were allocated randomly to patients, relatives and controls to ensure 
blindness at the time of working in the laboratory and obtaining the results. 
Barcodes and subject identification numbers were matched to the original 
database and paper folders.  
 
2.6.2.3 Genotyping 
This was carried out by different methods. In my sample, the methods used 
were: 
1-Internally with TaqMan at the SGDP centre 
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2-Externally by private companies  
3-Externally with Genome Wide Association Study (GWAS) 
 
In this section I will describe the TaqMan technique that I have performed. 
Additionally, I will highlight the other genotyping methods used for the different 
polymorphisms.  The specific genotyping techniques used for each SNP are 
shown in table 2.4. 
 
2.6.2.3.1 SGDP centre genotyping: TaqMan 
In this section I will describe in more details the genotyping that I carried out 
for the COMT rs4680 polymorphism. COMT Val/Met (rs4680) was genotyped 
using TaqMan® SNP Genotyping Assays from Applied Biosystems, which is 
based on 5‘ nuclease activity and fluorescent nucleotide chemistry.  
 
For the COMT genotyping, primers are at 900 nM final concentration. 
PCR followed standard procedure as per Applied Biosystems TaqMan® SNP 
Genotyping Assays standard dry DNA protocol (Table 2.2; Figure 2.2). 
 
Table 2.2: TaqMan® SNP Genotyping Assays standard dry DNA protocol 
Reaction Component 
 
Final Concentration Volume 
(ul) 
TaqMan Gene expression 
assay 20X Assay Mix  
1X 0.1ul 
DNA Template 10ng 2.ul 
ddH2O  0.9ul 
TaqMan® Universal PCR 
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PCR reaction was carried out in the Applied Biosystems 7900HT Fast Real-
Time PCR System machine. As per manufacturer protocol, the following 
conditions were applied:  
STEP 1 - hold at 50C for 2 minutes 
STEP 2 - denature at 92C for 15 seconds 
STEP 3 - anneal/extend at 60C for 1 minute 
STEP 4 - repeat step 2 and 3 for 40 cycles.  
Plates were then subjected to reading using the Applied Biosystems 7900HT 
Fast Real-Time PCR System. 
 
As shown in Figure 2.2, the TaqMan probe contains two types of dye: a 
reporter dye located at the 5‘ end and a quencher dye, located at the 3‘ end. 
The reporter dye is separated from the quencher dye during the reaction. The 
fluorescence increase can be detected only if the target sequence is present 
and has been amplified during the PCR reaction. Non specific amplification is 
not detected. 
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Figure 2.2 TaqMan Gene Expression assay Protocol shows the nuclease 




Presence of each allele is marked by colour and position on a generated plot 
according to the level of fluorescence present in each allele. Homozygotes 
are displayed in the expremities of the Y and X axes whereas, heterozygous 
are displayed in the middle. Allele discrimination can be visualized in a plot 
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`Figure 2.3 Allelic discrimination plot resulting from the TaqMan gene 
expression assay procedure. The two alleles are shown in the axis and in 
different colours: blue –homozygous G allele (Val/Val), red –homozygous A 
allele (Met/Met) and green –heterozygous A-G (Val/Met) 
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2.6.2.3.2 Genotyping conducted by external companies 
NRG1: SNP8NRG221533 was genotyped using the primer extension 
SNuPe/genotyping platform Megabase (Amesham International, UK) 
(Williams et al, 2003) 
 
NRG1: SNP8NRG241930 Taqman SNP assay was used for genotyping (kit 
format at http://www.appliedbiosystems.com) 
 
NRG1-243177 (rs6994992) Taqman SNP assay was used for genotyping (kit 
format at http://www.appliedbiosystems.com) 
 
DTNBP1P1757 (rs2005976) were genotyped using Kbioscience 
(https://kbioscience.co.uk) with a competitive allele-specific PCR system. 
 
DTNBP1P1320 (rs760761) were genotyped using Kbioscience 
(https://kbioscience.co.uk) with a competitive allele-specific PCR system. 
 
BDNFval/met polymorphism (rs6265) was genotyped using the primer 
extension SNuPe (Amesham International, UK), as previously described by 
Bramon et al (2006) in a previous study analysing part of this sample. 
 
2.6.2.3.3 Genome Wide Association Study (GWAS) 
Data were obtained from the GWAS carried out as part of the Wellcome Trust 
Case Control Consortium study of Psychosis Endophenotypes at the Institute 
of Psychiatry.  Samples were genotyped using the Affymetrix 6.0 genotyping 
array by Affymetrix.  Genotype calling and stringent quality control was 
performed by the Wellcome Trust Centre for Human Genetics, University of 
Oxford, UK. The SNPs selected for analysis in this thesis under the GWAS 
sample were selected according to the following approach:  
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1) I first carried out a literature review to search for specific genetic 
polymorphisms associated with brain volume, either in the general population 
or in patients with psychosis. 
 
2) After the literature research, the approach to the GWAS data was based on 
candidate genes using two strategies: 















C) Finally, I included a number of SNPs recently described by Taal et al., 
(2012); Ikram et al., (2012) and Stain et al., (2012) in a GWAS study as 
implicated with brain volume in healthy individuals;  
SBNO1_rs7980687 
HMGA2_rs1042725 
CRHR1_rs11655470.   
 
3) SNPs and proxy 
A number of the SNPs identified in the literature were not available from the 
GWAS data, so for these a proxy SNP was identified. Genetic association 
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tests depended on whether the sequence variant in question had a real 
functional effect on the phenotype, or works in probable linkage disequilibrium 
with a functional variant. These are identified by linkage disequilibrium, 
physical distance and/or membership in selected commercial genotyping 
arrays. Linkage disequilibrium simply represents the statistical correlation 
between two sequence variations due to a shared history. The extent of 
linkage disequilibrium is usually less than 200–300 kb. However, linkage 
represents a much more predictable force than disequilibrium, since it uses a 
well-known and precise mathematical form. To identify the proxies we used 
SNAP (http://www.broadinstitute.org/mpg/snap/). This site runs a pair-wise 
linkage disequilibrium which is pre-calculated based on phased genotype data 
from International HapMap project. A summary of these is presented in table 
2.5.  
 
Table 2.4 Genotyping methods 
GENE  Genotyping method 
SNP8NRG221533 primer extension SNuPe/genotyping platform 
Megabase 
  
SNP8NRG241930 Taqman SNP assay was used to geneotype 




NRG 243177 Taqman SNP assay was used to geneotype 




DTNBP1P1757rs2005976 Kbiosciences With competitive allele specific 
PCR system 




DTNBP1P1320 rs760761 Kbiosciences With competitive allele specific 
PCR system 
  
BDNF rs6265 primer extension SNuPe Technology 
  
































 Table 2.5 SNPs and their proxy and their r2 square 
GENE  SNP proxy Distance bp* 
and r2 
DTNBP1 rs875462 rs6937379    12439 bp  
    0.953 
    
OLIG2 rs1059004 rs762178 1062 bp   
0.901 
    
MCPH1 rs930557 rs2440416 711 bp     
0.891 
    
MCPH1 rs1057090 rs2912057 4440 bp   
0.875 
    
MCPH1 rs2912016 rs2959798 5432 bp   
0.844 
    
ASPM rs3762271 rs1360558 76469 bp 
1.000 
    




2.7 Statistical Analysis  
2.7.1 Coding 
As the sample is composed by three different studies, I recoded all subjects to 
make the overall sample homogeneous and comparable. I coded all subjects 
with a unique number as belonging to a family. Additionally, each individual 
had a family number followed by a suffix that would indicate the uniqueness 
identity of the person to the family.  
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2.7.2 Samples under investigation  
The whole sample was included in the analysis of brain volume, and three 
groups compared (patients, relatives, healthy volunteers). 
 
For the case control and the genetic analyses, I selected the sample 
according to the hypothesis tested.  The sub-samples for each analysis were 
selected as follows: 
 
-In the case-control brain volumes comparison: 
 -  Maudsley Family Study: I excluded all relatives  
- Maudsley Twin study: In order to avoid familial confounders, I selected one 
subject of each twin pair. The selection of the twin individuals was done randomly.  
In order to maintain blindness while manipulating the data, I first identified and 
organized in an ascending order the twin pairs according to their unique 
identification numbers. Then, I selected the first subject of the pair from the 
organized list in the database as follows: 
 
monozygotic concordant patient:  one subject from each pair 
monozygotic control twins: one subject from each pair.  
monozygotic discordant twin: the ill subject of each pair. 
dizygotic discordant pair: the ill subject of each pair 
dizygotic control twins: one subject of the pair 
The sample did not have any dizygotic concordant pairs 
 
-In the genetic analyses  
- From the whole sample, I excluded all non-Caucasian subjects 
- Maudsley Twin Study sample, I selected 1 twin from each monozygotic pair. 
Dizygotic discordant twins were included and coded as a relative in the same 
family, sharing about 50% of the genetic loading.  
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Finally, in the sample I collected from the Maudsley Twin Study there were 6 twins 
of the pair that were excluded due to movement artect in the neuroimaging. 
Therefore, 6 twins were not paired. 
 
2.7.3 Brain volume analysis 
For these analyses I used STATA (version 10; Stata Corp, College Station, 
TX, USA), applying the regress command and combining robust and cluster 
options. In this, STATA uses the sandwich estimator of variance (Rogers 
1993), which is model agnostic and robust against possible violations of the 
observations from assumptions of regression, including normality and 
independence of residuals. This approach has the advantage of correcting for 
type 1 error in cluster correlated data by correcting for observations between 
clusters (Binder, 1983). This method has been successfully used in previous 
studies for the assessment of potential endophenotypes familiarity (Bramon et 
al., 2004, 2005)  
 
I ran two different analyses: 
1- Cases vs Controls: For this analysis I excluded all the relatives from the 
Maudsley Family Study. From the Maudsley Twin Study, I excluded all the 
healthy twin of the pair. This was based on the rationale that the healthy twin 
of the pair is a relative of the ill twin. When the twins were concordant for the 
illness, I randomly selected one subject from the pair. I compared brain 
volumes between all patients as one group and the controls. The control 
group was the reference for the analysis in STATA. Subsequently, I compared 
the control group against patients with schizophrenia and then against 
patients with affective psychosis. Global grey and white tissue volumes 
differences between patients and controls were calculated using a linear 
regression analysis model with brain tissue volumes as the dependent 
variable, controlling for age, gender and Whole Brain Volume (WBV).  
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2- Whole sample comparison: I compared all patients with psychosis with the 
relatives and the control group. Additionally, I ran a familiality analysis of grey, 
white and whole brain volume in which the whole sample (patients, relatives 
and controls) was included. I carried out a linear regression analysis using 
standard errors that are robust against non-independence of observations 
from individuals within families (clusters) and against departures from normal 
assumptions. Patients and relatives were compared to the control group with 
their brain volumes as the dependent variable, controlling for age, gender and 
Whole Brain Volume (WBV).  
 
2.7.4 Statistical Genetic Analysis 
For the genetic statistical genetic analysis I used statistical software packages 
Stata version 10 (StataCorp LP, USA) and SPSS version 18 for Microsoft 
Windows (SPSS Inc., USA). The effect of candidate genes on brain volumes 
was examined using linear mixed models fitted with maximum likelihood 
methods. Correlations between members of the same family were accounted 
for by including random intercepts for families, which is needed to maintain 
correct type 1 error rates. The dependent variables were grey matter volume, 
white matter volume, and whole brain volume, while genotypes of the different 
SNPs were the main independent variables. In addition, all analyses were 
adjusted by the fixed effects of clinical group (patient, relative or control), age, 
sex and MRI protocol. Finally, for the genetic analysis, the power calculation 
was done using QUANTO: (http://hydra.usc.edu/gxe)  
 
2.7.4.1 Hardy Weinberg Equilibrium Test 
Hardy Weinberg Equilibrium (HWE) test was performed using chi-square test. 
Each SNPs was checked for deviation from HWE in the non-psychotic 
participants group. Due to the heterogenous nature of my sample that 
combined subjects from three different studies, HWE test was performed only 
in the Caucasian subjects to avoid ethnicity confounders (Kaufman et al., 
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2001; Thomas et al., 2002; The International HapMap Consortium, 2003; 
Holliday et al., 2008).  
 
2.8 Personal Contribution to the work of this Thesis 
My main involvement has been with the AESOP study. I joined the AESOP 
study in 2005 and I have participated in many aspects of the follow up phase 
of the study, while also working on the cleaning up of the baseline data. 
Additionally, I have worked with the Maudsley Family Study and the Maudsley 
Twin Study by facilitating recruitment of subjects for the additional phases of 
the studies.  
 
More specifically, I was involved in: 
 
Recruitment 
I coordinated, and personally contributed to, the collection and storage of DNA 
samples in the AESOP study. Since the AESOP study had only collected a 
small number of DNA samples in the baseline phase, I was responsible for 
tracing subjects, recruiting, consenting and extracting DNA samples during 
the follow up period. I personally collected about 40 to 50 DNA samples, and 
the rest of the samples were collected in collaboration with fellow researchers. 
This represented a significant increase in the number of samples. 
 
Socio-demographic and Clinical Evaluation 
In the AESOP study these assessments were already completed. However, to 
confirm the lifetime diagnosis and the progression of symptoms, some of the 
questionnaires were also carried out in the follow up stage. I administered the 
SCAN interview, Medication History, Medical History Checklist, Family 
interview for Genetic Studies (FIGS) to approximately 30 patients and 10 
controls. I entered all the data for FIGS, and some data medication history, 
into the database.  
 




MRI data collection had already been completed when I started this Thesis. 
However, the AESOP study was carrying out the follow up phase and I was 
involved in re-tracing and obtaining a second MRI scan of subjects for this 
phase. I single-handedly performed all quality checks, processing, and 
analysis of the MRI calibration study data and of the main MRI study 
presented in this Thesis. 
 
DNA 
In the AESOP study, I had responsibility for collecting DNA from participants 
and identifying samples acquired in the baseline recruitment phase. I 
personally collected approximately a fifty DNA samples. Finally, I contributed 
with the data-entry of the identification bar-codes for DNA samples. In the 
Maudsley Family Study and Maudsley Twin Study I collaborated with other 
researchers involved in these studies in subjects‘ tracing and recruitment. 
Once the subjects were recruited, I was responsible for obtaining consent for 
them to participate in the study and for obtaining DNA samples.  
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Chapter 3: MRI Calibration Study 
 
3.1 Background 
When looking at brain volumes from Magnetic Resonance Images scans there 
are generally 2 methodological approaches, manual and automated. The 
manual quantification of different brain volumes has been considered to be 
accurate and the golden standard for many years however; it has the 
disadvantages of being time consuming, it requires advanced knowledge of 
brain anatomy and may involve high inter-rater reliability when large samples 
are analyzed. In contrast, automated methods involve processing the images 
in an operator-independent way, with only minimal manual imputation. For this 
reason, is not only independent from inter or intra rater variability, but it has the 
additional advantage of analyzing larger neuroimaging data samples in shorter 
periods of time, hence providing increased statistical power in comparison to 
manual methods.  
 
In fact, investigations of complex psychiatric disorders require large number of 
subjects to increase the statistical power. This can be achieved by combining 
MRI data obtained from multiple studies. However, this approach has also its 
own problems. For example, challenges of measuring and analyzing brain 
volume from images collected in different studies include: 
1) they may differ slightly in their acquisition protocols; 
2) if different scanners have been used, it is important to take into account 
between-scanner and within-scanner variability (Gradin et al, 2010);  
3) the passage of time might change the quality of the images and requieres 
strict quality control (Simmons et al., 2011). 
4) the application of manual methods of analysis may not be feasible, and 
therefore automated methods would need to be considered, although more 
sensitive to acquisition and inter-scanner variability. 
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In my thesis I analyzed a large sample of images obtained from 3 different 
studies at the Department of Psychological Medicine at the Institute of 
Psychiatry, King‘s College London. In order to analyze the images of these 
three studies together, I first performed a pilot reliability study to explore the 
comparability of MRI scans acquired across the different studies.  
 
3.2 Aims of the pilot study 
1) Obtain MRI brain images of the same 12 healthy volunteers using the 
acquisition parameters of the original MRI protocols of each study; in this way, 
I would estimate how much variations the same brain volume would display 
when different protocols were used;   
2) Carry out automated segmentation of the images into grey, white matter and 
cerebrospinal fluid (CSF). These were in fact the main measures of interest in 
in my main study sample; 
3) From the segmented brain images, obtain volume measures for total grey 
and white matter and whole brain volumes; 
4) Assess the comparability across the 3 studies protocols. 
 
3.3 Sample characteristics 
Twelve healthy volunteers were recruited into this pilot study. These subjects 
underwent MRI scanning with the original protocols used in the 3 studies 
included in this thesis, more specifically: 1 protocol from the AESOP study, 1 
protocol from the Family study, and 2 protocols from the Twin study (table 3.1). 
This preliminary work was called Aesop-Family-Twin (AFT) calibration project, 
and it allowed me to assess the variability between protocols of the 3 different 
studies from which I included subjects for the main thesis hypotheses. All 
healthy participants were screened for medical illnesses, neurological or 
psychiatric disorders, and met the standard MRI safety criteria. Informed 
consent was obtained from all participants. The participants were six women 
and six men, with a mean age of 29.8 years (SD  4.5). The demographic 
characteristics of the sample are described in table 3.1.  




Table 3.1: AFT Calibration study sample demographic characteristics 
Number 12 
Gender (female/male)  6/6  
Age (mean) 29.83 +/- 4.52   
 
3.4 Magnetic Resonance Imaging 
The MRI images were all obtained with a 1.5T General Electric Signa System 
scanner (Milwaukee, WI) at the Maudsley Hospital.  For the volumetric 
analysis, a 3-D T1-weighted coronal spoiled gradient recalled echo scan 
(SPGR) was acquired according to each original study protocol. 
 
For each subject 3 Magnetic Resonance Image (MRI) T1-weighted sequences 
were acquired, one for each original study protocol.  The images were 
acquired between May 2006 and June 2007.  
 
3.5 Acquisition protocols for the three studies 
It is important to mention that during its duration, the Twin study had used 2 
different protocols (parameters for both protocols are included in table 3.2). 
The first one was called ―Long‖, and the second protocol was called ―Short‖. 
This change of protocol was done to make the MRI data more compatible with 
data acquired from other studies carried out in the Department, and specifically 
with the Family study. To achieve this, the Twin study ―Short‖ protocol used the 
same acquisition parameters used by the Family study protocol.   For the 
purposes of this calibration analysis therefore only the ―Long‖ protocol was 
included, since the ―Short‖ protocol used the same parameters already 
included in the ―Family study protocol. 
 
The parameters of acquisition of each protocol are described in table 3.2. The 
protocols included in my pilot project were therefore the following: 
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 Protocol A (4_A): Ethnicity and Aetiology in Schizophrenia and Other 
Psychosis (AESOP) 
 
 Protocol F (3_F): Maudsley Family Study (MFS)  
 
 Protocols T (7_T: Maudsley Twin Study (MTS). This was called the ―long‖ 
version     of the MTS. I chose to first estimate the correlation of the Long Twin 
protocol because a larger number of subjects had been scanned with this 
sequence. However, the Maudsley Twin Study had also used the same 
protocol as the Maudsley Family Study (MFS) and this was called the ―Short‖ 
Twin protocol. 
 









3_F 7_T 4_A 
Orientation Coronal Coronal Coronal 
TR 13.1 35 13.8 
TE 5.8 5 2.8 
TI 450 0 450 
Flip angle 20 35 20 
xdim 0.859375 0.78125 0.9375 
ydim 0.859375 0.78125 0.9375 
zdim 1.5 1.5 1.5 
 
3.6 Image pre-processing 
From the 12 health participants, 36 different images were obtained, 3 per 
subject. I performed quality control on all image data acquired, to increase 
consistency. This control ensured: full brain coverage, wrap around artifacts 
affecting the brain, motion artifacts, intensity inhomogeneity, adequate 
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grey/white matter contrast throughout the images, and any evident brain 
abnormality. All 36 images fulfilled criteria of good quality to be included in the 
calibration study.  
 
Images were processed using Sun workstation (Sun Microsystems, Mountain 
View, USA) using MAT-LAB (MathWorks, Natick, MA) and Statistical 
Parametric Mapping (SPM) (http://www.fil.ion.ucl.ac.uk/spm/software/spm2). 
During the course of the calibration project the SPM method was updated and 
developed further. Therefore, for the first correlation analysis I used Statistical 
Parametric Mapping (SPM) version 5, while for the following 2 analyses I used 
the upgraded version, SPM8.  
 
The full description of the image processing is described in Chapter 2. In 
summary (graph 3.1), SPM is a fully automated method used to examine 
structural MRI brain images with a voxel-based method (VBM) approach. VBM 
approach is used to identify differences in regional brain tissue, while taking 
into account large scale differences in anatomy and position. In the standard 
SPM method, this is achieved by spatially normalizing all the structural images 
to the same stereotactic space, segmenting the images into gray and white 
matter and finally smoothing the gray and white matter images for statistical 
analysis (Ashburner and Friston 2000).  
 
The newest versions of SPM use the optimized VBM method (Good et al., 
2001). This process includes one more steps than the standard method. These 
are summarized as: 1) Segmentation into grey and white matter tissues 2) 
Spatial Normalization and realignment to grey and white matter templates 4) 
Smoothing and 5) Segmentation into component tissues: grey and white 
matters, cerebro-spinal fluid (CSF) and dura/blood vessels.  
 
The optimized method has the benefit of reducing tissue classification in the 
segmentation process. In addition, a further step in the pre-processing of 
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neuroimaging called ―modulation‖ can be added to compensate the likely 
introduction of volumetric differences after warping a series of individual 
images to match a template during spatial normalization.  The modulation 
process is particularly useful, when trying to identify regional differences in the 
volume of a specific tissue, either gray or white matter, as it requires the 
information about absolute volumes to be preserved. This step involves 
multiplying the spatially normalised grey or white matter by its relative volume 
before and after the normalization process. With this additional step, the 
volume measurements of gray or white matter structures can be more 




Graph 3.1: Flow diagram of the preprocessing steps in standard (left) and 
optimized (right) VBM. GM = gray matter images; WM = white 
matter images from Mechelli A et al., 2005 
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3.7 Results  
 
3.7.1 First analysis 
 
3.7.1.1 Image Processing  
All images for the AFT calibration project were acquired in coronal orientation. 
However, SPM requires image files to be in axial orientation. Therefore, all 
images were first converted to axial orientation. I carried out this step by 
running an ad hoc script prepared by the Centre for Neuroimaging Sciences. 
Once the images had been converted into axial orientation, I was able to run 
and estimate the brain volumes. The pre-processing was done with SPM 
version 5. 
The SPM5 segmentation was run using the default settings. The quality of the 
segmented images was visually checked by me. More specifically, I examined 
the quality of both the modulated and unmodulated segmented brains. All 
segmented images were of good quality to be included in the analysis. From 
the probability maps obtained, volumes of grey and white matters and 
Cerebro-Spinal Fluid (CSF) were calculated as both voxels and volumes. In 
addition, Whole Brain Volume (WBV) was calculated by adding the white and 
grey volumes. At the time of this analysis SPM was still undergoing 
optimization. Therefore, to check for consistency and reliability of the 
segmentation, and establish whether any of the two should be chosen against 
the other, I also compared volumes obtained with the modulated and 
unmodulated maps. 
3.7.1.2 Correlation analysis 1 
All statistical analyses were carried out using SPSS package version 13 
(SPSS Inc., Chicago, IL). 
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I first estimated the correlation between the two measures of volume, voxel 
versus litres, for each subject for the 36 images obtained. This was to ensure 
they were expressing the same measure. The Pearson‘s r correlation was 1 
across all data.  
The second analysis evaluated the intra-class correlation among the 3 
protocols, on both the modulated and unmodulated data. This was done to 
assess if it was worth adding an additional modulation step into the pre-
processing pipeline. Since the intra-class correlation coefficient increases 
when the correlation between the items (in my case the volumes) also 
increases, a level above 0.9 is considered significant and is therefore 
desirable. I found that the correlation among protocols was higher, although 
the difference was not significant, for the modulated than for the unmodulated 
data. This was somehow not surprising, since the modulation corrects for the 
effects of spatial normalization. Results are shown in table 3.3. Therefore, for 
subsequent analyses, I used the modulated images.  
Table 3.3 Results of brain volumes correlational analysis 1 
 Grey matter White matter CSF 
ICC modulated .89 .99 .86 
ICC 
unmodulated 
.85 .96 .83 
 
Once I decided to work with the modulated data, I explored the correlation in 
grey and white matter volumes between the AESOP, Family, and ―Long‖ 
version of Twin protocols. I chose to first estimate the Long Twin protocol 
because a larger number of subjects had been scanned with this sequence (in 
comparison to the Short Twin sequence). Therefore, if this sequence proved to 
be compatible with the ones obtained from the other studies, I would be able to 
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include more subjects, and hence have a higher statistical power to investigate 
the hypotheses of the study.  
3.7.1.3 Intra-class correlation analysis: 
The preliminary results on grey and white matter volumes are described on 
table 3.4. 
 
Table 3.4: Gray and white matter volumes on the three studies and Intra-class 
Correlation Coefficient (ICC)  
Study Grey volume (mean voxels) Standard  Deviation ICC
AESOP 84358 6957.53 0.894
Family 84865.17 6545.87 (0.688 - 0.971)
Twin 87074.36 8635.08
Study White volume (mean voxels) Standard Deviation ICC
AESOP 55731.75 6957.53 0.977




I calculated the intra-class correlation coefficient across the 3 protocols using 
the modulated data. I evaluated this using Cronbach's alpha. This is a 
coefficient, between 0 and 1, that is used to rate the internal consistency 
(homogeneity) or the correlation of the items in a test.  
 
This analysis showed that while white matter volumes were significantly 
correlated, with a Cronbach‘s alpha of 0.977, there was a worse correlation 
across grey matter volumes, for which the Cronbach‘s alpha was 0.894. I then 
looked at the correlation between each study with Paerson Correlation 
Coefficient. The results of these analysis showed that there was good 
correlation between the Maudsley Family Study protocol and the AESOP 
protocol (grey matter: r=0.84, p-value: 0.003; white matter: r=0.95, p-value: 
<0.001). However, the correlation was significantly worse for both grey and 
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white matter volumes between the Maudsley Twin Family Study (MTS) ―Long‖ 
version protocol and the AESOP protocol (grey matter: r=0.23, p-value: non-
significant; white matter: r=0.44, p-value: non-significant) and with the 
Maudsley Family Study (grey matter: r=0.03, p-value: non-significant; white 
matter: r=0.55, p-value: non-significant)  
3.7.1.4 Conclusions of the first analysis 
In summary, the first analysis of the correlation among protocols showed that: 
1) Although with little effect, modulated data showed better segmented 
volumes correlation between protocols than unmodulated data, and therefore 
this pre-processing step should be incorporated in further analyses.  
2) In line with previous studies, the CSF segmented volumes showed more 
heterogeneity across protocols than grey and white matter volumes (Good et 
al., 2001).  
3) Given the unreliability of the CSF segmentation measures with this fully 
automated pre-processing method, CSF volume analysis was excluded from 
the computation of Total Intracranial Volume (TIV). 
4) In order to assess if the reliability and comparability could be increased 
among different protocols by manual reorientation, I decided to also re-orient 
the images manually. 
3.7.2 Second analysis  
In this analysis I intended to explore further the poor correlation between the 
three protocols I identified in the previous section. In this phase of the 
calibration project I also corrected the MRIs for intensity in-homogeneities, and 




Genetic influence in brain volumes in psychosis                                        PhD Ana Miorelli 
104 
 
3.7.2.1 Image Processing  
Magnetic resonance signal intensity form homogenous tissue is not always 
uniform. This is due to artifacts introduced by differences in the sensitivity of 
the scanner reception coil, non-uniform excitation and induced eddy currents 
(Sled et al 1998). It was particularly important to apply this correction as in my 
main study I was going to include MRI images obtained with different protocols 
and at different times. Therefore, to increase the accuracy of the segmentation 
and the subsequent brain volumes extraction, I applied the N3 algorithm (Sled 
et al., 1998) to improve the intensity non-uniformity of the images. Additionally, 
this method has been shown to improve VBM if used prior to the SPM analysis 
(Acosta-Cabronera et al. 2008). The N3 function algorithm was applied using a 
script that corrects intensity non-uniformities and also converts the images 
from coronal to axial orientation and also from UNC to Analyze format. 
Therefore, all the images obtained after this step were ready to be processed 
with SPM8. 
 
I also addressed the previous conclusion that poor correlation in tissue 
segmentation across protocols could be related to the orientation parameters 
and alignment of the images. For these reasons, in this second analysis I 
manually re-oriented all the images, using the key landmarks of the Talairach 
and Tournoux atlas (1988). I manually reoriented each image along the 
anterior-commissure posterior-commissure axis in the sagittal plane and along 
the inter-hemisferic fissure in the coronal and axial planes. The guide-brain 
image I used to reorient my scans is shown in Graph 3.2; 3.3 and 3.4. The 
reorientation was done using the reorientation tool of SPM, where the image 
can be reoriented by manually manipulating the parameters. Once I was 












Graph 3.2 Axial orientation         Graph 3.3 Coronal orientation 
                       
 
 
Graph 3.4 Sagittal orientation 
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These images were then used for tissue classification and segmentation. As I 
applied the N3 algorithm to the images, for the SPM8 segmentation I selected, 
for the ―bias regularization‖ field: ―extremely heavy regularization‖ (10) and for 
the ―Bias FWHM‖: ―150mm cutoff‖ as these are the recommended parameters 
in the SPM manual. The remaining parameters were the SPM8 default ones. 
From the probability maps obtained, volumes of grey and white matter and 
Whole Barin Volume (WBV) were calculated as both voxels and volumes. 
WBV was calculated by summing the grey and white matter volumes. As 
mentioned in the previous section, in this analysis I did not include the CSF 
values as these had proved to have a high coefficient of variation (Good et al 
2001). 
As in the previous analysis, I visually checked the quality of the segmented 
images before the statistical analysis. All segmented images were of high 
quality and therefore included in the analysis.  
3.7.2.2 Correlation analysis 2 
All statistical analyses were carried out using SPSS package, version 15 
(SPSS Inc., Chicago, IL). As in the previous analysis, although the intra-class 
correlation (ICC) was generally good and showed a slight improvement for 
grey matter volumes, no considerable changes were observed after applying 
the correction. This analysis showed that while white matter volumes were still 
significantly correlated, with a Cronbach‘s alpha of 0.977, there was a poor 
correlation across grey matter volumes, for which the Cronbach‘s alpha was 
0.92. Even more, when looking at the between-protocols correlations with the 
Twin ―Long‖ protocol, the results were still unsatisfactory. I then checked the 
correlation between studies, and found that there was good correlation 
between the Maudsley Family Study protocol and the AESOP protocol, 
Pearson correlation: grey matter: r=0.84, p-value: 0.003; white matter: r=0.95, 
p-value: 0.000. However, there was poor correlation in grey and white matter  
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volumes between the Maudsley Twin Study (MTS) long version protocol and 
the AESOP protocol grey matter: r=0.33, p-value: non-significant; white matter: 
r=0.44, p-value: non-significant and with the Maudsley Family Study grey 
matter: r=0.03, p-value: non-significant; white matter: r=0.55, p-value: non-
significant  
Given the lack of improvement in the correlation results despite more 
meticulous approach, particularly with the Maudsley Twin long-protocol, I 
considered and reviewed the acquisition parameters again (Table 3.5). The 
different parameters used in the Twin-Long protocol seemed to provide the 
most obvious explanation for these differences.  
 
Table 3.5: Protocol acquisition parameters highs in red the protocol from 
Maudsely Twins Study as the one different from the other two protocols 









3_F 7_T 4_A 
Orientation Coronal Coronal Coronal 
TR 13.1 35 13.8 
TE 5.8 5 2.8 
TI 450 0 450 
Flip angle 20 35 20 
xdim 0.859375 0.78125 0.9375 
ydim 0.859375 0.78125 0.9375 
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3.7.2.3 Conclusions of second analysis 
Since the aim of the AFT calibration project was to establish the comparability 
of MRIs obtained across 3 different studies, I explored the possibility of 
including the second, different, protocol used in the Twin study: the ―Short‖ 
protocol. As mentioned above, during the recruitment period, The Maudsley 
Twin Study used 2 protocols: the ―long version‖ which was included in the AFT 
calibration study, and the ―short version‖, which had the same acquisition 
parameters as the Maudsley Family Study.  Including data collected with this 
short protocol meant that I would only have to explore the correlation of 2 
protocols. As I decribed above, I originally considered the MRIs obtained with 
the long version because there was a larger number of subjects on whom MRI 
and genetic data relevant for my main study were available. I looked at the 
potential number of MRI images that could be included in my study if the short 
version of the Maudsley Twin Study was included. There were 100 MRIs 
obtained with the short version protocol (same acquisition parameters as the 
Maudsley Family Study). Therefore, I decided to consider including these in 
my main study.  
 
In my next analysis, I will refer to the short version of the Maudsley Twin Study 
as the Maudsley Family-Twin protocol, as the protocol was the same as the 
one of the Maudsley Family study. 
 
3.7.3 Third analysis 
3.7.3.1 Image Processing  
In order to increase the quality of the segmentation and correlation across 
protocols, in this phase I first applied the same processing steps to the images 
as described in the previous section. However, after applying the N3 algorithm, 
rather than reorienting all the images, I reoriented the images acquired with the 
Maudsley Family-Twin protocol and realigned the images acquired with the 
AESOP protocol to the reoriented Maudsley Family-Twin protocol images. 
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All the realigned images were segmented applying the same parameters as 
described in the previous analysis. The volumes were extracted by segmenting 
the brain images with SPM8. 
 
3.7.3.2 Correlation analysis 3  
 
I explored the correlation between volumes using SPSS. I run a between-
protocol reliability test again to estimate the intra-class correlation coefficient 
(ICC) for the volumes of interest. Using the Maudsley Family-Twin Study and 
AESOP protocols, the correlation between studies improved significantly, as 
shown in Table 3.6. The Pearson‘s correlation between the AESOP and the 
Maudsley Twin-Family protocol was, for the grey matter r=0.98 (p=000), and 
for white matter r=0.95 (p=000). The reliability test was conducted and the 
Cronbach‘s Alpha was above 0.98 for all volumes. 
 
Table 3.6 Results of correlation between studies after in the third analysis: 
Paired Samples Correlation 
 N Correlation Sig 
Pair 3_F&4_A  Grey matter vol 12 .980 .000 
Pair 3_F&4_A  White matter 
vol 
12 .995 .000 
Pair 3_F&4_A  Whole brain vol 12 .992 .000 
 
 
3.7.3.3 Conclusions of the third analysis  
Using MRIs acquired with more similar acquisition parameters increased the 
correlation of the brain volumes obtained with SPM. I therefore decided that, 
for my main study analysis, only the individuals who had been scanned in the 
Twin study using the Maudsley Family-Twin sequence were to be included. 
 
   




I described a method that can be applied to combine MRIs from different 
studies. Twelve healthy volunteers were scanned with the same scanner and 
acquisition protocols used in the original studies.  All the images were checked 
for quality, explored for differences between modulated and unmodulated data, 
and processed to obtain grey, white and CFS volumes.  
 
I carried out 3 different analyses looking at the correlation and reliability of 
brain volumes when combining data obtained from three protocols in the same 
scanner. In the firsts analysis, although the intra-class correlation among the 3 
studies was good (above 0.8 for grey matter and 0.9 for white matter), the 
correlation between studies was below 0.5. This was particularly evident with 
the Maudsley Twin Study long-protocol in comparison with the other two 
protocols. 
 
In view of this, I then modified the image pre-processing. I reoriented the 
images manually and also applied an additional intensity non-uniformity 
correction with the N3 function. Despite these additional steps the correlations 
continued to be unsatisfactory. After reviewing the acquisition paramenters, it 
appeared that the Maudsley Twin long-version protocol accounted for the poor 
correlation. I then decided to use the short version of the Twin protocol, 
obtaining better volume comparability.   
 
3.9 Conclusion 
This comparability study suggests that, when using SPM, modulated images 
provide more robust and reliable correlation of volumes obtained with different 
protocols. SPM is a fully automated method that adds a great value to the pre-
processing and analysis of a large number of neuroimaging data. However, 
similarly to other automated methods, this also has some disadvantages. For 
instances, although SPM runs an intensity non-uniformity correction during the 
segmentation pre-processing, it has been shown that the application of 
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another step  by applying N3 algorithm ensures better segmentation, and 
therefore should be applied to increase reliability (Acosta-Cabronera et al. 
2008). This is particularly important when analyzing images that have been 
obtained over a long period of time, as the sensitivity of the scanner reception 
coil, induced eddy and non-uniform excitation can change in time (Sled at al., 
1998). In addition to this, the orientation and rotation of images along the 
same axes is also important and should be checked and corrected if 
necessary.  
 
Finally, I believe that the most important conclusion for this study is that when 
seeking to combine MRI images from different studies/centers, it is important 
to first explore comparability of MRI scanners and establish correlation 
between data acquired with different parameters. This can be more easily 
assessed by scanning the same subjects in the different scanners and with 
the different protocols. This will allow to take into consideration the variability 
that may accounts for subjects differences. In fact, as shown in this calibration 
study, even small differences in acquisition parameters can play an important 
role when analyzing multicentre or multi-study scans.  
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Chapter 4: Results: Demographic and clinical characteristics 
 
4.1 Methods 
I collected information from subjects recruited from three studies conducted in 
the Division of Psychological Medicine: Aetiology and Ethnicity of 
Schizophrenia and Other Psychosis (AESOP), Maudsley Family Study (MFS), 
and the Maudsley Twin Study (MTS) of psychosis. All subjects had a 




A total of 541 subjects were included from the three studies (Table 4.1).  
 
4.2.1 Aetiology and Ethnicity in Schizophrenia and Other Psychoses (AESOP) 
A total of 281 patients met the inclusion criteria and were invited to participate; 
90 of these refused to take part in the investigation. Of the 191 patients who 
participated in the study, 90 disengaged before completing the assessments, 
and a total of 101 subjects underwent an MRI scan in the baseline recruitment 
process. A total of 110 healthy volunteers were recruited from the same 
sociodemographic area to match patients in terms of gender, ethnicity, and 
years of education and 96 agreed to have an MRI scan. From this final 
sample, I ensured that all images were of a good quality, and following this, I 
was able to include them all in my study. 
 
4.2.2 Maudsley Family Study 
In the original sample from the Maudsley Family Study, the age range was 
broad, and included subjects over the age of 68 years. Since in the other 2 
studies included in my thesis the maximum age for inclusion was 65 years, to 
make the sample more homogeneous for statistical analysis removed from the 
analysis subjects older than 68 years of age. These were: 5 Relatives (ages: 
80, 75, 73, 72 and 69 years old) and 1 Control (69 years old). After these 
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subjects were excluded, the final sample of my study reached a total number 
of 535. 
 
4.2.3 Maudsley Twin Study 
The final study groups consisted of 30 pairs of MZ twins concordant for 
schizophrenia or schizoaffective disorder; 21 pairs of MZ twins and 12 pairs of 
DZ twins discordant for schizophrenia, in which the co-twin was free of any 
psychotic illness. Finally, 55 pairs of MZ and 18 pairs of DZ control twins with 
no personal or family history of a psychotic or schizophrenia spectrum 
disorder up to the second-degree relatives were also included. From the 
images obtained in this study, I excluded 24 subjects that were identified as 
having acquisition parameters not compatible with the rest of the sample. In 
addition, 1 subject of a pair was excluded due to poor image quality. This left 
MRI scans from 40 pairs, 5 single affected twins and 1 single non-affected 
twin for inclusion in the analyses.  
 
Table 4.1: whole sample distribution according to study. 







Patients 101 82 42 225 
Relatives - 111 19 130 
Controls 96 58 26 180 
 
 
4.3 Statistical Analysis 
All demographic statistical analyses were carried out using SPSS package 
version 13 (SPSS Inc., Chicago, IL). I used chi square (x²) for non-parametric 
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4.4 Results of the whole sample  
 
4.4.1 Sample demographics 
For this analysis, the final sample was composed of a total of 225 cases, 130 
relatives and 180 healthy volunteers. The patient groups was composed by 
144 subjects with a diagnosis of schizophrenia, 69 subjects with an bipolar 
disorder and 12 subjects with other psychosis. The demographic 
characteristics of the final sample are outlined in the tables 4.2 and 4.3 
 
Table 4.2: Clinical characteristics of the sample 
 





AESOP 59 31 11 - 96 
MFS 43 38 1 111 58 
MTS 42 - - 19 26 




4.4.1.1 Gender: There were significantly more males in the patients group 
(x²=11.06; p=0.001). However, relatives and controls were well matched for 
gender (x²=1.01; p=0.29 and x²=1.3; p=0.25 respectively), with a larger 
number of male subjects in both groups. There was a significant gender 
difference within diagnoses in the patients group, with the bipolar disorder 
group having more females than males in their group (x²=11.06; p=0.001).  
 
4.4.1.2 Height: There were no significant differences in height among patients, 
relatives, and healthy controls. 
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Table 4.3: Demographic characteristics of the final sample. 
 
 
4.4.1.4 Age: To test for age differences I used t-test and Univariate Analysis of 
Variance. There was a significant difference in age between groups. Patients 
were significantly younger than relatives (t-test: t=-8.9, p=.000; 95% CI=-14.7 
to -9.4). Relatives were significantly older than healthy volunteers (t=7.36, 
p=.000; 95% CI=8.2 to 14.2). There were no differences in age between 
patients and controls.  
 
When age was compared across studies (table 4.4), there was significant 
difference in mean age across studies. Patients in the AESOP study were 
significantly younger (mean age=27.0, SD=7.96) than patients in the 
Maudsley Family Study (mean age=37.9, SD=10.5; T-test: p=.001, 95% CI=-
13.7 to -8.08) and the Maudsley Twin Study: (mean age=33.31, SD 10.66; T-
test: p=.018, 95% CI=-9.56 to -2.96). Also, controls from the Maudsley Family 
Study were significantly older (mean age=39.7, SD=14.59) than in the AESOP 
study (mean age=28.3, SD=7.7; T-test: p=.000; 95% CI=-15.37 to -7.35) and 
in the Maudsley Twin Study (T-test: p=.000; 95% CI=0.73 to 13.1). There was 
 Patients Relatives Controls 
Subjects n 225 130 180 





162/17/27/19 129/0/0/1 128/14/25/13 
Mean age, years (SD) 32.2 (10.5) 44.3 (14.8) 33.6 (11.7) 
Age range, years 17-64 16-68 16-68 








Handedness, n right (%) 177 (77.3) 105 (80.8) 100 (81.3) 
Mean height, cm (SD) 173.1 (9.2) 169.6 (10.4) 171.4 (8.9) 
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no statistically significant difference between controls in the AESOP study and 
the Maudsley Twin Study. Relatives from the Maudsley Family Study (mean 
age=46.6, SD=14.3) were significantly older than those in the Maudsley Twin 
Study (mean age=31.2; SD=10.8; T-test: p=0.005, 95% CI=8.6 to 22.2). All 
these differences remained significant when corrected for gender.  
 
 
Table 4.4 Age according to study 
 
 
4.4.1.4.1 Age and diagnosis: The results are shown in table 4.5. The Patients 
with schizophrenia were significantly younger than patients with bipolar 
disorder and the relatives (p=.008; 95% CI=-8.1 to -1.2 and p=.000; 95% CI=-
15.9 to -1.1 respectively). 
 
There was also a significant age difference between bipolar patients and 
those with other psychosis (p=.024; 95% CI=1.1 to 15.8) and the relatives 
(p=.000; 95% CI=-12.1 to -5.1). Finally, the control and the other psychosis 
groups were also significantly younger than the relatives (p=.000; 95% CI=-
13.4 to -8 and p=.000; 95% CI=-24.26 to -10). However, when corrected for 
multiple comparisons with Tukey's HSD (Honestly Significant Difference) test, 









 Patients Relatives Controls 





























Table 4.5: Age according to diagnosis  
 
4.4.1.4.2 Age, gender and diagnosis: Female subjects were consistently older 
in all the groups. However, the differences were not significant when corrected 
for multiple comparisons with Tukey's HSD (Honestly Significant Difference) 
test.  
 
4.4.1.5 Ethnicity: The sample was formed of subjects from different ethnic 
backgrounds. The description is represented in table 4.3. The majority of the 
participants were Caucasian (n: 419, 78.3%), followed by Afro-Caribbean (n: 
52, 9.7%) then other ethnic background that would include Asian, Pakistani 
and Indian origins (n: 33, 6.1%) and finally, Black African (n: 31, 5.8%). 
Subjects from the Maudsley Twin Study were all Caucasian. There were 2 
Asian subjects in the Maudsley Family Study. The rest of the variations in 
ethnicity were related to the AESOP study sample. The x² test showed a 
significant difference in ethnicity in the three groups where the Caucasian 
were significantly outweighed: patients group x²=263.8 p: .000; relatives group 
x²=126 p:.000 and healthy volunteers group x²=295.5  p: .000.) 
 
4.4.1.6 Medications:  
I obtained information on medication at the time of the MRI on 134 patients. In 
the schizophrenia groups: 13 patients (8.9%) were on typical antipsychotics, 











n  144 69 12 130 180 
Gender 
female/mal
e n  
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45 (30.8%) were on atypical antipsychotics, 1 (0.7%) on mood stabilizer, 3 
(2.1%) on both mood stabilizer and antipsychotic, 12 (8.2%) on both 
antidepressant and antipsychotic and 1 on both mood stabilizer and 
antidepressant.  In the affective psychosis group: 1 subject (1.4%) was on 
atypical antipsychotic, 14 (20.3%) on mood stabilizer, 10 (14.5%) on both 
mood stabilizer and antipsychotic, and 9 (13%) on both mood stabilizer and 
antidepressant. Finally, 23 patients (32.8%) were taking lithium.  
 
4.4.1.7 Brain volume analysis 
The brain volumes were normally distributed in the 3 groups in the whole 
sample. The results of brain volume according to group are described in each 
chapter accordingly.  
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Chapter 5: Neuroimaging results: Case-Control  
 
5.1 Introduction 
The literature on brain volumetric changes in patients with schizophrenia and 
bipolar disorder was described in Chapter 1: Introduction. In summary, there 
have been a number of studies that have also been the subject of various 
meta-analyses that consistently identify a reduction of whole brain and grey 
matter volumes in these patients. In contrast, the findings on white matter 
have remained inconsistent.  
 
In this chapter I will describe the analysis of brain volumes that I have 
conducted comparing patients with psychosis and healthy volunteers.  
 
I predicted that subjects with a psychotic illness would present with smaller 
whole brain, grey and white matter volumes than healthy volunteers. In 
addition, I predicted that the differences in brain volumes between patients 
with schizophrenia and healthy volunteers would be larger for whole brain and 




In this chapter I will look at differences in total grey and white matter volume 
and whole brain volume in patients versus the control group. Therefore, to 
avoid the potential effect of familiality, for this analysis I selected cases and 
controls from the three studies excluding all the relatives included in the 
Maudsley Family Study. Additionally, from the Maudsley Twin Study I 
excluded 1 subject from each pair of monozygotic concordant twins in both 
the patient (11 subjects) and the control (10 subjects) groups. Finally, I 
excluded 1 subject from each pair of the dizygotic twin from the control group 
(3 subjects). The selection of the individuals was done randomly. I first 
identified and organized the twin pairs in ascending order according to their 
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unique identification number. Then, I selected the first subject of each pair 
from the organized list. Finally, as for the monozygotic discordant twins, I 
excluded all the healthy subjects of the pairs (12 subjects). The Maudsley 
Family Study and AESOP study inclusion criteria for the healthy volunteers 
was that they should have not had any family or personal history of psychotic 
disorder. Therefore, I included all the healthy volunteers from these studies. 
 
The final sample used for the case-control analyses was composed by a total 
of 219 cases and 167 controls. The patient group included 138 subjects with a 
diagnosis of schizophrenia, 69 subjects with bipolar disorder and 12 subjects 
with other psychoses. This distribution is represented in table 5.1. The clinical 
and demographic characteristics of the sample are described in chapter 2.  
 
Table 5.1. Case control sample 
 
 
5.3 Magnetic Resonance Images analysis 
The acquisition, pre-processing and analysis of the structural MRI images 
have been described in chapter 2.  
 
Here, I first compared differences in brain volumes between patients group as 
a whole and healthy volunteers, by using linear regression. For the second 
part of this analysis, I divided the patients into two main diagnostic groups: 
schizophrenia (which included diagnoses of paranoid schizophrenia, 
schizophrenia NOS and schizoaffective psychosis), and bipolar disorder 
(which included a diagnosis of bipolar 1 and 2 disorder). Each diagnostic 
Group Number of 
participants 
healthy volunteers 167 
schizophrenia 138 
bipolar disorder 69 
other psychoses 12 
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group was compared to the healthy volunteers in a single analysis for each 
tissue measure. Each tissue volume was regarded as the dependent variable, 
while group, gender, protocol, age, height and whole brain volume were 
entered as covariates. To investigate the potential influence of years of illness 
on brain volume, I ran a partial correlation analysis between brain volumes 
and years of illness, correcting for age, gender and whole brain volume. All 
tests were two-tailed. The analyses were performed using STATA version 10 
(Stata Corp., College Station, Tex). 
 
5.4 Results 
The unadjusted brain volume among the different clinical groups is described 
in table 5.2. 
 
 
Table 5.2 Unadjusted brain volumes according to group  
 Grey matter,  









together   
.68 (.078) .42 (.058) 1.10 (.13) 
Schizophrenia .66 (.076) .43 (.058) 1.06 (.12) 
Bipolar disorder .69 (.075) .40 (.050)        1.10 (.13) 
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5.4.1 Brain volumes in all patients and healthy controls 
There were no significant differences between patients and healthy volunteers 
in grey, white, or whole brain matter volumes. The box-plot in Graph 5.1 












white matter whole brain volume
grey matter
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5.4.2 Brain volumes across different diagnostic groups and healthy 
controls  
I explored whether there was any difference in brain volumes between 
patients with different diagnoses, and in comparison to healthy volunteers. For 
this analysis, I only included the two major diagnositic groups in the sample in 
order to reduce heterogeneity due to diagnostic classification. Therefore, I 
analyzed patients with schizophrenia or bipolar disorder and healthy volunteer 
groups. 
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5.4.2.1 Grey matter 
Patients with schizophrenia showed significantly smaller grey matter volumes 
when compared to healthy volunteers (B=-.007, 95% CI=-.014 to -.0007; 
p=.03). Patients with schizophrenia also showed significantly smaller grey 
matter volume when compared to subjects with bipolar disorder (B=-.013, 
95% CI=-.004 to -.022; p=.004).  There was no significant difference in grey 
matter volume between patients with bipolar disorder and healthy volunteers.  
 
Graph 5.2: Total grey matter volume according to clinical groups 
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5.4.2.2 White matter 
Both patients with schizophrenia and patients with bipolar disorder had 
significant differences in white matter volume when compared to healthy 
controls. However, these changes were in different directions. While patients 
with schizophrenia showed larger white matter volume than healthy 
volunteers, patients with bipolar disorder had a significantly smaller volume 
than healthy volunteers (B=.005, 95% CI=.0002 to .010; p=.04 and B=-.006, 
95% CI=-.011 to -.0001; p=.04 respectively). When comparing patients with 
schizophrenia with patients with bipolar disorder, the difference was even 
more statistically significant. Patients with bipolar disorder showed smaller 
total white matter volumes than patients with schizophrenia (B=-.011, 95% 
CI=-.017 to .004; p=.001) 
 
 
Graph 5.3: Total white matter volume according to groups 
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5.4.2.3 Whole brain matter volume 
When comparing whole brain volume between different diagnostic groups and 
with healthy volunteers, only patients with schizophrenia showed a significant 
difference. They presented a smaller whole brain volume (B=-.024, 95% CI=-
.048 to -.0001; p=.04) than healthy volunteers. It is worth noting that this 
difference seems to be related to the grey matter decrements since, as I 
previously described, white matter volume in this group was larger than the 
healthy volunteers. There were no differences in whole brain volumes 
between patients with schizophrenia and patients with bipolar disorder.  
 
 
Graph 5.4: Whole brain matter volume according to groups 
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5.4.3 Years of illness and brain volumes 
There was no significant correlation between duration of illness (in years) and 
grey and white matter volumes. However, whole brain volume was negatively 
correlated with duration of illness (r=.229; p=.001).  
 
When I explored if there were differences in the correlation between brain 
volumes and years of illness across the two main diagnostic groups, I found 
that, albeit at trend level (r=.231; p=.008), only schizophrenia showed a 
positive correlation between whole brain volume and the duration of illness.  
 
5.4.4 Medication and brain volumes 
I run a post-hoc partial correlation analysis looking at medication influence on 
brain volumes and this was not significant. However, this study was not 
designed to specifically answer that question. Hence, some of the brain matter 
changes could still be explained by the effects of different pharmacological 
treatments on the brain.  
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Chapter 6: Neuroimaging results: Brain volumes comparison 
with relatives and familiality analysis 
 
6.1 Introduction 
The inheritance of whole brain volume in schizophrenia has been described 
as between 66% and 97% (Peper et al., 2007; Rijsdijk et al., 2005). One of the 
most consistent findings in relatives of patients with schizophrenia has been 
the reduction in hippocampus volume (Kashavan et al 1997, Lawrie et al 
1999; Johnstone et al., 2002) and whole brain and grey matter volumes (Boss 
et al., 2007). However, results remain inconsistent.  
 
Twin studies have shown that co-twins with schizophrenia have smaller whole 
brain volumes than their healthy co-twin, who however also showed smaller 
brain volume than healthy control twins (Baare et al., 2001). This trend has 
been later replicated by another twin study by van Haren and colleagues 
(2004), which concluded that similarities in whole brain volume reductions 
were higher when pair members were more closely genetically related. A 
meta-analysis carried out by Boos and colleagues (2007) supports the initial 
findings of hippocampus and whole grey matter reductions in the relatives of 
patients with schizophrenia in comparison to healthy controls. In contrast, 
studies of relatives of patients with bipolar disorder have reported no 
morphological differences in comparison to healthy controls (McDonald el al., 
2006). A study by McDonald et al., (2004) on structural brain 
endophenotypes, measuring genetic liability in families of psychosis, 
evaluated the genetic risks for brain volumes. The authors found illness-
specific (i.e. schizophrenia or bipolar disorder) association in gray matter 
regional volume reductions, while white matter volume reductions were not 
illness-specific. These findings suggest that a genetic risk for psychosis is 
strongly related to brain structural alterations.  
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In order to understand brain deviations in complex psychiatric disorders like 
psychosis, studies have attempted to reach relatively large number of subjects 
to achieve the statistical power needed to detect subtle brain changes. In 
particular, some studies have explored the possibility of combining MRIs 
acquired with different scanners (Van Haren et al 2003; Meda et al 2008), and 
others have used a multicentre scanner design in patients with schizophrenia 
(Meda et al 2008; Segall et al 2009).  
 
For my project I run a calibration study looking at the comparability of two 
different protocols and I addressed the difficulties of this approach in chapter 
2. In the present chapter, I present the results of the analysis that uses 
computational morphometry to identify brain volumes differences in subjects 
affected with psychosis, first degree of healthy relatives and healthy 
volunteers. In addition, I explored the familiality of any brain deviation. 
 
To my knowledge this is the first study that has compared patients with 
psychosis with a group of first degree relatives of patients with psychosis and 
healthy volunteers as a part of a multi-study design.  
 
I predicted that subjects with a psychotic illness would present smaller brain 
matter volumes when compared with the relatives and healthy controls. 
Additionally, I predicted that the unaffected relatives would present brain 
reductions similar to those of patients but less prominent. A 
 
6.2 Methods and Sample 
In this section, I compare brain volumes among patients with psychosis, their 
unaffected first degree relatives and healthy volunteers.  
 
The final sample used for this neuroimaging analysis included a total of 535 
subjects: 225 patients, 130 relatives and 180 healthy volunteers. The full 
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description of the demographic of the sample has been described in Chapter 
4: Clinical and Demographics Results. For this analysis I considered the 
relatives of each major disorder separately. The sample included 69 relatives 
of schizophrenia patients and 61 relatives of bipolar disorder patients. The 
summary of the sample demographics is shown in table 6.1. 
 
 
Table 6.1: Sample summary. 
Groups N 
Schizophrenia 144 
Bipolar Disorder 69 
Relatives of schizophrenia 69 




6.3 Magnetic Resonance Images 
The acquisition, pre-processing and analysis of the structural MRI data were 
described in detail in chapter 2.  
 
In summary, I combined neuroimaging obtained with two different protocols, 
and carried out the quality control and pre-processing of all the images. 
 
6.4 Statistical Analysis 
For this analysis I clustered the subjects into families. Therefore, each family 
was given an identification number and each subject a status identification 
code depending on whether they were patients, relatives or healthy 
volunteers. For these analyses I used STATA (version 10; Stata Corp, College 
Station, TX, USA), applying the regress command and combining robust and 
cluster options.  
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I first compared brain volumes between patients and relatives versus the 
control group, using linear regression analysis, with brain volumes as the 
dependent variable, and controlling for age, whole brain volume, protocol and 
gender. When analyzing whole brain volume, the results were corrected for 
height rather than whole brain volume.   
 
Then, to explore whether familiality had an effect on brain volumes, brain 
volume values were subject to a mixed model analysis with fixed effect (group, 
age, gender, protocol and whole brain volume) and random effects (family). 
The linear mixed models provide an estimate of the between-family variability 
and the within-family variability. Therefore, I used the intra-family correlation 
coefficient (which measures the percentage of the total residual variability due 
to family differences) as an index of familiality. A likelihood ratio test was then 
used to assess the significance of the random (i.e., family) effect. The 
commands for these analyses were xtreg and xttest0. This method has been 
previously described (Bramon et al., 2004; 2005).  
 
 
6.5 Results: Brain volume comparisons 
The main brain volumes for each group are described in Table 6.2 and 6.3 
 
Table 6.2 Unadjusted brain volumes according to group  
 Grey matter,  
mean litres  (SD) 
White matter, 
mean litres (SD) 
TIV,  
mean litres (SD) 
Patients .681 (.078) .422 (.058) 1.10 (.127) 
Relatives .684 (.080) .422 (.065) 1.10 (.136) 
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Table 6.3 Uncorrected brain volumes according to diagnosis 
 Grey matter, 








Schizophrenia .67 (.074) .43 (.058) 1.08 (.12) 
Relatives of 
schizophrenia 
.67 (.078) 42 (.066) 1.10 (.14) 
Bipolar 
disorder 
.69 (.075) .40 (.050) 1.10 (.12) 
   Relatives of 
bipolar disorder 
.69 (.077) 42 (.056) 1.12 (.12) 
 
 
6.5.1 Patients with schizophrenia, their relatives and healthy volunteers 
When I analyzed grey and white matter and whole brain volumes, I found no 
statistically significant differences between patients with schizophrenia and 
their relatives or between relatives of patients with schizophrenia and healthy 
volunteers. 
 
6.5.2 Patients with bipolar disorder, their relatives and healthy 
volunteers 
When I compared grey and white matter volumes in patients with bipolar 
disorder, with those of their relatives, I found no statistically significant 
difference between the groups. However, patients with bipolar disorder had 
significantly smaller whole brain volume than their relatives (B=-.04; p= .01, 
95% CI=-.01 to -.07). The comparison between the relatives of patients with 
bipolar disorder and the healthy volunteers did not reveal any signifficant 
difference in any of the three brain volumes analized.  
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All the analyses were carried out including the whole twin sample. In order to 
avoid duplication of genetically identical brains, I re-ran the analysis excluding 
1 pair of the monozygotic twins following the same criteria as for the case-
control analysis. This approach did not produce any change in the results.  
 
6.6 Assessment of familiality  
 
6.6.1 Schizophrenia Families 
To estimate the familiarity of the different brain volumes, I compared the 
within-family variance against the between-family variance. In families with 
schizophrenia, for grey matter volume, the family clusters accounted for 48% 
of the total variance. For the white matter volume, the family clusters 
accounted for 27% of the total variance and for whole brain volume for 35% of 
the total variance.  The results are summarized in tables 6.4, 6.5 and 6.6. 
 
Table 6.4 Comparison of grey matter volume within and across 
schizophrenia families 
 Standard Deviation Variance 
Between family factor 0.21 0.0004 
Within family factor 0.20 0.043 
Fraction of the total 
variance endorsed to 
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Table 6.5 Comparison of white matter volume within and across 
schizophrenia families 
 Standard Deviation Variance 
Between family factor 0.01 0.012 
Within family factor 0.02 0.0003 
Fraction of the total 
variance endorsed to 





Table 6.6 Comparison of whole brain matter volume within and across 
schizophrenia families 
 Standard Deviation Variance 
Between family factor 0.06 0.004 
Within family factor 0.09 0.007 
Fraction of the total 
variance endorsed to 
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6.6.2 Bipolar Disorder Families 
In families with bipolar disorder, for grey matter volume, the family clusters 
accounted for 48% of the total variance. For white matter volume, the family 
clusters accounted for 43% of the variance and for whole brain volume for 
22% of the total variance.  The results are summarized in tables 6.7, 6.8 and 
6.9. 
 
Table 6.7 Comparison of grey matter volume within and across bipolar 
disorder families 
 Standard Deviation Variance 
Between family factor 0.01 0.0001 
Within family factor 0.014 0.0002 
Fraction of the total 
variance endorsed to 





Table 6.8 Comparison of white matter volume within and across bipolar 
disorder families  
 Standard Deviation Variance 
Between family factor 0.01 0.00016 
Within family factor 0.01 0.0002 
Fraction of the total 
variance endorsed to 
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Table 6.9 Comparison of whole brain matter volume within and across 
bipolar disorder families 
 Standard Deviation Variance 
Between family factor 0.042 0.0018 
Within family factor 0.078 0.0061 
Fraction of the total 
variance endorsed to 




As shown in the tables, the three volume measured are highly familial. 
However, out of the three, white matter, although statistically significant, 
seems to have less familial influence.  
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Chapter 7: Genes and brain volumes 
 
7.1 Introduction 
Currently, it is widely accepted that psychosis aetiology is based on a 
combination of genetic and environmental factors (Sullivan et al., 2003; Braff 
et al. 2007a). One recent approach to elucidate the pathways into these 
disorders has been the exploration of endophenotypes. As noted in chapter 1, 
endophenotypes are defined as a heritable disease trait (Gottesman & Gould, 
2003), including a mong these brain morphometric deviations (Braff et al. 
2007b). A number of global and regional volumes such as those of whole 
brain, grey and white matter, have been described as highly heritable, with an 
heritability estimated at around 85% (Sullivan et al., 2003; Peper et al., 2007; 
Kaymaz and van Os, 2009). These findings suggest that there is likely to be a 
considerable genetic influence in the brain differences observed in patients 
with psychosis. In addition, the progressive whole brain volume changes 
often reported in schizophrenia (Hulshoff et al., 2008) also are claimed to be 
related to genetic factors (Brans et al., 2008). 
 
In this chapter I will explore the genetic influence of a number of relevant 
candidate genes involved in neurodevelopment of whole grey and white 
matter volume as well as in whole brain matter volume. I also explore the 
genetic influence of a number of candidate and neurodevelopmental genes 
that have been described in gene wide association studies (GWAS) to 
influence brain volume in healthy populations, namely SBNO1, NTRK2, 
HMGA2 and CRHR1. To my knowledge, this is the first time that the role of 
these genes has been assessed in a sample of patients with psychosis and 
their relatives.  
 
7.2 Sample 
The sample characteristics were fully described in Chapter 4: Results: Socio-
demographics). For the genetic analyses, I included all subjects with 
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neuroimaging and genotyping data. In order to minimize the confounding 
effect of ethnic admixture, I only included Caucasian subjects from the 
AESOP, Maudsley Twin Study and Maudsley Family Study.  Moreover, I 
selected twins with the same criteria I used for the neuroimaging analysis. The 
selection of the twins was described in detailed in Chapter 2: Aims and 
Methods. In summary, given that monozygotic twins share 100% of their 
genes, I randomly selected 1 twin of each monozygotic pair. Dizygotic twins 
were included and coded as part of the same family, since they share 
approximately 50% of the genetic loading, similarly to non-twin siblings. The 
final sample was therefore composed of 387 Caucasian subjects with genetic 
data. The sample was composed of 152 patients, 117 relatives and 118 
healthy controls. The patient group included 99 patients with schizophrenia 
disorder, 48 patients with bipolar disorder and 5 subjects with another 
psychosis (psychosis NOS). I have summarized the demographics of the 
sample in Table 7.1.  
 
Table 7.1: Sample demographics for genetic analysis 
 Patient Relative Control 
Total number = 389 152 117 118 
male, n (%) 
92 (60%) 51 (43%) 65 (55%) 
Mean age (SD) 
34.36 (10.8) 45.8 (14.5) 34.8 (17.7) 
Diagnosis 
Schizophrenia 99 NA NA 
Affective Psychosis 48 NA NA 









7.3.1 Neuroimaging and brain volumes 
The full details of the MRI pre-processing and volume extraction were 
described in chapter 2 ‗Aims and Methods‘.  
 
7.3.2 Genotyping 
The method has been described in Chapter 3. Briefly, the DNA was obtained 
from blood or cheek swab samples. The DNA extraction method was the 
same for all subjects from the different studies. The summary of the 
genotyping methods used was fully described in Chapter 2: Aims and 
Methods. 
 
7.3.3 Candidate gene selection 
As noted earlier, I selected a number of candidate genes based on the most 
consistent finding on candidate genes for psychosis and brain volumes. 
Among these, I selected: Catechol-methyl-transferase -(COMT), Brain-
Derived-Neurotrophic-Factor (BDNF), Neuregulin1 (NRG1) and Dysbinding 
(DTNBP1), as described in the Chapter 1: Introduction. Since the sample is 
composed of a combination of three different studies, I explored the role of the 
three SNPs that have been consistently genotyped across the three studies. 
These were: COMTval/met polymorphism (rs4680), BDNFval/met 
polymorphism (rs6265) and SNP8NRG243177 (rs6994992). Additionally, from 
the original MRI sample, I selected for this study four other SNPs. These 
were: SNP8NRG221533, SNP8NRG241930), DTNBP1P1757 (rs2005976) 
and DTNBP1P1320 (rs760761), consistently in the Maudsley Family and Twin 
Studies but not in the AESOP sample.  
 
7.3.4 Genome-Wide Association Study: GWAS 
In order to assess brain volume changes influenced by genetic factors, I also 
analyzed genetic data derived from the GWAS project carried out in the 
Department of Psychosis Studies, at the Institute of Psychiatry – see Chapter 
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2 Methods. I selected specific candidate genes based on a literature research, 
according to two criteria: 
1) SNPs that have been described as candidate genes by playing a role in 
brain morphometry or white matter integrity in psychosis, which therefore 















3) Finally, I evaluated the effects on brain volumes of three genes that have 
been recently described by genome-wide association studies to affect brain 





A number of SNPs that have been described in the literature to influence brain 
volume were not available in our GWAS sample. Therefore, I identified a proxy 
SNP for those SNPs and I described the results of this selection in Chapter 2: 
Aim and Methods.    
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7.4 Statistical analysis 
The allele frequency and the deviations from Hardy-Weinberg equilibrium 
were assessed by chi-square tests using SPSS version 18 for Microsoft 
Windows (SPSS Inc, USA). For the statistical analysis of the genetic influence 
in brain volumes, I used both packages Stata version 10 (StataCorp LP, USA) 
and SPSS version 18 for Microsoft Windows (SPSS Inc., USA). The effect of 
candidate genes on brain volumes was examined using linear mixed models 
fitted with maximum likelihood methods. This method has been previously as 
described by Dutt et al (2009). Correlations between members of the same 
family were accounted for by including random intercepts for families, which is 
needed to maintain correct type 1 error rates. The dependent variables were 
grey, white and whole brain volume, while genotypes were entered as the 
main independent variables. In addition, all analyses were adjusted for the 
fixed effects of clinical group (patients, relatives and control). I also assessed 
genotype effect in brain volumes between patients and healthy volunteers 
using a linear regression analysis model with brain tissue volumes as the 
dependent variable. For these analyses the other additional independent 
variables were, age, sex and height.  
 
7.5 Results 
A total of 387 subjects were genotyped. However, from the genotyping 
obtained from the GWAS, only 149 passed Quality Control. The allele 
frequency for each group is summarized in the complementary table 1 and 
can be found in the Complementary Tables Section.  
 
As described in chapter 2: Methods, 7 SNPs were genotyped either in the 
SGDP or by external companies focusing on a single SNP. COMTval/met 
polymorphism (rs4680), BDNFval/met polymorphism (rs6265) and 
SNP8NRG243177 (rs6994992) genotyping included subjects from the AESOP 
study, the Family Maudsley Study and the Maudsley Twin Study and thus the 
final genotyping data was obtained from more than 300 subjects. However, 
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when the sample was reduced for the SNPs genotyped in the Maudsley 
Family and Twin studies (SNP8NRG221533, SNP8NRG241930), 
DTNBP1P1757-rs2005976 and DTNBP1P1320-rs760761) the number of 
genotyped samples was reduced to around 230. In each genotyped SNP 
carried out in a smaller scale (i.e. locally or by external companies and no 
GWAS), there was a variation in sample sizes from the original 387 included 
subjects in sample size (complimentary tables and table Table 7.3). This 
variance is usually expected as a consequence of genotyping problems due to 
a number of factors such as biochemical artefacts and equipment factors 
i.e.Taq polymerase errors or low quality reagents; sample quality factor i.e. 
low quality or quantity of DNA and, human factor i.e. sample manipulation and 
confusion between samples (for example, mislabeling or tube mixing) 
(Pompanon et al., 2005).  
 
The remaining 13 SNPs (DTNBP1_rs1047631, DTNBP1_rs875462, 
NTRK2_rs10868219, RELN_rs7341475, MCPH1_rs2305022, 
MCPH1_rs930557, MCPH1_rs1057090, MCPH1_rs2912016, 
ASPM_rs3762271, OLIG2_rs1059004, SBNO1_rs7980687, 
HMGA2_rs1042725, CRHR1_rs11655470) that I included in my thesis were 
extracted from GWAS data. Although GWAS data is less sensitive to human 
error than smaller scale genotyping, it is still greatly influenced by DNA low 
quality or quantity as well as population structures (Cardon and Palmer, 2003; 
Turner at al., 2011) and the Wellcome genotyping Centre has particularly 
stringent standards . These factors have played an important role in my study 
as the DNA samples had been collected over a period of up to 15 years,  the 
demographic information such as ethnicity was recorded by self-asserted 
ethnicity by participants in combination with information from FIGS. In addition, 
DNA samples have been used for this and other genotyping before. All these 
factors have influenced both the quality and quantity of DNA leading to a 
significant reduction in sample size after undergoing GWAS quality control 
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(QC). The final sample for the remaining SNPs was therefore around 100 
subjects.  
 
7.5.1 Genetic analysis results 
Genotype frequencies between patients and healthy controls did not deviate 
from the Hardy–Weinberg equilibrium. Complementary table 2. Bi-allele 
frequencies among each group with calculated Hardy–Weinberg equilibrium 
 
For the statistical analysis, I combined the genotypes for which frequencies 
were less than 10 in either of the groups. Therefore the following: NRG 
221533; NRG 241930; DTNBP1_rs2005976, DTNBP1_rs6937379, 
OLIG2_rs762178, SBNO1_rs12322888, NTRK2_rs10868219, 
RELN_rs7341475, MCPH1_rs2440416, MCPH1_rs2912057, 
MCPH1_rs2959798, ASPM_rs1360558, HMGA2_rs1042725, 
CRHR1_rs11655470 and BDNF rs6265 had two categories (i.e. heterozygous 
of low frequency were combined with the homozygous).  
 
7.5.2 Genotypes and brain volume  
I first analyzed brain volumes according to the genotype. Grey matter volume 
(GMV), white matter volume (WMV) and whole brain volume (WBM) in each 
group and according genotyping are described in Tables 7.2 to 7.10. In the 
statistical analysis all brain volume analysed were adjusted for age, gender, 
protocol and height and group.  
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Table 7.2: Neuregulin (NRG) and brain volume distributions among groups 






Mean WBV  
in Litres 
(S.D.) 
NRG 221533     
Patient     
CC/CT 63 0.69 (.071) 0.43 (.057) 1.13 (.121) 
TT  37 0.7 (.082) 0.43 (.07) 1.13 (.141) 
Relative     
CC/CT 70 0.67 (.076) 0.42 (.06) 1.1 (.14) 
TT  43 0.68(.072) 0.42 (.067) 1.1 (.137) 
Control     
CC/CT 41 0.69 (.07) 0.43 (.048) 1.12 (.112) 
TT  18 0.69 (.08 0.42 (.065) 1.14 (.142) 
NRG 241930     
Patient     
GG 37 0.69 (.07) 0.42 (.054) 1.11 (.115) 
GT/TT 58 0.7 (.08) 0.44 (.06) 1.15 (.136) 
Relative     
GG 40 0.68 (.077) 0.42 (.056) 1.1 (.128) 
GT/TT 64 0.67 (.078) 0.43 (.07) 1.11 (.148) 
Control     
GG 18 0.7 (.076) 0.44 (.062) 1.14 (.133) 
GT/TT 31 0.68 (.077) 0.42 (.051) 1.11 (.123) 
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Table 7.2 cont: Neuregulin (NRG) and brain volume distributions among 
groups 






Mean WBV  
in Litres 
(S.D.) 
NRG 243177     
Patient     
CC 32 0.71 (.08) 0.44 (.068) 1.16 (.138) 
CT 56 0.7 (.074) 0.43 (.053) 1.15 (.118) 
TT 21 0.67 (.075) 0.41 (.055) 1.08 (.125) 
Relative     
CC 33 0.68 (.084) 0.41 (.06) 1.09 (.141) 
CT 53 0.66 (.06) 0.42 (.062) 1.09 (.128) 
TT 10 0.7 (.09) 0.44 (.077) 1.15 (.162) 
Control     
CC 19 0.68 (.086) 0.42 (.07) 1.1 (.155) 
CT 29 0.68 (.083) 0.43 (.05) 1.11 (.125) 
TT 15 0.69 (.09) 0.42 (.055) 1.11 (.143) 
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Table 7.3: Dysbindin  (DTNBP) SNPs and brain volume distributions among groups 






Mean WBV  
in Litres 
(S.D.) 
DTNBP1P1757     
Patient     
AA/AG 31 0.7 (.075) 0.45 (.05) 1.16 (.115) 
GG 45 0.69 (.069) 0.42 (.063) 1.11 (.127) 
Relative     
AA/AG 44 0.68 (.084) 0.43 (.066) 1.12 (.152) 
GG 58 0.67 (.07) 0.42 (.06) 1.09 (.125) 
Control     
AA/AG 14 0.69 (.082) 0.42 (.048) 1.06 (.127) 
GG 29 0.69 (.068) 0.43 (.047) 1.12 (.109) 
DTNBP1P1320 rs760761     
Patient     
CC 35 0.7 (.068) 0.43 (.064) 1.13 (.125) 
CT/TT 28 0.7 (.074) 0.45 (.052) 1.16 (.116) 
Relative     
CC 53 0.67 (.074) 0.42 (.06) 1.09 (.129) 
CT/TT 33 0.68 (.078) 0.44 (.064) 1.13 (.15) 
Control     
CC 24 0.69 (.07) 0.42 (.052) 1.11 (.117) 
CT/TT 15 0.68 (.07) 0.42 (.044) 1.09 (.113) 
Genetic influence in brain volumes in psychosis                                        PhD Ana Miorelli 
147 
 
Table 7.3 cont: Dysbindin (DTNBP) SNPs and brain volume distributions among 
groups 






Mean WBV  
in Litres 
(S.D.) 
DTNBP1_rs6937379     
Patient     
CC/CT 29 0.7 (.08) 0.4 (.05) 1.12 (.13) 
TT 32 0.7 (.062) 0.42 (.04) 1.1 (.104) 
Relative     
CC/CT 26 0.68 (.08) 0.42 (.06) 1.1 (.13) 
TT 37 0.68 (.084) 0.42 (.06) 1.1 (.14) 
Control     
CC/CT 21 0.7(.08) 0.44 (.045) 1.14 (.13) 
TT 6 0.6 (.07) 0.4 (.054) 1.02 (.122) 
DTNBP1_rs1047631     
Patient     
CC/CT 13 0.71(.08) 0.43 (.044) 1.14 (.11) 
TT 48 0.69 (.066 0.41 (.054) 1,1 (.11) 
Relative     
CC/CT 15 0.7 (.085) 0.43 (.06) 1.13 (.14) 
TT 48 0.68 (.081) 0.42 (.056) 1.1 (.13) 
Control     
CC/CT 7 0.71 (.088) 0.45 (.05) 1.16 (.13) 
TT 20 0.67 (.09) 0.42 (.049) 1.1 (.13) 
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Table 7.4: BDNF and COMT SNPs and brain volume distributions in groups 






Mean WBV  
in Litres 
(S.D.) 
BDNF rs6265     
Patient     
AA/AG 39 0.69 (.06) 0.43 (.057) 1.12 (.104) 
GG 94 0.7 (.083) 0.43 (.061) 1.14 (.136) 
Relative     
AA/AG 32 0.69 (0.85) 0.43 (.07) 1.11 (.151) 
GG 82 0.67 (.073) 0.42 (.06) 1.1 (.133) 
Control     
AA/AG 26 0.68 (.09) 0.44 (.06) 1.12 (.145) 
GG 54 0.69 (.08) 0.42 (.05) 1.11 (.125) 
COMT rs4680     
Patient     
AA 37 0.69 (.074) 0.42 (.064) 1.11 (.131) 
AG 62 0.7 (.081) 0.43 (.056) 1.13 (.127) 
GG 32 0.72 (.071) 0.45 (.057) 1.16 (.119) 
Relative     
AA 24 0.69 (.071) 0.43 (.06) 1.13 (.121) 
AG 58 0.67 (.077) 0.41 (.06) 1.08 (.132) 
GG 30 0.67 (.08) 0.43 (.07) 1.11 (.16) 
Control         
AA 23 0.68 (.056)  ???  ??? 
AG 39 0.68 (.09) 0.43 (.06) 1.11 (.145) 
GG 17 0.7 (.097) 0.44 (.052) 1.14 (.145) 
  




Table 7.5: NTRK2 and brain volume distributions in groups 






Mean WBV  
in Litres 
(S.D.) 
NTRK2_rs10868219     
Patient     
CC/CT 32 0.7 (.07) 0.42 (.047) 1.12 (.11) 
TT 27 0.69 (.072) 0.41 (.06) 1.1 (.12) 
Relative     
CC/CT 35 0.69 (.088) 0.42 (.058) 1.11 (.14) 
TT 28 0.68 (.073) 0.42 (.057) 1.1 (.12) 
Control     
CC/CT 11 0.69 (.074) 0.43 (.044) 1.12 (.11) 
TT 15 0.69 (.098) 0.43 (.056) 1.12 (.15) 
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Table 7.6: RELN and OLIG2  SNPs and brain volume distributions among groups 






Mean WBV  
in Litres 
(S.D.) 
RELN_rs7341475     
Patient     
AA/AG 16 0.68 (.062) 0.41 (.06) 1.1 (.11) 
GG 45 0.7 (.072) 0.42 (.05) 1.1 (.11) 
Relative     
AA/AG 17 0.67 (.075) 0.42 (.062) 1.1 (.13) 
GG 46 0.69 (.084) 0.42 (.056) 1.1 (.13) 
Control     
AA/AG 9 0.68 (.09) 0.43 (.046) 1.12 (.13) 
GG 18 0.68 (.09) 0.43 (.052) 1.1 (.13) 
OLIG2_rs762178     
Patient     
CC 35 0.68 (.072) 0.4 (.054) 1.1 (.11) 
CT/TT 25 0.69 (.067) 0.42 (.051) 1.12 (.12) 
Relative     
CC 44 0.7 (.08) 0.41 (.048) 1.07 (.12) 
CT/TT 14 0.66 (.08) 0.43 (.06) 1.13 (.13) 
Control     
CC 19 0.66 (.089) 0.44 (.032) 1.17 (.1) 
CT/TT 8 0.73 (.07) 0.42 (.055) 1.1 (.14) 
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Table 7.7: Microcephalin (MCPH1) SNPs and brain volume distributions between 
groups 






Mean WBV  
in Litres 
(S.D.) 
MCPH1_rs2305022     
Patient     
AA 35 0.68 (.066) 0.41 (.053) 1.1 (.11) 
AC/CC 26 0.7 (.074) 0.43 (.05) 1.13 (.11) 
Relative     
AA 40 0.69 (.07) 0.42 (.057) 1.1 (.12) 
AC/CC 23 0.68 (.09) 0.42 (.06) 1.1 (.15) 
Control     
AA 13 0.68 (.09) 0.42 (.054) 1.1 (.14) 
AC/CC 14 0.68 (.086) 0.43 (.047) 1.1 (.12) 
MCPH1 _rs2440416     
Patient     
CC 37 0.69 (.069) 0.41 (.05) 1.1 (.11) 
CG/GG 24 0.7 (.074) 0.43 (.053) 1.12 (.12) 
Relative     
CC 41 0.67 (.073) 0.41 (.062) 1.1 (.12) 
CG/GG 22 0.7 (.09) 0.43 (.054) 1.14 (.15) 
Control     
CC 14 0.68 (.095) 0.42 (.051) 1.1 (.14) 
CG/GG 12 0.68 (.092) 0.43 (.052)  1.1 (.13) 
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Table 7.7 cont: Microcephalin (MCPH 1) SNPs and brain volume distributions 
between groups 






Mean WBV  
in Litres 
(S.D.) 
MCPH1 _rs2912057     
Patient     
AA/AG 36 0.69 (.072) 0.41 (.055) 1.1 (.12) 
GG 23 0.7 (.067) 0.42 (.047) 1.13 (.1) 
Relative     
AA/AG 39 0.69 (.086) 0.43 (.062) 1.12 (.14) 
GG 23 0.68 (.075) 0.42 (.05) 1.1 (.12) 
Control     
AA/AG 17 0.69 (.099) 0.44 (.052) 1.12 (.14) 
GG 10 0.67 (.072) 0.42 (.044) 1.1 (.11) 
MCPH1 _rs2959798     
Patient     
CC/CT 35 0.69 (.07) 0.41 (.054) 1.1 (.11) 
TT 26 0.69 (.069) 0.41 (.051) 1.1 (.11) 
Relative     
CC/CT 37 0.69 (.08) 0.43 (.058) 1.13 (.13) 
TT 26 0.67 (.78) 0.41 (.053) 1.08 (.12) 
Control     
CC/CT 14 0.69 (.097) 0.44 (.056) 1.13 (.15) 
TT 12 0.68 (.077) 0.42 (.044) 1.1 (.11) 
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Table 7.8: ASPM and brain volume distributions between groups 
 






Mean WBV  
in Litres 
(S.D.) 
ASPM _rs1360558     
Patient     
CC/CT 49 0.68 (0.69) 0.41 (.054) 1.1 (.11) 
TT 12 0.72 (.064) 0.43 (.042) 1.16 (.1) 
Relative     
CC/CT 51 0.68 (.075) 0.42 (.056) 1.11 (.12) 
TT 12 0.69 (.1) 0.41 (.065) 1.1 (.17) 
Control     
CC/CT 18 0.69 (.07) 0.43 (.042) 1.13 (.1) 
TT 9 0.66 (.12) 0.42 (.064) 1.08 (.18) 
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Table 7.9:SBNO1and HMGA2 CHRH1 SNPs and brain volume distributions among  
groups 






Mean WBV  
in Litres 
(S.D.) 
SBNO1 _rs12322888     
Patient     
AA/AG 23 0.7 (.073) 0.42 (.056) 1.13 (.12) 
GG 38 0.68 (.067) 0.41 (.05) 1.1 (.11) 
Relative     
AA/AG 26 0.7 (.09) 0.43 (.067) 1.13 (.15) 
GG 37 0.67 (.071) 0.41 (.049) 1.1 (.11) 
Control     
AA/AG 8 0.69 (.11) 0.44 (.063) 1.13 (.17) 
GG 19 0.68 (.078) 0.42 (.042) 1.1 (.11) 
HMGA2_rs1042725     
Patient     
CC 19 0.68 (.07) 0.41 (.056) 1.1 (.12) 
CT/TT 41 0.7 (.067) 0.42 (.051) 1.12 (.11) 
Relative     
CC 17 0.69 (.963) 0.43 (.051) 1.12 (.11) 
CT/TT 46 0.68 (.088) 0.42 (.059) 1.1 (.14) 
Control     
CC 12 0.66 (.084) 0.42 (.052) 1.08 (.13) 
CT/TT 14 0.7 ( .097) 0.44 (.05) 1.14 (.13) 
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Table 7.10:CHRH1 SNP and brain volume distributions among groups 
 






Mean WBV  
in Litres 
(S.D.) 
CRHR1_rs11655470     
Patient     
AA/AG 40 0.69 (.078) 0.42 (.052) 1.1 (.12) 
GG 20 0.69 (.052)  0.41 (.054) 1.1 (.1) 
Relative     
AA/AG 44 0.69 (.076) 0.42 (.057) 1.1 (.12) 
GG 19 0.68 (.095) 0.41 (.058) 1.1 (.14) 
Control     
AA/AG 14 0.7 (.11) 0.43 (.056) 1.13 (.16) 
GG 13 0.67 (.062) 0.42 (.043) 1.1 (.09) 
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7.6 Genetic analysis 
 
7.6.1 DTNBP1_rs1047631 and brain volumes 
The patients group homozygous for thymidine (i.e. TT) showed smaller 
volumes than healthy volunteers homozygous TT in the three brain volumes 
measured. This was statistically significant as the estimated mean difference 
in litres for grey matter was – 0.025 (95% CI= -.45 to -.023; p=0.028), for white 
matter was -0.018 (95% CI=-.039 to -.0009; p=0.038) and for whole brain 
volume, it was -0.043 (95% CI=-.08 to -.007; p=0.016). No differences were 
found in other group comparisons. 
 







control patient control patient
grey_vol white_vo
wbv_volu
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7.6.2 OLIG2_rs762178 and brain volumes 
OLIG2_rs762178 gene did not correlate with grey matter volume in any of the 
assessed groups. However, when I compared homozygous for cytosine (i.e. 
CC) between patients and healthy control groups, white matter volume in 
patients showed smaller white matter volume than healthy controls with an 
estimated mean difference in litres of -0.017 (95% CI=-.03 to -.004; p= 0.012) 
as well as smaller whole brain volume with estimated mean difference in litres 
of -0.035 (95% CI=-.065 to -.0047; p=0.023). Since OLIG2 is involved in the 
development of white matter cells, it was expected that its effect was more 
significant in white matter volume. No differences were found in other group 
comparisons 
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7.6.3 MCPH_rs930557 and brain volumes 
No significant differences in grey matter volumes were observed between 
genotypes. However, in the patients group those homozygous for cytosine 
(CC) showed significantly smaller white matter than healthy volunteers 
homozygous for cytosine (CC) with a estimated mean difference in litres of -
0.015 (95% CI= -.029 to -.0009; p=0.036 and, at trend level smaller whole 
brain volume with an estimated mean difference in litres -0.027 (95% CI= -
.058 to .003; p=0.078). No differences were found in other group comparisons 
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Although the differences discussed above which were nominally significant, 
no association would survive Bonferroni corrections for 20 independent tests 
(Bonferroni corrected p-value should be 0.05/20 ie 0.0025). In addition, given 
the small sample size and the multiple testing corrections needed for this 
analysis, I was not able to compare the two diagnostic groups, schizophrenia 
and bipolar disorder separately. The combined analyses including the three 
groups did not showed statistical significant difference. 
 
7.6.4 Other genes 
With regards to the other 17 SNPs included in the analyses, there were no 
significant associations between variations in any of them against either of the 
brain matter volumes measured.  
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 Chapter 8: Discussion 
 
In this study I examined brain matter volumes as plausible endophenotypes 
for psychosis. For this, I aimed to explore the potential role that genes 
involved in psychosis and in neurodevelopment may play in brain volumes in 
a large sample of patients with psychosis, their relatives, and a group of 
healthy individuals. Since the brain volumes had been acquired with MRI 
scans that used different protocols, the first step of this analysis was to design 
and carry out a calibration study to evaluate the compatibility of these MRI 
protocols, which although different, were all obtained on the same scanner. 
The results of this calibration study showed a high intra-class correlation in 
volumes between the protocols used (above 0.9). Therefore, I was able to 
combine MRI data from the samples from the three original studies. This 
approach enabled me to increase the statistical power necessary to evaluate 
total grey and white matter volume, as well as the whole brain volume, in 
relation to diagnosis risk and familiality, and assess them as potential 
endophenotypes. After this first step, I could proceed to compare patients with 
psychosis with healthy controls. In particular, I assessed grey and white 
matter volume as well as whole brain volume differences between patients 
with psychosis and healthy volunteers. I then compared these volumes in 
these two groups with those of the relatives of subjects with psychosis, to 
estimate brain volume differences as well as familiality. In the final step, I 
explored the genetic influence of certain SNPs on brain volumes. 
 
8.1 Case control brain volume  
 
8.1.1 Patients vs healthy volunteers: 
In the case-control analysis, I first explored the question of to what extend 
psychotic disorders can be considered as different expression of one disorder, 
where Schizophrenia and Bipolar disorder would represent the extremes 
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along a continuum of psychosis. Therefore, I compared patients group 
(schizophrenia and bipolar disorder together) against the healthy volunteers. 
 
8.1.1.1 Patients vs healthy volunteers: Grey matter volume 
I found that the comparison of the two disorders, Schizophrenia and Bipolar, 
pooled together as one disorder group against healthy controls, showed no 
statistically significant differences in total grey matter volume. In a previous 
extensive review (Shenton et al., 2001) and several meta-analytical studies, 
which evaluated larger samples, grey matter volume reductions have been 
found in both chronic and first-episode schizophrenia patients (Vita et al., 
2006; Ellison-Wright et al., 2010), in bipolar disorders (Strakowski et al., 2005) 
and in both, schizophrenia and bipolar disorder (Arnone et al., 2009; De Peri 
et al., 2012) against healthy volunteers. However, the evidence for grey 
matter reduction in bipolar disorder in comparison to healthy volunteers has 
not been consistently found, as shown in MacDonald and colleagues (2004) 
meta-analysis. In addition, McDonald and colleagues have found reductions in 
grey matter volumes in patients with schizophrenia but not in bipolar disorder 
when compared to healthy volunteers (McDonald et al., 2005). However, all 
these studies compared each psychosis diagnosis separately against the 
healthy volunteers, rather than as one single patient group as I did in my 
analysis. Therefore, this methodological difference between those studies and 
mine might have contribited to the lack of difference in grey matter volumes 
identified in my analysis. 
 
However, a recent multimodal meta-analysis that analyzed grey matter 
volumes in patients with schizophrenia and bipolar disorder together against 
healthy volunteers found significant total grey matter reductions in patients 
relative to the healthy volunteers, and interestingly, this was influenced by the 
use of antipsychotics (Radua et al., 2012). Although the methodology was 
similar to mine, in Radua‘s study patients were all at their illness first onset 
while my study included patients who were in both, their first onset and 
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chronic stages of the illness. Therefore, my sample is clinically and, may be 
demographically, more heterogeneous. Moreover, including patients at 
different illness stages might give rise to more variability and less accuracy in 
the results and thus, contribute to the lack of positive findings in this type of 
analysis. Another possible explanation for the absence of differences in grey 
matter volume that I found is that the first episode patients and some of the 
healthy controls I used were recruited as part of the AESOP study. For this 
study, the participants were recuited using an epidemiological approach, from 
the same catchment area. In previous studies that have reported on patients 
with first-episode schizophrenia or psychosis, the referrals came from 
university clinics, referral centres and in-patient samples, which attract 
subjects not necessarily representative of first-episode psychosis in general 
(Morgan et al., 2007). It is possible that my sample included subjects with a 
less severe illness than those used in previous studies. Furthermore, the 
healthy controls were also intended to represent the general population and 
were not just selected from hospital or university staff. Consistently with my 
findings, even the comparison between patients and controls in the original 
AESOP study did not reveal any difference in global volumes between these 
groups (Morgan et al, 2007). This highlights the importance of selecting 
epidemiologically representative comparison groups when comparison 
measures such as brain volumes that can be affected by socio-environmental 
factors. 
 
8.1.1.2 Patients vs healthy volunteers: White matter volume 
In my study I did not find a significant difference in white matter volumes 
between the combined patient group (i.e. schizophrenia and bipolar disorder 
together) and healthy controls. There is scarce evidence of global white 
matter volume differences when patients with different psychoses are 
compared as a group to healthy volunteers. Previous studies with a combined 
sample of first episode of psychosis did not report a comparison of global 
white matter volumes, but rahter regional white matter reductions in several 
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temporal lobe areas in patients in comparison to healthy volunteers (Price et 
al., 2010). However, a recent study that included patients at their first episode 
psychosis using VBM found no differences when patients as a single group 
were compared to healthy controls (Colombo et al., 2012). This evidence is 
consistent with the negative findings of my analysis of white matter volumes, 
in the comparison between patients groups as one group and controls. On the 
other hand, another very recent study showed that both patients with 
schizophrenia and bipolar disorder had smaller total white matter volume than 
healthy controls (De Peri at al., 2012). Previous studies that evaluated white 
matter volumes in these disorders separately but against the same control 
group have reported contradictory findings. Some studies have found white 
matter reductions in both schizophrenia (Buchanan et al., 1998, Wright et al., 
2000, De Peri et al., 2012) and bipolar disorder (De Peri et al., 2012), while 
others found no difference in patients with schizophrenia (Ananth et al 2002) 
or bipolar disorder (McDonald et al., 2005) in comparison to healthy 
volunteers. However, similarly to studies in grey matter volume, most of these 
studies did not analyze the patient‘s group sample together but as two 
separate groups against healthy volunteers. As mentioned above for the grey 
matter, the lack of findings in my sample might also be explained by the 
inclusion of patients and controls recruited with an epidemiological approach, 
hence possibly less sick (for patients) and not selected (Morgan et al., 2007). 
 
8.1.1.3 Patients vs healthy volunteers: Whole brain volume 
In my study I did not find a significant difference between the patients as a 
whole and the healthy controls. As for total grey and white matter volume, the 
comparison of whole brain matter volume between patients with psychosis 
analyzed as only one disease entity (i.e. schizophrenia and bipolar disorder 
together) and healthy volunteers, is not usually reported. Previous studies 
have consistently reported reductions in whole brain matter volume between 
patients with established schizophrenia and healthy volunteers, as suggested 
in several meta-analyses (Wright et al., 2000, Vita et al., 2006; Ellison-Wright 
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et al., 2010). On the other hand, no differences in whole brain matter volume 
have been reported between bipolar disorder patients and healthy volunteers 
(Hoge et al., 1999; McDonald et al., 2004; Kempton 2008). However, more 
recently, studies have shown reductions of whole brain matter volume in both, 
schizophrenia and bipolar disorder, when compared to healthy volunteers 
(Arnone et al., 2009, De Peri et al., 2012).  
 
In conclusion, due to the dichotomous classification of psychosis, most 
studies have compared schizophrenia and bipolar disorder separately against 
the same healthy control group, with only few studies comparing both 
illnesses together versus a control group. There is evidence from symptom 
factorial analyses that schizophrenia and bipolar disorder might be the 
expression of different extremes of a continuous illness (Dikeos et al 2006, 
Demjaha et al., 2009), sharing epidemiological as well as neurobiological risk 
factors (Murray et al., 2004; Craddock et al., 2005b, Arajarvi et al., 2006), and 
a genetic overlap (Bramon and Sham, 2001; Sklar et al., 2002; Craddock et 
al, 2005a; Lake, 2007), providing a potential endophenotype overlap (Arts et 
al 2008, Ivleva et al., 2010). Interestingly, in my study the combination of 
these two diagnostic categories into one did not highlight any significant 
difference in brain volumes in comparison to healthy volunteers.  
 
These findings can be the result of a lack of power to detect subtle brain 
volume differences between patients and healthy volunteers. In addition, there 
is increasing evidence that the brain changes in psychosis are distributed in 
nature, and therefore global brain tissue volumes may not represent the best 
candidate endophenotype for these disorders (Mourao-Miranda et al, 2012). 
Moreover, the additional morphometric heterogeneity that derives from the 
combination of schizophrenia and bipolar disorder as a single group might 
explain the lack of significant differences in the brain measures evaluated. 
Moreover, the use of medication might have also played a role in these 
findings. There is evidence that psychoactive medications, including 
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antipsychotics (Navari & Dazzan, 2009; Lieberman et al., 2005) and lithium 
(Moore et al., 2000; Smieskova et al., 2009; Moncrieff and Leo, 2010; 
Hallahan et al., 2011) might affect grey and white matter as well as whole 
brain volume volumes.  
 
8.1.2 Diagnostic Groups 
 
The second case-control analysis I conducted followed the dichotomous 
theory of psychosis. In this analysis I sought to define a possible 
endophenotype that is illness specific. For this, the patient group was split into 
two diagnostic groups: schizophrenia and bipolar disorder. I decided to 
exclude patients with a diagnosis of other psychoses to eliminate further 
heterogeneity in the sample. Therefore, I centred the analysis on the 
comparison of patients with schizophrenia and patients with bipolar disorder, 
comparing each group to the same healthy volunteer group as well as against 
each other.  
 
8.1.2.1 Grey matter differences 
 
8.1.2.1.1 Schizophrenia vs Healthy volunteers 
In the grey matter volume analysis, patients with schizophrenia showed 
statistically significant smaller grey matter volume when compared to the 
healthy volunteers. This difference in grey matter between patients with 
schizophrenia and healthy controls is consistent with findings from previous 
studies (Shenton et al., 2001; McDonald et al., 2005; Bose el al., 2009) and 
meta-analyses (Ward, 1996; Wright et al., 2000; Fornito et al., 2009; Haijma et 
al., 2012). Moreover, this deficit has been also reported in a recent study 
using VBM methods of analysis (Yuksel et al., 2012). Furthermore, and 
relevant to my study, recent meta-analyses show that deficits in grey matter 
volumes are more marked in schizophrenia than in bipolar disorders (Ellison-
Wright and Bullmore, 2010; De Peri et al., 2012).  
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When comparing structural imaging data of patients with schizophrenia with 
those of normal controls, the more consistent evidence has been that of a 
reduction of whole brain volume, as well as of total grey and white matter 
volumes, in patients, as summarized by a recent meta-analysis (Olabi et al., 
2011). Interestingly, these reductions have been reported to be progressive in 
nature and proposed as an indicator of poor prognosis (Andreasen et al., 
2011). Moreover, the evidence of progressive grey matter loss has also been 
considered to suggest that the illness may have a degenerative component 
(Rund, 2009; Gupta & Kulhara, 2011). However, this has been difficult to 
prove, and there is indeed evidence to suggest that the brain changes 
observed in schizophrenia may result from a neurodevelopmental abnormality 
in this illness (Weinberger 1986, 1987; Murray & Lewis1987; Van Os & Kapur, 
2009; Gupta & Kulhara, 2011; Owen et al., 2011). Furthermore, the 
progressive changes seen in psychosis have also been related to the 
prolonged exposure to antipsychotics in later illness stages. For example, a 
recent longitudinal study by Ho and colleagues (2011) has prospectively 
evaluated a large sample of patients with recent onset schizophrenia and 
evaluated brain volume changes overtime in relation to the use antipsychotic 
medication. The authors found that more use of antipsychotic medication was 
associated with greater brain volume loss in both white and grey matter 
volumes. This effect remained significant after correcting for illness severity 
and substance misuse. Although in my study I included patients at their first 
and more chronic stages of schizophrenia, the cross-sectional comparison of 
brain volumes in the two stages was thought to be inappropriate. To assess 
brain volumes progression or changes over time, the same sample would 
need to be assessed at two or more times. However, as a proxy measure for 
time, I assessed the impact of illness duration on brain volumes and, although 
only at trend level, the results go in line with this evidence. In fact, I found that 
a longer duration of illness was correlated with smaller whole brain volume in 
patients with schizophrenia. It is important to consider that in this study the 
white matter volume in patients with schizophrenia was significantly larger 
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than in the other two groups (patients with bipolar disorder and healthy 
volunteers). Therefore, this finding may be interpreted as indirect evidence 
that the association between longer illness duration and smaller whole brain 
volume was due to a reduction in grey matter in individuals with longer illness 
duration.  
 
With regards to medication, there is evidence from animal models that 
antipsychotics (both haloperidol and olanzapine) medication might have a 
direct effect on brain structure, and hence cause some of the volume deficits 
found in schizophrenia (Vernon et al., 2011). However, an MRI study of 
patients with schizophrenia (and all psychoses) found slightly different results 
in grey matter reductions with different antipsychotics (Lieberman et al., 
2005). For example, the authors found that the effects on grey matter 
reductions were related to haloperidol but not olanzapine. In addition, 
antipsychotics seem to act differently in different brain structures. For 
example, typical antipsychotics seem associated with basal ganglia volume 
increase (Scherck et al., 2006; Wright et al., 2000) but with cortical grey 
matter decrease (Scherck et al., 2006). In my study, 9 patients with 
schizophrenia were drug naïve, 25 were taking typical antipsychotics, 85 were 
taking atypical antipsychotic and 4 were on a combination of both at the time 
of the MRI. This heterogeneity of medication, as described in previous 
studies, might play a role in the results and highlights the importance of 
obtaining a detailed treatment history in neuroimaging studies.  
 
Finally, my findings of grey matter reductions in patients with schizophrenia in 
comparison to healthy volunteers are consistent with those previous studies 
using also VBM and a multi-study neuroimaging design (Meda et al., 2008; 
Segall et al., 2009). Therefore, my findings lend further support to the 
application of VBM in multi-site/protocol studies. 
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8.1.2.1 2 Bipolar disorder vs Healthy Volunteers 
Unlike schizophrenia, patients with bipolar disorder in my study showed no 
differences in grey matter volume when compared to healthy controls. The 
number of studies looking at volumetric changes in bipolar patients in 
comparison to healthy controls is significantly smaller than that of 
schizophrenia. Additionally, most studies looked at regional volumes rather 
than global volumes (Paerlson et al., 1997; Paerlson et al., 1999; Strakowsky 
et al. 1999, McDonald et al 2004; McDonald et al 2005). However, previous 
studies looking at segmented global volumes have reported contradictory 
findings, with some describing smaller grey matter volumes (Lim et al., 1999; 
Lopez-Larson et al., 2002; De Peri et al., 2012), and others finding no 
differences between patients with bipolar disorder and healthy volunteers 
(Zipursky et al., 1997; Brambilla et al., 2001; McDonald et al., 2005; Wilke et 
al 2004). Furthermore, De Peri and colleagues found that grey matter volume 
reductions seem to be less marked in patients with bipolar disorder than in 
schizophrenia when compared to healthy volunteers (De Peri et al., 2012). 
Therefore, the relative lack of loss of grey matter volume at first presentation, 
in combination with recent evidence that lithium might increase grey matter 
volume in patients taking lithium (Hallahan et al., 2011), might help explain the 
lack of differences in grey matter volume I found between patients with bipolar 
disorder and healthy volunteers. In my sample, 23 patients were taking lithuim 
at the time of the MRI, and all of these patients were in the chronic stages of 
the bipolar illness. Although this study was not designed to evaluate 
psychotropic drugs effects on brain volume, one could argue that at least 
some patients might have been taking lithuim for long enough to explain the 
less marked reduction of grey matter volume I observed in comparison to 
healthy volunteers.  
 
8.1.2.1 3 Schizophrenia vs Bipolar disorder 
There have been only few studies that have compared these two major 
psychotic illnesses. However, consistently with previous literature, patients 
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with schizophrenia in my study showed a statistically significant smaller grey 
matter volume when compared to bipolar patients (McDonald et al., 2005; 
Yuksel et al., 2012). In addition, most studies evaluating regional grey matter 
volumes have described signifficant reductions in grey matter in areas such as 
the insula (Kasai et al., 2003) in patients with schizophrenia in comparison to 
patients with bipolar disorder. Also, Kubicki and colleagues (2002) used a 
VBM approach and found statistically significant smaller medial temporal grey 
matter in schizophrenia compared with bipolar disorder. However, other 
studies have not found grey matter differences between bipolar disorder and 
schizophrenia patients in these medial temporal areas (Hirayasu et al., 1998) 
or in the insula (Kubicki et al., 2002).  
 
A recent meta-analysis by Ellison-Wright and Bullmore (2010) showed a 
difference in grey matter between patients with bipolar disorder and patients 
with schizophrenia, when compared to healthy volunteers. While grey matter 
reductions in paralimbic regions were present in bipolar, grey matter 
reductions in schizophrenia were more widespread, involving limbic, 
neocortical structures and the paralimbic regions. Although this was a not a 
direct comparison between bipolar disorder and schizophrenia, the findings of 
more extensive areas of grey matter reductions in patients in schizophrenia 
than in patients with bipolar disorder could be consider indirect evidence of 
grey matter reductions in schizophrenia compared to bipolar disorder. 
Moreover, a more marked reduction in grey matter volume in schizophrenia 
than in bipolar disorder in comparison to healthy volunteers has been recently 
shown to be already present at illness onset in children and adolescent onset 
(Arango et al., 2012) and in adult onset (De Peri et al., 2012) schizophrenia. 
However, a meta-analysis that directly compared schizophrenia and bipolar 
disorder failed to find global grey matter differences between the two groups 
(Kempton 2008).  
 
In my study I included patients in both chronic and early stages of their illness. 
Therefore, there might be a number of issues that could have played a role in 
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the results. For example, having a heterogeneous sample makes it more 
difficult to account for the effects of medication. It has been described that 
grey matter volume increases in bipolar disorder patients in comparison to 
healthy controls in association with the use of lithium (Hallahan et al., 2011). 
Moreover, there is also evidence that the use of antipsychotic medication is 
associated with smaller grey matter volumes (Lieberman et al., 2005; Moncrief 
& Leo 2010, Leung et al., 2011), and that this is more evident with the use of 
typical antipsychotics (Navari & Dazzan, 2009). Moreover, changing from 
typical to atypical antipsychotic may have an effect on regional volumes, such 
as for example those of the basal ganglia (Scherk et al., 2006). In my study, 9 
patients with schizophrenia were drug naïve, 25 were taking typical 
antipsychotics, 85 were taking atypical antipsychotic, 4 were on a combination 
of both, and among patients with bipolar disorder 14 were taking 
antipsychotics and 23 were taking lithium at the time of the MRI. Therefore, 
although my findings are consistent with previous reports of grey matter 
differences between patients with bipolar disorder and patients with 
schizophrenia, these findings should be investigated further, further exploring 
of the role of medication in explaining brain volume differences between two 
groups which tend to be exposed to different kinds of psychotropic drugs.  
 
8.1.2.2 White matter differences 
 
8.1.2.2.1 Schizophrenia vs Healthy Volunteers 
With respect to white matter volume, there is less evidence from existing 
literature on differences between patients with schizophrenia and healthy 
controls. The findings of structural white matter changes reported to date have 
been inconsistent. Previous studies have described reductions in white matter 
volume when comparing patients with schizophrenia and healthy controls 
(Sigmundsson et al., 2001; Paillere-Martinot et al., 2001). The reduction has 
been shown both in patients at their first episode as well as in those at more 
chronic stages (Whitford et al., 2007; Di et al., 2009; De Pieri et al., 2012). 
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However, some studies have failed to replicate these findings (Hulshoff Pol et 
al., 2004; Moreno et al., 2005). Additionally, most recent studies have put their 
emphasis on regional rather than global white matter changes, as also 
outlined in a recent meta-analysis (Di et al., 2009). Also, they have looked at 
white matter integrity, rather than volume, with sequences such as diffusion 
tensor imaging (DTI) (Lim at al., 1999). Still, DTI data show evidence of 
altered white matter integrity in schizophrenia (Lim at al., 1999; Kubicki et al., 
2005; Bora et al., 2011). This evidence supports the hypothesis that there 
might be structural white matter volumetric changes in patients with 
schizophrenia, but that these may be difficult to identify in group comparisons 
that use VBM methods of analysis. In the current study, patients with 
schizophrenia presented with larger global white matter volume than controls. 
This finding is in contrast with those of a recent meta-analysis by Di et al (Di et 
al., 2009). Although this meta-analysis included studies of patients at first and 
chronic stages of illness, making it more similar to my sample, the authors 
commented on a number of technical limitations, suggesting that the results of 
the meta-analysis may have depended on the heterogeneity introduced by 
illness stage. For instance, they note that white matter concentration (WMC, 
from unmodulated data) or white matter volume (WMV, from modulated data) 
measurements were reported depending on whether the modulation step had 
been applied. Modulation is a step thought to be more appropriate when 
evaluating brain volumes, as this optional step in the pre-precessing pipeline 
aims to correct for deformations that might occur during spatial normalization 
(Good et al., 2001; Mechelli et al., 2005). Importantly, differences between 
modulated or unmodulated brain volume measurements have been 
demonstrated for grey matter measurements (Eckert et al., 2006). However, 
the theory applies to both white and grey matter (Good et al. 2001; Mechelli et 
al., 2005), and therefore methodological issues such as using modulated data 
might have impact white matter volume measure in my study. Another 
important point is that the smoothing kernel used across studies could also 
have affected VBM results and their comparability. So, although my study did 
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not found a reduction in white matter volume in patients (but rather an 
increase), it has the advantage that all neuroimaging data were processed by 
one investigator only, with the same method, and applying the same kernel 
giving more reliable results. This evidence suggests that white matter, for its 
very nature, may be particularly susceptible to the limitations of VBM 
approaches, and that potential alterations of this tissue need further 
investigation, possibly with methods more suited to white matter such as DTI. 
 
8.1.2.2.2 Bipolar Disorder vs Healthy volunteers 
In this study I found that patients with bipolar disorder have smaller white 
matter voulmes than healthy volunteers. The literature in structural white 
matter changes in bipolar disorders brings contradictory evidence. Most 
studies have described no volumetric differences in white matter volumes in 
bipolar disorder patients in comparison to healthy individuals (Zipursky et al., 
1997; Brambilla et al., 2001; Lim et al., 1999; Lopez-Larson et al., 2002). 
However, more recently, some studies have described smaller white matter 
volume in patients with bipolar disorder in comparison to healthy volunteers 
(Kieseppa et al., 2003; McDonald et al., 2005; Vita et al, 2009). In addition, 
reduced white matter volume in patients with shizophrenia and bipolar 
disorder in comparison to healthy volunteers have also been described in a 
recent meta-analysis (De Peri et al., 2012). Moreover, the authors of this 
meta-analysis concluded that smaller white matter volumes in patients with 
psychosis seem to be more characteristic of bipolar disorder than 
schizophrenia. The suggestion that white matter alterations may be more 
specific to bipolar disorders seems supported by previous studies finding an 
increase in white matter hyperintensities in patients with bipolar disorder than 
in healthy volunteers (Figiel et al., 1991; Aylward et al., 1994; Dupont et al., 
1995; McDonald et al., 1999). However, as for white matter volume, others 
have failed to find a significant association (Lewine et al., 1995; Persaud et 
al., 1997). White matter hyperintesnities have been understood as a marker of 
ischaemic lesions, as shown by neuropathological inspection (Awad et al., 
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1986; Fazekas et al., 1993). Althought these hyperintensities do not seem to 
be specific to bipolar disorder, as they are strongly correlated with age in non-
psychiatric populations (Schmidt et al., 1999), several meta-analysis have 
found strong evidence for an association between increased hyperintensity 
lesions and bipolar disorder (Altshuler et al., 1995; Videbech et al., 1997; 
Kempton et al., 2008; Beyer et al., 2009). Although in my study I did not 
assess white matter hyperintensities, evidence of increased white matter 
hyperintensities in patients with bipolar and the evidence that they are likely to 
reflect an ischaemic damage possible leading to volume reductions, may 
indirectly support my finding of smaller white matter volume in patients with 
bipolar disorder.  
 
Finally, previous studies have described that while lithuim does not seem to 
have an effect on segmented white matter volume, antipsychotics  may have 
a negative correlation with this measure (Kieseppa et al., 2003; Ho et al., 
2011). In my sample, 14 patients with bipolar disorder were taking 
antipsychotics and 23 were taking lithium at the time of the MRI. It is possible 
that some of my findings could have been related to the exposure to these 
psychotropic medications.  
 
8.1.2.2.3 Schizophrenia vs Bipolar disorder 
In the current study, patients with bipolar disorder showed smaller whole white 
matter volumes than patients with schizophrenia. This finding is novel, as for 
both illnesses white matter volumes have been reported as reduced in 
comparison to healthy controls (MCDonald et al., 2005), but not between 
patients with schizophrenia and patients with bipolar disorder. There is less 
evidence on differences in white matter volumes between the two as 
suggested in a recent meta-analysis by Kempton et. al. (2008). The authors 
included only 3 studies reporting global white matter volume (with a total of 50 
bipolar and 78 schizophrenia patients) and found no differences in global 
white matter volume between schizophrenia and bipolar disorder.   
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As described above, white matter hyperintensities seem to be related to small 
brain injury, possibly leading to volume reductions (Awad et al., 1986; 
Fazekas et al., 1993), and these have been more frequently described in 
patients with bipolar disorder (Altshuler et al., 1995; Videbech et al., 1997; 
Kempton et al., 2008; Beyer et al., 2009; Emsell and McDonald, 2009) and 
their relatives (Hajek et al., 2005) than in healthy volunteers. Interestingly, a 
study by Rivkin et al. (2000) found that even when the frequency of white 
matter hyperintensities was compared in young and elderly people with 
shizophrenia and healthy volunteers, there were no differences. This suggests 
again that white matter volume might be more extensevely affected in bipolar 
disorder than in schizophrenia.  
 
Finally, the lack of structural neuroimaging evidence for white matter 
differences between schizophrenia and bipolar disorder may be related to 
technological advances in the evaluaiton of white matter. Most studies 
evaluating white matter have been focusing on white matter integity as 
measured by tractography or DTI. These more modern approaches are 
preferred to structural neuroimaging in psychosis, as they are more likely to 
provide information more closely related to the integrity and function of this 
tissue. In addition, they might be more able to distinguish diffent 
neuroconnectivity patterns related to the different clinical presentations of 
schizophrenia and bipolar disorder (Cui et al., 2011). 
 
8.1.2.3 Whole brain volume differences 
 
8.1.2.3.1 Schizophrenia vs Healthy Volunteers 
The comparison of whole brain matter volume showed a statistically 
significant difference between these two groups, with larger volumes in 
healthy controls than in patients with schizophrenia. This result is not 
surprising and is in line with previous studies of brain volumes using both 
regional and whole brain VBM methods of analysis (Wright et al., 2000, 
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Ellison-Wright et al., 2008; De Peri et al., 2012). Moreover, the reduction of 
whole brain volume in patients with schizophrenia in comparison to healthy 
volunteers seems to be present from the illness onset (Vita et al., 2006). The 
present study is a combination of first episode and chronic presentations of 
schizophrenia, similarly to those included in meta-analysis by Wright and 
colleagues (Wright et al., 2000). To observe such reductions in this patient 
group, one should assume that patients at both stages, onset and chronic, 
would present with whole brain volume reductions. Moreover, in my study, I 
found that a longer duration of illness was correlated with whole brain volume 
reduction in patients with schizophrenia. The evidence for whole brain volume 
change over time in patients with schizophrenia has been contradictory, with 
some studies describing progressive volume loss (DeLisis et al., 2004; Ho et 
al., 2003) and others not finding these changes (Steen et al., 2006; Whitworth 
et al., 2005). Interestingly, a recent meta-analysis seems to confirm evidence 
of a progressive reduction (Olabi et al., 2011). This finding supports the 
hypothesis that combining first onset with chronic patients increases the 
statistical power needed to detect brain volume differences. However, as 
mentioned above, it is important to assess to what extent these differences 
reflect a medication effect or whether they are a result of specific 
psychopathological mechanisms, or of a genetic predisposition, which may be 
addressed by more specifically designed studies. 
 
8.1.2.3.2 Bipolar Disorder vs Healthy Volunteers  
In this study I did not find any difference in whole brain volume in patients with 
bipolar disorder when compared to healthy controls. My results seem 
consistent with previous findings (Zirpursky et al., 1997; Brambilla et al., 
2001). In addition, my results support the findings of three previous meta-
analyses, which have found no differences between chronic patients with 
bipolar disorder and healthy controls (Hoge et al., 1999; McDonald et la., 
2004, Kempton 2008), and with those of one meta-analysis of patients at their 
first episode of bipolar disorder (Vita et al., 2009). However, Arnone‘s meta-
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analysis (2009) reported a reduction of whole brain volume in patients with 
bipolar disorder compared to healthy controls. The authors pointed out that 
the heterogeneity in sample characteristics and the methods used in the 
studies may have explained their findings. Although the present study should 
have enough statistical power to detect structural brain volume differences 
between patients with bipolar disorder and healthy controls (Friston et al., 
1999), these might be very subtle and therefore, a larger sample might be 
needed. Arnone‘s meta-analysis included 661 participants with bipolar 
disorder and 723 healthy controls, carrying more statistical power than the 
one of my study and of previous meta-analyses (Hoge et al., 1999; McDonald 
et al., 2004). However, the meta-analysis by Kempton et al., (2008) also 
included a very large sample size and still failed to find statistically significant 
differences in whole brain volume between patients with bipolar disorder and 
healthy volunteers. Therefore, it is possible that more homogeneity in clinical 
presentations might be needed to detect whole brain volume differences in 
patients with bipolar disorder and healthy controls. 
 
8.1.2.3.3 Bipolar Disorder vs and Schizophrenia 
In this study I did not find any difference in whole brain volume in patients with 
bipolar disorder when compared to patients with schizophrenia. There is very 
limited data comparing whole brain volume between these disorders. Most 
studies report regional differences using whole brain volume to correct for 
volumetric differences accounted for by differences in brain size. However, 
previous studies have reported no differences in whole brain volume between 
patients with schizophrenia and patients with bipolar disorder (Harvey et al., 
1994, Zipursky et al., 1997). Moreover, these results have been supported by 
a recent meta-analysis of 98 structural neuroimaging studies of patients with 
bipolar (Kempton et al., 2008). The authors reported a meta-analytical 
comparison of 121 patients with bipolar disorder and 236 patients with 
schizophrenia from 5 studies and found no differences in whole brain volume 
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between the two groups. Therefore, my finding of lack of whole brain volumes 
differences between schizophrenia and bipolar is in line with previous studies.  
 
8.2 Familiarity: Brain volumes comparisons 
 
8.2.1 Patients with schizophrenia and bipolar disorder, their relatives and 
healthy volunteers 
For this analysis, the relatives of patients with psychosis were included. To my 
knowledge, there is no other study that has compared grey and white matter 
volume in these groups looking at familiality in a combined sample of scans 
obtained with different MRI protocols. Moreover, most previous studies 
focused their hypothesis on specific brain regions as a way to understand the 
pathophysiology of psychosis. In contrast, in this study the hypotheses were 
not related to the physiopathology of psychosis, but rather to their potential as 
biomarkers. This has been, to my knowledge, the first study that has looked at 
brain differences in such a sample, and also the first one that has assessed 
the potential of global volumes rather than regional volumes as possible 
biomarkers.  
 
In this study, I found no significant differences between patients with 
schizophrenia and the group of relatives of these patients. Additionally, I found 
no differences between healthy volunteers and the relatives of patients with 
schizophrenia. McDonald and colleagues evaluated part of my sample, from 
the Maudsley Family Study. Here, similarly to my findings, when compared to 
healthy volunteers the relatives of patients with schizophrenia did not show 
any volumetric difference in brain structures (McDonald et al, 2006). However, 
the authors did not report global grey, white or whole brain matter volumes. In 
addition, the findings of my study are consistent with those of a more recent 
and large study using VBM methods that explored differences in brain 
volumes in schizophrenia, their non-affected siblings and healthy controls 
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(Boos et al., 2011). The authors found no differences in global volumes 
between the relatives and the patient or control groups.  
 
Few studies have looked at global grey, white and whole brain matter volumes 
in the relatives of patients with schizophrenia (Cannon et al. 2002b; McDonald 
et al., 2002; Gogtay et al., 2003; Boss et al., 2007, 2011). The results of these 
studies have been contradictory. A recent study by Boos and colleages (2011) 
found no differences in global grey and white matter volumes between 
relatives of patients with schizophrenia and healthy volunteers. Moreover, a 
study by Goldman et al. (2009) found reduction of total grey matter thickness 
in patients with schizophrenia but in their relatives when compared to healthy 
controls. However, a meta-analysis by Boos and colleagues (2007) showed 
that whole gray matter volume in relatives of patients with schizophrenia was 
significantly smaller than the volume of healthy volunteers. The authors also 
described a trend for smaller white matter and whole brain volumes in the 
relatives group than in controls. However, they also described a significant 
heterogeneity in effect size across individual studies, which make the results 
less comparable. In addition, previous studies described structural brain 
changes found in schizophrenia such as accelerated grey matter loss seem to 
be also progressive in their unaffected relatives (Brans et al., 2008). These 
findings would support the evidence for grey matter reduction in relatives of 
schizophrenia found in Boos et al (2007) meta-analysis. However, it is worth 
mentioning that meta-analyses tend to have a larger statistical power to detect 
the more subtle differences that relatives of patients with schizophrenia seem 
to present. Therefore, sample size might be a reason for the lack of 
morphometric differences I was able to observe in my sample.  
 
Nevertheless, my study is quite innovative in describing global brain volumes 
in a rather large sample. Additionally, although grey, white and whole brain 
volumes can be reliable biomarkers when comparing cases and controls, the 
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subtle differences conferred by genetic loading in their relatives might need a 
more specific marker.  
 
In my study, patients with bipolar disorder showed significantly smaller whole 
brain volume than their relatives. Very few studies have described brain 
volume differences between patients with bipolar disorder and their relatives 
and as in schizophrenia, most studies have described regional differences 
(Marshall et al., 2004; McDonald et al., 2006). However, a twin study in bipolar 
disorder by van der Schot et al. (2009) described that in both the affected and 
non-affected co-twin group presents with smaller white matter volumes than 
healthy twins and reported these differences as related to genetic loading. On 
the other hand, the grey matter reductions found in both the affected and non-
affected co-twins seem to be related to environmental factors. In addition, 
these authors specifically assessed the effect of lithium and described that 
this seems to attenuate both white and grey matter volume reductions in the 
affected co-twins. In my study, I did not find a significant difference when grey 
and white matter volumes were analyzed separately. However, when added 
together to produce a measure of whole brain matter volume, this measure 
was significantly smaller in the bipolar disorder patients in comparison to their 
relatives. This might be the result of subtle additive changes in different brain 
areas that only when added together become significant.  
 
The comparison between relatives of patients with bipolar disorder and 
healthy volunteers did not highlight any signifficant difference in any of the 
three brain volumes I analized. These findings are consistent with those of 
previous studies (McIntosh et al., 2004; 2005; McDonald et al., 2006). In 
addition, a number of studies that explored brain volume differences in 
patients with bipolar disorder, their relatives and healthy controls were based 
on twin populations, mainly evaluating the genetic influence accounted for 
brain volume differences found in bipolar disorders (Kieseppa et al., 2003; van 
der Schot et al., 2009). However, these studies have also described brain 
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volume differences between the unaffected co-twin and healthy volunteers. 
Kieseppa et al (2003) reported a significant reduction in white matter volumes 
in the affected co-twins but no significant differences between the unaffected 
co-twins and the healthy volunteers. In the study by van der Schot et al., 
(2009) as described above, the unaffected co-twins had smaller grey and 
white matter volumes than the healthy twins, suggesting a genetic liability in 
these brain structures. However, the paper does not report if the difference 
was statistically signifficant, making it difficult to make any comparison with 
my findings.  
 
8.2.2 Familiality of brain volumes 
Structural brain volumes can be explored as quantitative traits. These traits 
show significant variation in healthy human populations as well as in patients 
with psychiatric disorders like psychosis. One way of understanding these 
differences might be by looking at the influence that genetic factors have on 
them. These, in combination with environmental factors, could help identifying 
the biological mechanisms underlying neuroanatomical phenotypes and the 
possible identification of risk factors for psychosis. In previous studies 
heritability estimates have shown a strong genetic component contributing to 
neuroanatomical phenotypes (Posthuma et al. 2002; Kremen at al., 2010). 
Brain volumes seem to have substantial heritability, with rates ranging from 70 
to 95% for total brain volume, cerebellar, gray and white matter volumes, and 
corpus callosum (Kaymaz and Van Os, 2009). The higher the heritability rate, 
the less likely it is that the environment may have a prominent influence on the 
development of a particular phenotype. Therefore, looking at highly heritable 
structural brain phenotypes might provide an endophenotype for genes that 
are involved in the regulation of brain volumes in psychosis.  
Brain volumes, particularly smaller whole brain and grey matter volumes, have 
been accepted as possibly reliable endophenotypes for psychotic disorders 
(Glahn et al., 2007; Prasad and Keshavan, 2008). However, these changes 
seem to be related not only to the presence of the illness, but also to the 
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presence in unaffected relative of a patient with psychosis (McDonald et al, 
2002 and 2006; Gottesman et al., 2003; Prasad and Keshavan, 2008). 
Therefore, in this study I aimed to examine the role of familial risk in measures 
of brain volume. The sample I used has several advantages. First, it 
comprises a large pool of MRI and genetic data. Second, it includes the 
relatives of patients with two major psychotic disorders, namely schizophrenia 
and bipolar disorder. This has allowed me to look at the familiality of brain 
volumes. To explore whether brain volumes represent a familial trait, I 
compared the within-family variance against the between-family variance 
using a mixed model analysis. This method has been successfully used to 
estimate the familiality of clinical symptoms in schizophrenia (Wickham et al., 
2001) and to assess possible endophenotypes in psychosis (Bramon et al., 
2004, 2005). I found that for both, schizophrenia and bipolar disorder, family 
clusters accounted for 48% of the global grey matter total variance. For both 
disorders the findings reached statistical significance. In previous studies, 
grey matter volume reductions have been shown to be also present in the 
unaffected relatives of patients with schizophrenia (Cannon et al 1998a; 
McDonald et al, 2002 and 2006; Boos et al., 2007). These results support my 
finding and previous studies that proposed grey matter volume as a plausible 
endophenotype for psychosis (McDonald et al., 2004b; Kaymaz and Van Os, 
2009).  
Interestingly, belonging to the same family accounted for 43% of the total 
variance of white matter volume for subjects with bipolar disorder, but only for 
27% of variance in families with schizophrenia. Although in both groups the 
results were statistically significant, this was more significant for the families in 
the bipolar group. These results are in correspondence with recent studies 
supporting a genetic influence in white matter reduction in both disorders 
(McIntosh et al., 2005; Hulshoff Pol et al., 2012). However, white matter 
changes, such as increased white matter hyperintensities (Altshuler et al., 
1995; Videbech et al., 1997; Kempton et al., 2008; Beyer et al., 2009) have 
been more extensively reported in patients with bipolar disorder than in 
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patients with schizophrenia (Rivkin et al. 2000). Moreover, white matter 
hyperintensities have been also reported as present in relatives of bipolar 
disorder patients (Hajek et al., 2005). Therefore, my findings of greater 
familiality for white matter changes in patients with bipolar disorder than in 
schizophrenia might reflect differences in genetic liability for white matter in 
these disorders. 
In conclusion, grey matter volume seems to be a useful biomarker for 
psychosis in general, while white matter volume appears more specific for 
bipolar disorder in which it shows substantial familial influence.  
 
8.3 Brain volume and genes 
There is evidence that normal brain development is greatly influenced by 
genetic factors (Lenroot and Giedd, 2008). In psychosis, brain development 
has been suggested to deviate from normal development (DeLisi et al., 1997; 
Liberman et al., 2001). It has been hypothesized that this might be due to a 
genetic predisposition in patients with psychosis (Brans et al., 2008). Changes 
occurring in neurodevelopment in subjects with psychosis might lead to the 
reduction of about 2% of brain volume consistently described in comparison to 
matched healthy controls (Wright et al, 2000). As discussed in previous 
sections, a number of studies in patients with schizophrenia have reported 
smaller volume of not only whole brain, but also of grey matter in comparison 
to healthy controls (Wright et al 2000; Steen et al., 2006, Tanskznene et al., 
2009). This reduction seems to be also evident in adolescent onset 
schizophrenia, supporting the theory of schizophrenia as a 
neurodevelopmental disorder (Rapoport at al., 1999). In addition, subjects at 
high risk of developing the disorder because of their positive history for 
psychosis present similar changes, suggesting that genetic loading may play 
a role in the brain volume changes reported in psychosis (Lawrie at al., 1999; 
2001). This is also consistent with evidence that relatives of patients with 
schizophrenia show grey matter volume reduction when compared to healthy 
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controls (McDonald et al, 2002 and 2006, Boos et al., 2007). Whole brain 
volume heritability has been estimated to be between 66% and 97% (Sullivan 
et al., 2003; Peper et al., 2007; Kaymaz and Van Os, 2009). In addition, twin 
studies have supported the theory of genetic influence in morphometric brain 
differences in psychosis by showing smaller whole brain volume in both co-
twins with schizophrenia and in non-schizophrenic co-twins when compared to 
healthy control twins (Baare et al., 2001; van Haren et al., 2004). Furthermore, 
the progressive loss of grey matter described in patients with schizophrenia 
has also been shown in their healthy co-twins and seems to be greatly 
influenced by a genetic component (Brans et al., 2008).  
 
Despite the strong evidence for genetic influence in the development of 
psychosis, there is a lack of consistent replication in candidate gene 
association studies so far (Harrison et al., 2003; Craddock et al., 2005b, 
2009). This lack of replication has been interpreted as related to insufficient 
statistical power.  
 
It has become widely accepted that the aetiology of psychosis is based on a 
combination of both complex genetic and environmental factors (Sullivan et 
al., 2003; Braff et al. 2007a). The most recent approach used to elucidate the 
pathways into these disorders has been based on the exploration of potential 
endophenotypes. Moreover, in recent GWAS studies a meta-analytical 
approach was used to increase the power to detect genome-wide significance 
associations (Shi et al., 2009; Scott et al., 2009; McMahon et al., 2010; 
Vassos et al., 2012). These results further highlight the importance of sample 
size when trying to disentangle a role for genetic influence in complex 
diseases such as psychosis.  
 
Besides sample size, other sources for conflicting results in genetic 
association studies might lay on the studies‘ samples heterogeneity or due to 
the overlapping symptoms that schizophrenia and bipolar disorders present 
Genetic influence in brain volumes in psychosis                                        PhD Ana Miorelli 
184 
 
with (Ivleva et al., 2007). This heterogeneity might be responsible for 
overlapping evidence of susceptibility genes across schizophrenia and bipolar 
disorder, such as DAOA (G72), DTNBP1, COMT, BDNF, DISC1, and NRG1 
(Craddock et el., 2006). In addition, there is also evidence that gene 
expression might be influenced by the effect of environmental factors adding 
further heterogeneity to the sample characteristics and the endophenotypes 
tested (Caspi et al., 2002; Caspi & Moffit 2006).  
 
In this project I looked at a number of candidate genes that have been 
described to be associated with brain volume changes in patients with 
psychosis. In addition, I looked at genes that have been described as 
implicated in brain development, to assess the potential influence in the brain 
changes described so far. My aim was to evaluate if specific SNPs could 
account for the brain volume differences I identified across groups.  
 
I found that three SNPs collected from GWAS showed brain volume 
differences between patients and healthy controls. Patients homozygous for 
DTNBP1rs1047631-thymidine (TT) presented with smaller grey, white and 
whole grey matter volumes than healthy volunteers with the TT genotype. 
These results show that DTNBP1 has an effect in global brain volumes and 
this is supported by previous reports showing DTNBP1 mRNA to be 
widespread in the brain. In addition, DTNBP1 mRNA is reduced in patients 
with schizophrenia compared to healthy volunteer‘s areas such as the 
dorsolateral prefrontal cortex (Weickert et al., 2004). There is also evidence 
that smaller hippocampal volume in patients with schizophrenia relative to 
healthy volunteers might be due to the reduced DTNBP1 protein expression in 
the brain during its formation (Weickert et al., 2008). These findings suggest a 
potential role of DTNBP1 in neurodevelopment in schizophrenia and support 
my findings of smaller brain volumes in patients with psychosis than in healthy 
volunteers.  
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Another gene that showed positive association with brain volumes was 
OLIG2. OLIG2 is expressed throughout the brain during neurodevelopment 
and in adulthood with the main function of regulating the differentiation 
between motor neurones and oligodendrocytes (Ono et al 2009). Moreover, it 
is also involved in the glial reconstitution after brain injury (Ono et al 2009). In 
patients with schizophrenia, OLIG2 expression has been shown to be reduced 
(Gerogieva et al 2006; Mitkus et al., 2008). The OLIG2-rs10590004 allele A 
has particularly been associated to schizophrenia (Gerogieva et al 2006) and 
patients with psychotic symptoms in obsessive compulsive disorder (Stewart 
et al., 2007).  In my study, the results showed that patients homozygous for 
OLIG2 (CC) showed smaller whole white matter and whole brain volume than 
healthy controls with the CC genotype. A recent study by Prata et al (2012) 
showed altered white matter integrity in healthy volunteers with OLIG2 allele A 
carriers. However, the authors did not report white matter volume assessment 
in their report. The difference in risk allele A reported by Gerogieva et al 
(2006) and Prata et al. (2012), and my finding of C allele as the risk allele, 
might be related to C allele being more specific to brain volumes and 
psychosis. Thus, the C allele might be the risk allele for reduced white and 
whole brain volume in patients with psychosis but not in healthy volunteers. 
This is supported by a study by Huang et al (2008) who found a possitive 
association with C allele in patients with schizophrenia with the OLIG2 proxy 
(rs762178) I used in my study. To my knowledge this is the first study that 
examines the genetic variation of OLIG2 on brain volumes in patients with 
psychosis. Therefore, the evidence that OLIG2 is associated with 
schizophrenia, brain volume reductions in healthy volunteers and in patients 
with psychosis suggests its potential role in brain development in both groups 
and requires further investigation.  
 
In addition, I found that patients homozygous for MCPH s1057090-cytosine 
(CC) showed significantly smaller white matter and, at trend level, smaller 
whole brain volume than healthy volunteers. None of the other MCPH SNPs 
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evaluations showed a significant association with brain volumes in any of the 
groups assessed. MCPH has been shown to be associated with the brain 
volume reduction found in primary microcephaly (Jamieson et al., 2000; 
Pattison et al., 2000; Moynihan et al 2000). Due to the role of MCPH in the 
development of smaller brains, it has been hypothesized that MCPH might 
influence brain volume in the general population and possibly in psychosis. 
One previous study reported larger cranial volume in males in Chinese 
population associated with MCPH rs1057090 (Wang et al 2008). However, 
others have failed to find associations between MCPH and brain volume in 
healthy populations (Woods et al., 2006; Dobson et al., 2007). To my 
knowledge there are only a few studies evaluating MCPHs effects in patients 
with psychosis and they have reported conflicting findings. Rivero et al. (2006) 
reported negative results while Rimol et al (2009) found a significant 
association on brain volume reductions in male patients with psychosis.  
 
Despite the described positive associations of the above three SNPs with 
brain volumes, none of the SNPs reached statistical significance after 
Bonferroni test for multiple testing. As described above, the most likely reason 
for this lack of association seems to be related to the sample size.  
 
Sample size does not seem to be the only issue interfering when assessing 
genetic associations. This was shown by the failure to replicate previous 
findings for several candidate genes in a large European Sample, which 
included about 4000 cases (Sanders et al., 2008). This result contradicts 
previous predicted differences from earlier and smaller samples. The reasons 
for these contradictory results have been discussed by Ioannidis (2008). The 
author highlights that there are a number of factors leading towards false 
positive findings, such as inflated effect sizes due to thresholds selection and 
suboptimal power as shown in simulated power calculation for a study or; 
selective reports. More recently, it has become more generally accepted that 
genetic studies on average require large sample sizes, estimated between 
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1,000 and 3,000, to have the power to detect small to medium genetic effects 
(OR of 1.1-1.3) (Tiwari et al., 2010; Gejman et al., 2010; Byerdley and 
Bradner 2011). On the other hand, the use of large sample sizes might in itself 
lead to phenotypic heterogeneity and population stratification resulting in 
spurious associations (McCarthy et al., 2008).  
 
There is a number of ways to increase the statistical power to detect real 
associations in genetic studies of complex genetic diseases. For example, by 
increasing the sample size, the power to detect associations directly 
increases. Another way is to use measures that increase the effect size. This 
is done by either choosing an accurate and specific phenotype and/or 
genotyping a specific region of interest (Evans and Purcell, 2012). In my study 
I have applied these principles to explore associations between selected 
genes and the specific phenotypes. However, for the 13 SNPs genotyping 
data from the original 387 samples of European origin, less than half of the 
sample passed QC, thus by significantly reducing the number of participants 
available for analysis and therefore, its statistical power.  
 
The decision to include data from GWAS in my study was based on the 
evidence that GWAS has the advantage of low-cost, high-density genotyping 
and large, well-characterized sample sets (Turner et al., 2011). With this 
approach, I would have been able to obtain genotyping data from 13 SNPs in 
around 380 subjects at a lower financial cost than if the genotyping was done 
for each SNP separately. However, in the GWAS approach, because of the 
inclusion of very large samples, false-negative results may be increased by 
failure to control for experimental factors such as low-quality DNA samples, 
poorly performing SNP assays, and errors in sample identification, leading to 
artefacts in the system and reduced power (Turner et al., 2011). These 
samples therefore require a stricter QC. Undergoing the strict QC is very 
important for genome wide association studies, where large sample sizes are 
needed to detect small effects and hundreds of thousands of polymorphisms 
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are studied. Due to the inclusion of very large samples, GWAS might be more 
able to afford a reduction in sample size without losing statistical power. 
However, the candidate gene approach I used in my study was shown to have 
a great impact on the reduction of sample size by using GWAS genotyping 
data. I believe that in my study this was particularly true as samples had been 
collected and stored over many years, and also used for genotyping other 
genes and therefore, affecting the quality and quantity of DNA (Pompanon et 
al., 2005). All these factors might have affected the quality and quantity of 
DNA samples used for the GWAS genotyping, leading to the reduction of 
almost three quarters of my sample. In addition, the assessment of population 
structure in the GWAS study identified about 20 out of the 387 participants 
that had been wrongly identified as Caucasian. Therefore, those subjects 
were also excluded from the genotyping possibly compromising the statistical 
power of the sample.  
 
In this study I also explore the potential role of RELN gene in brain 
morphometry in psychosis. RELN has been associated with schizophrenia 
(Shifman et al., 2008, Liu et al. 2010) and bipolar disorder (Fatemi et al., 
2000; Guidotti et al., 2000; Goes et al., 2010). In my study I found not 
association between RELN and total grey and white matter volume as well as 
whole brain volume as probable endophenotypes. To my knowledge this is 
the first time that RELN has been evaluated against these putative 
endophenotypes. These results concur with a previous study which had 
evaluated an association of RELN with intermediate phenotype such as 
measures of brain structure, brain function, and gene expression and found a 
not significant association (Tost et al., 2010). However, other studies have 
reported association between working memory and the RELN gene in patients 
with schizophrenia (Wedenoja et al., 2009). This finding continues to support 
the hypothesis that RELN is implicated in the pathway of the development of 
psychosis however; it might not be implicated in brain structural changes but 
in neuropsychological endophenotypes such as working memory.  




In addition, in my study I also included some of the most frequently reported 
candidate genes for psychosis such as BDNF, NRG and COMT, which were 
genotyped with a smaller scale genotyping method (i.e. at the SGDP or by 
commercial companies). There are previous reports of association of regional 
brain volume differences between psychosis and healthy volunteers with 
BDNF (Szeszko et al., 2005; Ho et al., 2006); COMT (Ohnishi T. et al, 2006) 
and NRG1 (Mata et al., 2009). However, in my study I found that none of 
these genes were associated with total brain volume. The lack of positive 
associations between these genes and brain volume might be related to the 
choice of different endophentypes from previous studies as they have mostly 
used regional rather than global brain volume measures. However, a study by 
Dutt et al. (2009), which included some participants from my sample, also 
failed to find an association between previously reported reductions in 
hypothalamus volume and BDNF (Szeszko et al., 2005). The lack of 
consistency in gene-morphometry associations might be related to the use of 
different endophenotypes, methodology used to measure brain volume, 
sample heterogeneity or again, to an underpowered sample for the genetic 
analysis.  
 
The issue of statistical power creates another challenge when looking at 
genetic association with endophenotypes such as brain structure. Most 
neuroimaging studies may be powered at sample sizes as little as 10–20 
subjects to detect between-group differences, but these require strong a priori 
hypotheses to show statistically significant differences between patients and 
healthy controls (Friston et al., 1999). In the case of whole brain volume and 
global grey and white matter volume, these requirements are not always 
fulfilled. In this study, for the genetic analysis, I had run a power calculation. 
The results were that with genes with 1% allele frequency, α of 0.003 and a 
sample of above 350 participants, I would have had 80% power to detect 4% 
of the variance in brain volumes. This power would have allowed me to detect 
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brain volume differences as described in the literature (reductions in 
psychosis at around 2% (Wright et al., 2000). In addition to my calculations, a 
number of candidate gene studies have reported significant associations 
between a certain SNP and brain volume changes, with samples sizes similar 
to mine. These studies included samples between 100 and 400 subjects of 
healthy volunteers (Zinkstok at al., 2006; Pezawas et al., 2004), and 
sometimes even smaller samples of patients with psychosis (n=78) 
(Addington et al., 2007), (n=51) (Zinktok et al., 2008) and in patients (n=19) 
compared to controls (n=25) (Szeszko et al. 2005). However, these studies 
have not been consistently replicated seeding doubts about their truthness. 
Analyses of statistical power can sometimes shed light on study results, 
particularly in the interpretation of negative results or lack of replication such 
as mine. Statistical power is considered the most pertinent factor that 
influences findings in genetic studies particulalrly in the context of modern 
whole-genome association studies, in which issues of coverage and multiple 
testing are dominant. Power analysis can either be done prospectively or 
retrospectively. Typically, a prospective power analysis is conducted prior to 
the research study, to estimate the sample size required to achieve adequate 
power. In my study I carried out a prospective power analysis. Differently, a 
retrospective power analysis is conducted after a study has been completed 
using the obtained sample and effect sizes to determine what the power was 
in the study, assuming the effect size in the sample was equal to the effect 
size in the population. Most GWAS studies take the approach of a 
retrospective power analysis, while introducing the risk of what is called the 
"power approach paradox". Here, a study with a null result is considered to 
show more evidence that the null hypothesis is actually true when the p-value 
is smaller, since the apparent power to detect an actual effect would be higher. 
In fact, a smaller p-value is properly understood to make the null hypothesis 
less likely to be true. Therefore, special attention should also be paid to GWAS 
positive results.  
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Besides altering the critical value, there are two other ways to increase the 
power of a statistical test: increasing the size of the sample on which the 
GWAS approach is being used, and by increasing the effect size. In my study I 
was not able to increase the sample size since the neuroimaging data had 
been obtained in the past and I could not enlarge the sample. Therefore, I 
sought to increase the effect size by selecting a specific phenotype. However, 
as described before, due to the number of SNPs tested, the power to detect 
statistically significant effects was potentially affected by to the adjustments for 
multiple corrections 
Some of the SNPs of SBNO1, HMGA2 genes assessed in this study have 
been only described to influence brain volume in healthy individuals (Taal et 
al., 2012, Stain et al., 2012). SBNO1 showed an effect on brain growth in 
early life (Taal et al., 2012) while HMGA2 gene, that encodes for protein that 
regulates stem cell renewal during neurodevelopment (Nishino et al., 2008), 
was associated with development of intracranial volume in healthy adults 
(Stein et al., 2012). In my study I did not find an association between these 
genes and brain volume therefore it is possible that they are not specifically 
implicated in the brain changes described in psychosis. In addition, a recent 
GWAS study also described an association between CRHR1 and brain 
volume in a healthy population (Ikram et al., 2012). Corticotrophin-release 
hormone (CRH) is released during stress and it is thought to create changes 
in the synaptic spines stability leading to possible brain cortical malfunctioning 
and the development of depression and psychoses (Bennett, 2008). 
Moreover, CRF has been found to be increased in the cerebrospinal fluid of 
patients with post-traumatic stress disorder with psychotic symptoms (Sautter 
et al., 2003). These findings suggest a potentail role of CRHR1 gene for brain 
volume changes in psychosis. However, in my study, I have not found an 
association between CRHR1 and any of the brain volume assessed in any of 
the groups.  
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To my knowledge no previous studies have looked at the potential role of 
SBNO1, HMGA2 and CRHR1 in psychosis and as mentioned above is 
possible that they are not specifically implicated in the brain changes 
described in psychosis. In addition, these genes have been identified as part 
of GWAS studies where a larger number of participants (about 9000) was 
included. These studies therefore had more statistical power to detect 
associations than my current sample.  
Finally, another factor to consider when exploring possible reasons for the 
lack of significant findings in the genetic analysis might be related to the 
characteristics of the sample I used, which is in many ways atypical. For 
instance, I combined subjects at their first presentation with patients in chronic 
stages of the illness. The current literature suggests that whole brain volumes 
as well as global grey and white matter volume changes are present at all 
stages, and even before the illness outbreak. However, meta-analyses 
suggest that these changes are considerably subtler in the early illness 
stages, as shown by Steen and colleagues (2006), and therefore the overall 
effect might have been diluted in my sample. On the other hand, there is also 
evidence that medications might play a role in brain morphology in patients, 
even after relatively short periods of treatment (Dazzan et al 2005, Lieberman 
et al, 2005; Ho et al., 2011). Therefore, medications might act as confounding 
factors obscuring results. Moreover, I combined patients with schizophrenia 
and bipolar disorder as I was not able to evaluate them separately due to 
small sample size. Although there is evidence of a genetic and brain 
morphometric overlap between these two illnesses, it is possible that again 
some of the differences between the two diagnoses have affected the results, 
in terms of carrying different genetic vulnerability. Therefore, the heterogeneity 
of the sample might have blurred the association between specific SNPs and 
their impact on brain volumes.  
 
In conclusion, although I was able to detect genetic association between three 
SNPs and patients with psychosis, this loss significance after multiple testing 
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corrections was applied. In addition, although I used data from the GWAS, 
which allows the evaluation of millions of SNPs, my approach was that of a 
candidate gene for brain volume in psychosis, and the analysis of such 
association was limited to subjects with structural MRI collected with two 
particular protocols. Although large, my sample could still have been 
underpowered to detect such associations. 
 
8.4 Strengths of the study 
Combination of neuroimaging data increases the statistical power to detect 
brain volume differences and its genetic influences. In this study I was the 
only rater of quality control and processing of the images. Additionally, I was 
blind to subject status. Also, I pre-processed all the images with the same 
pipeline. The pre-processing and analysis of a large neuroimaging sample 
was possible thanks to the application of a semi-automated method, SPM8. 
The combination of all these factors increased the consistency and made 
some of the most discussed pitfalls of multicentre studies less likely to occur. 
Another advantage in comparison to other studies that have combined 
multiple samples, is that the all the subjects were recruited from the same 
catchment area. This, to a certain extend, makes the effect of potential 
confounders such as environmental factors that could influence genetic 
expression less likely. Finally, one of the advantages of the design I used is 
that I included the relatives of patients affected with different psychotic 
illnesses. This approach increases the power to detect familiality of certain 
traits, and to assess the potential influence of genetic loading of brain volume 
deviations from the general population.  
8.5 Limitations 
There are a number of limitations in the current study. The neuroimaging data 
obtained for this study were acquired over a period of about 6 years. It has 
been described that with time, MRI scanners quality declines due to changes 
in magnetic fields strength, and this changes the quality of the images 
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obtained. Therefore, this might have had an impact on the pre-processing and 
the segmentation processes that were used to obtain grey and white matter 
volumes. Additionally, given that the brain undergoes changes with age, the 
large variability in age in the sample makes the interpretation of findings more 
difficult. Also, as for age, the influence of genetic and environmental factors on 
brain volumes may change with time, making the interpretation of genetic 
influence less reliable in the current study design.  
The assessment of familiarity in this study takes into account the variability of 
certain traits within families, in comparison to the trait variability in not related 
individuals. Although this model cannot differentiate genetic from 
environmental factors, it is thought to estimate the genetic influence in the 
assessed traits (Bramon et al., 2004; 2005). This differs from a more specific 
approach taken by family and twins studies. In both of these models a 
phenotypic variance is studied to assess the contribution of genetic and 
environmental factors. Therefore, although I showed that the familial 
contribution to the brain volume differences was statistically significant, I was 
not able to draw any conclusion about the extent of genetic versus 
environmental contributions. Additionally, in my study I did not have enough 
statistical power to explore the allelic familial risk due to small sample size. 
This should be investigated in larger samples, which would allow 
distinguishing genetic variations in patients and their relatives. This would 
enable us to understand how potential risk alleles for psychosis are clustered 
in families. Moreover, although I found a positive association in three 
genotypes and brain volume and psyhsis, the sample was too small and the 
data underwent multiple testings. Therefore, these suggesting results should 
be further explore with a larger sample assessing specific SNPs to ensure 
more accurate results. 
Another limitation of the study has been related to the fact that my project 
involved merging and using data from 3 different research groups, with a setup 
agreement already in place on data sharing. Because of this, I had difficulties 
in gathering additional information on all the variables that could have 
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potentially acted as confounders in my analysis. This is important because the 
apparent relationship or lack of it, between an independent variable and a 
dependent variable may in fact be related to a confounding factor. The 
presence of this apparent result is called omitted-variable bias, and potentially 
creates a biased effect estimates.  
 
Should I have had access to more data, I would have liked to include detailed 
information on different type of medication exposure (i.e. number and type of 
anti-psychotics, antidepressants and lithium; cumulative dose of medication 
since onset); duration and severity of illness and use of recreational drugs. 
The addition of these potentially relevant variables would have been 
appropriate as it could have increased the sensitivity of the analysis. However, 
increasing the number of comparisons conducted to account for confounders 
can in itself affect the statistical power to detect statistical significant results, 
as the significance threshold would need to be corrected in order to reduce the 
risk of type I error (i.e. difference found by chance).  
 
Lastly, although VBM has become widely used, this method comes with some 
pitfalls. For example, it is sensitive to the pre-processing stage. The reliability 
of VBM in combining different protocols was tested in the calibration study. I 
found that modulated images provide more robust and reliable correlation of 
volumes obtained with different protocols. In addition, although SPM is a fully 
automated method that allows to easily analyzing large number of 
neuroimaging data reducing researcher bias, it also has some disadvantages. 
For instances, the pre-procesing semi-automatic program runs intensity non-
uniformity correction during the segmentation pre-processing. Therefore, if 
applying N3 algorithm to ensure better segmentation (Acosta-Cabronera et al. 
2008), some of the default SPM should be modified to avoid double 
correction. This is particularly important when analyzing images that have 
been obtained over a long period of time (Sled at al., 1998). Finally, small 
differences in acquisition parameters can play an important role when 
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analyzing multicentre or multi-study scans. However, I believe that despite 
these limitations, this study supports the use of combined neuroimaging data 
from different datasets to achieve a better understanding of brain changes in 
psychosis and as a strategy to identify endophenotypes. 
 
8.6 Final conclusion and future research 
This study provide evidence that neuroimaging data acquired with different 
protocols can be reliably combined depending on the parameters used; in 
fact, special attention should be paid to the MRI acquisition parameters as I 
showed that these can greatly influence the possibility of combining data. 
Adequate sampling and considering a symptom dimension rather than a 
categorical approach may help reduce the heterogeneity of clinical 
presentation. Similarly, achieving an appropriate sample size is important to 
localize relevant genes involved in pathological variation in brain volumes 
according to different symptoms dimensions. In addition, future neuroimaging 
analyses of this sample should include the assessment of regional volumes, 
of areas such as the pre-frontal cortex and the medio-temporal lobes. These 
regions have been shown to be highly heritable and to be involved in the 
neuropathophysiology of psychosis. In addition, in future studies it will be also 
important to further assess the effects of medication in the brain volume 
particular white matter which has been less extensively explored in structural 
neuroimaging studies.  
 
More specifically, as mentioned above, one of the limitations of the genetic 
analysis in this study has been the power to detect statistical signifficant 
results. I was unable to increase the number of subjects included in the study 
as the MRI had already been already collected. In order to increase the 
statistical significance of the tests, in future work I will explore specific brain 
areas to provide more accurate phenotyping, for example through genotyping 
a specific region of interest or adding certain co-variates to refine the results. 
For instance, since I found an association (albeit not significant) between 
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whole white matter volume and OLIG2, in my future work, I would like to 
further explore this results with a region of interest approach specifically 
evaluating the prefrontal cortex in patients with bipolar disorders and patients 
with schizophrenia separately.  
 
In addition, it is now well establish that complex disorders such as psychosis 
arise from a combination of genetic and environmental factors and that the 
interaction between the different factors may be important. If two variables of 
interest interact, the relationship between each of the interacting variables and 
the dependent variable depends on the value of the other interacting variable. 
Therefore, it is more difficult to predict the consequences of changing the 
value of a variable. However, if this interaction is included in the model one 
can control for this obtaining more reliable results.  
 
Some of the environmental factors of relevance for the development of 
psychosis are the use of recreational drugs. It has been reported that the use 
of cannabis may increase risk of schizophrenia, as suggested by a number of 
systematic reviews (Arseneault et al., 2004 and Moore et al., 2007). Moreover, 
brain morphology has been considered to be useful as an intermediate 
phenotype in genetic research in psychiatric disorders (Baare et al., 2001; 
Durston et al., 2005). Therefore, another area of interest for my future 
research is the evaluation of gene-environment interaction. I will explore 
interactions between genes such as COMT and the use of recreational drugs 
like cannabis, exploring the effect of this interaction in the Pre-Frontal Cortex 
in my study sample.  
 
Finally, in my future work I will use a polygenic score analysis approach. This 
method has recently created interest for assessing the explanatory power of 
an ensemble of markers. This approach is therefore most suited to addressing 
some of the power limitations implicit to my study that were discussed above. 
From the data obtained from the GWAS analysis on an initial training sample, I 
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will be able to rank markers on the neurodevelopmental genes I included in my 
thesis according to their evidence for an association, usually with their P-
values. Then, an independent replication sample is analysed by constructing, 
for each subject, a polygenic score consisting of the weighted sum of its trait-
associated alleles, for a subset of the top ranking markers. Once these ranks 
are obtained, two related but distinct applications of this score are then 
possible. Firstly, testing for an association between the score and the trait in 
the replication sample can determine whether associated markers reside 
within those contributing to the score. Secondly and perhaps more usefully, 
the polygenic score can be used to predict individual trait values such as 
whole brain volumes. Effect sizes are estimated for each marker and can be 
used to construct a polygenic score for each subject in an independent 
replication sample. The score is tested for association in the replication 
sample, in which the tested trait may differ from that in the training sample. 
One of the advantages of using the polygenic score is that it reduces the 
number of tests needed in the analysis. As a result, this method allows limiting 
or reducing threshold of strictness to reject a null hypothesis in order to 
compensate for the multiple comparisons, which was one of the limitations of 
my study that could potentially obscur the results.   
 
An alternative approach could rely on the fact that very recently, at the 
International Conference of Psychiatric Genetics in October 2012, it was 
announced that a large collaboration involving approximately 25,000 people 
with schizophrenia and 28,000 controls had identified 62 risk genes for 
schizophrenia. Although not yet published, this should allow the construction 
of a polygenic score which can be used to summarise the degree of genetic 
loading, and this score then related to brain volumes. Finally, although the 
limitation of measurable endophenotypes for genetic associations continues, 
this study provides evidence to support the use of multiple protocols or multi-
centre scanners that would enable to increase the sample size for this type of 
genetic analysis.  
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Appendix 1  
Psychosis Screening Questionnaire 
 






Interviewer ……………………………………………………..     Date……………………………   
 
 













In this health survey we have to ask about a whole range of experiences.  Some of 
these experiences are quite rare.  However, I would be very much obliged if you 
would bear with us and answer the questions I am going to ask you now. 
 
 
     
 
Q1. Over the past year, have there been times when you felt very   
 happy indeed without a break for days on end? 
 
 
 (a)  Was there an obvious reason for this?     
 
 
 (b) Did your relatives or friends think it was strange or  





Q2. Over the past year, have you ever felt that your thoughts were  
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 directly interfered with or controlled by some outside force or  
person? 
 
 (a) Did this come about in a way that many people would  
  find hard to believe, for instance through telepathy?                     If 2 stop 
 
 
                                 No = 0     Unsure = 1     Yes = 2 
________________________________________________________________ 
 
Q3. Over the past year, have there been times when you felt that 
 people were against you? 
 
 
 (a) Have there been times when you felt that people were 
  deliberately acting to harm you or your interests? 
 
 
 (b)  Have there been times when you felt that a group of  
  people was plotting to cause you serious harm or injury?           If 2 stop 
 
 
Q4. Over the past year have there been times when you felt that 
 something strange was going on? 
 
 
 (a)  Did you feel it was so strange that people would find 
  it very hard to believe?            If 2 stop 
 
 
Q5. Over the past year, have there been times when you heard or 
 saw things that other people couldn't                                                        If 1 or 2 
                                                                                stop 
       
       
       
   
 
 (a) Did you at any time hear voices saying quite a few  
  words or sentences when there was no-one around  
  that might account for it?            If 2 stop 
 
 
Q6. Have you ever received treatment for any psychiatric or psychological 
 problem? 
 





















Respondent ID  _____________ Name of Interviewer
 ________________________ 
 
Date of Interview   ________________________ 
 
 
ANNETT HAND PREFERENCE QUESTIONNAIRE 
 
HAND:  
Ask subject to demonstrate (tick hand used to perform): 
 
1. Writing    R L  7. Sweeping   R
 L 
2. Throwing a ball   R L  8. Shovelling   R
 L 
3. Hammering nail   R L  9. Unscrewing a jar lid  R
 L 
4. Brushing teeth   R L  10. Dealing cards  R
 L 
5. Striking match   R L  11. Threading a needle  R
 L 




Ask subject to demonstrate:  
 




1. Hold pen vertically at arms length and line up tip with point in distance with both 
eyes open, then cover each eye in turn and see if still lined up.  
Tick side that, when covered, prevents pen from being aligned  R L 
 
2. Fold sheet of paper as if it was a telescope, and ask subject to use it to look at a 
distance.  
    Tick eye used.       R L  




The definition of the Classes of Hand Preference 
 
Actions Preference Classes 
  
A. Writing* 1. Right (or R+E) for all actions 
B. Throwing* 2. Left for any of F, G, H only 
C. Using a racquet* 3. Left for L and no others except above 
D. Striking a match* 4. Left for I and no others except above 
E. Cutting with scissors 5. Right writing but left for any other primary action 
F. Threading a needle 6. Left writing but right for any other primary action 
G. Sweeping with broom 7. Left for all primary actions but right for any others 
H. Shovelling with long-handled shovel 8. Left (or L+E) for all actions 
I. Dealing playing cards  
K. Using a toothbrush*  
L. Unscrewing a jar  
(Revised from Annett 1976) *Primary actions: those most highly intercorrelated (Annett, 1970)  
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Appendix 3  
Family Interview for Genetic Studies: FIGS  
FIGS Family Tree 
 
This page left intentionally blank for Family Tree to include first degree relatives with date of birth, gender, and place of birth 
Genetic influence in brain volumes in psychosis                                        PhD Ana Miorelli 
248 
 
FIGS General Screening Questions 
Interview date:    —   —     




















     
 First  MI  Last       
INTERVIEWER: Before you begin, you need to generate or obtain a family tree, with date of 
birth and gender, on which to record all of the responses to the following 
General Screening Questions.  (See FIGS Manual for details.) 
Step 1: Let’s go over your family. (Include parents, siblings and offspring aged 18 or 
above) 
Step 2: Now I am asking you to keep in mind all those in your family as I go through this 
list of questions.  (Note all positive responses on the pedigree.) 
 Did anyone: 
 Feel very low for a couple of weeks or more, or have a diagnosis of 
depression? 
 Attempt or complete suicide? 
 Seem overexcited (or manic) day and night, or have a diagnosis of mania? 
 Have visions, hear voices, or have beliefs that seem strange or unreal? 
 Have unusual or bizarre behavior, or have a diagnosis of schizophrenia? 
 (Was anyone) hospitalized for psychiatric problems? 
Step 3: For each of these given a positive response in the General Screening, complete the 
symptom checklist for any suspected: Depression/Mania, Psychosis, or 
Paranoid/Schizoid/Schizotypal Personality. 
 
FIGS Depression checklist 
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Interview date:    —   —     












     
 
Person being 
















        
 
Code for a single episode (best recalled, worst episode if possible). 
 No Yes Un
k 
1. During depression…    
1.a) …was he/she depressed most of the day, nearly every day, for as long 







1.b) …did he/she lose interest in things or become unable to enjoy most 





















1.e) …did he/she become unable to work, go to school, or take care of 
household responsibilities? 
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1.l) …did he/she have visions, or hear voices, or have beliefs or behavior 
that seem strange or unusual,  at the same time as (symptoms 







 Code Response 
2. Code and describe professional treatment: 
 
 0.  None 
 
 1.  Inpatient:  
__________________________________________________ 
 
 2.  Outpatient:   
________________________________________________ 
 
 3.  ECT:  
_____________________________________________________ 
 
 4.  Medication: 
________________________________________________ 
 














3. Age of onset   
 Episodes 
4. Number of episodes    
 Weeks 
5. Duration of longest episode in weeks    
 Code Response 
6. Rate and code impairment or incapacitation: 
 
 0.  None 
 1.  Modified RDC Impairment 
 2.  Modified RDC Incapacitation 
 3.  RDC Minor Role Dysfunction 
 4.  Change from previous functioning 













7. Interviewer judgement on reliability of this information: 
 
 1.  Good 
 2.  Fair 










FIGS Mania checklist 
Interview date:    —   —     
 Month  Day  Year 
 













     
 
Person being 
















        
 
 No Yes Un
k 
1. For most of the time day and night over several days, did he/she (more than 
usual)… 
   


























1.e) …show poor judgement (e.g., spending sprees, sexual indiscretions?) 
 






























































1.l) …have visions?  Hear voices?  have beliefs or behavior that seem 
strange or unusual?  at the same time as (above symptoms)?  (If YES, 
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 Code Response 
 
2. Code and describe professional treatment: 
 
 0.  None 
 
 1.  Inpatient:  
__________________________________________________ 
 
 2.  Outpatient:   
________________________________________________ 
 
 3.  ECT:  
_____________________________________________________ 
 
 4.  Medication: 
________________________________________________ 
 














3. Age of onset   
 Episodes 
4. Number of episodes    
 Weeks 




6. Rate and code impairment or incapacitation: 
 
 0.  None 
 1.  Impaired 
 2.  Incapacitated 










7. Interviewer judgement on reliability of this information: 
 
 1.  Good 
 2.  Fair 











FIGS Psychosis checklist 
Interview date:    —   —     
 Month  Day  Year 
 













     
 
Person being 
















        
Code for a single episode (best recalled, worst episode if possible). 
 
1. What were his/her unusual beliefs or experiences? 




   







1.a) …believe people were following him/her, or that someone was trying to 





















1.d) …believe his/her thoughts were broadcast, or that an outside force took 







1.e) …have any other strange or unusual beliefs? 
 

















1.g) …hear voices or other sounds that were not real? 
 













Skip to question 
1.h 
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 No Yes Un
k 
 
1.g.1) (Code YES if: voice with content having no relation to 
depression or elation, or voice keeping up running commentary 









1.h) …speak in a way that was difficult to make sense of? 
 











1.i) …seem to be physically stuck in one position, or move around excitedly 














2. How long did the longest of these experiences last?    
INTERVIEWER: If less than 1 week (unless successfully treated), STOP 
HERE.  Otherwise continue, if informant is 
knowledgeable about this person. 
    
 
 No Yes Un
k 
3. When any (SX above) happened, did he/she also have the mood disturbance we 










 No Yes U
n
k 
4. (Probe and code YES if mania and/or depression lasted at least 30% of total 







5. (Probe and code YES if illness described above, or medication for it, was ever present 









INTERVIEWER: If subject did NOT have any episode of Major Depression or Mania (by 
FIGS checklists from this informant), skip to question 6. 
Skip to question 
6 
INTERVIEWER: For the rest of this checklist, “illness duration” refers to total time of illness, including 
active and prodromal and/or residual symptoms and/or treatment (include time on 
medication). 
Skip to question 
6 











 Code Response 
 
6. Code and describe professional treatment  (Code and describe all that apply): 
 
 0.  None 
 
 1.  Inpatient:  
__________________________________________________ 
 
 2.  Outpatient:   
________________________________________________ 
 
 3.  ECT:  
_____________________________________________________ 
 
 4.  Medication: 
________________________________________________ 
 
 9.  Unknown 
 


















7. Age of onset   
 Episodes 
8. Number of episodes (Code 001 if chronic symptoms and/or treatment since onset)    
 











10. Rate and code impairment or incapacitation: 
 0.  None 
 1.  Impaired 
 2.  Incapacitated 









11. Interviewer judgement on reliability of this information: 
 1.  Good 
 2.  Fair 
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FIGS Psychosis checklist 
INTERVIEWER:  Use this page only if Schizo-affective is ruled out (by questions 3 to5 
above), or if the psychosis symptoms lasted at least one week (or shorter 
duration if successfully treated). 
Establishing the Prodromal Period: (Ask after completing question 16.a-n for the Prodromal 
period:) 
Establishing the Residual Period: 
 
16. Now I would like to ask you about the 
year before his/her (psychotic 
symptoms) started.  During that time 
did he/she… 
Now I would like to ask you about the year after his/her 































16.b) …have trouble doing his/her job, going to school, or 



















































16.f) …speak in a way that was hard to understand, or was 

























16.h) …have unusual perceptions, like sensing the presence of 

































































   
INTERVIEWER: If informant apparently does not know subject well enough to give 
information on Prodromal/Residual symptoms, STOP HERE. 
 If duration criterion for DSM III-R Schizophrenia, Chronic Type, already 
met, (question 9, total illness duration > 2 years), STOP HERE. 
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17.a) How long did he/she have these experiences?     
 
   
    
INTERVIEWER: Return to top of question 16 to establish the Residual period 








17.b) How long did he/she have these  experiences after 
his/her (Active psychotic features) stopped? 










18. Was he/she always this way? 







Code based on Informant’s Report: 
 
Did person being described have: No Yes Unk 
1. Depression 0 1 9 
1.a) Single 0 1 9 
1.b) Recurrent 0 1 9 
1.c) Impaired/Incapacitated 0 1 9 
1.d) Treatment 0 1 9 
 Age 
1.e) Age of onset   
2. Mania 0 1 9 
2.a) Single 0 1 9 
2.b) Recurrent 0 1 9 
2.c) Impaired/Incapacitated 0 1 9 
2.d) Treatment 0 1 9 
 Age 
2.e) Age of onset   
3. Psychosis 0 1 9 
3.a) (1) Chronic or (2) acute? 1 2  
3.b) Outside of mood disorder 0 1 9 
3.c) Treatment 0 1 9 
 Age 
3.d) Age of onset   





Complementary table 1: Genotyping frequencies 
Genotyping groups according to frequencies for statistical analysis  
Genotype patient relative control 
NRG 221533    
CC/CT 63 70 41 
TT  37 43 18 
    
NRG 241930    
GG 37 40 18 
GT/TT 58 64 31 
    
NRG 243177    
CC 32 33 19 
CT 56 53 29 
TT 21 10 15 
    
DTNBP1P1757    
AA/AG 31 44 14 
GG 45 58 29 
    
DTNBP1P1320 
rs760761 
   
CC 35 53 24 
CT/TT 28 33 15 
    
BDNF rs6265    
AA/AG 39 32 26 
GG 94 82 54 
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COMT rs4680    
AA 37 24 23 
AG 62 58 39 
GG 32 30 17 
    
DTNBP1_rs1047631    
CC/CT 13 15 7 
TT 48 48 20 
    
NTRK2_rs10868219    
CC/CT 32 35 11 
TT 27 28 15 
    
RELN_rs7341475    
AA/AG 16 17 9 
GG 45 46 18 
    
OLIG2_rs1059004_rs762178   
CC 25 14 8 
CT/TT 35 44 19 
    
    
MCPH1_rs2305022    
AA 35 40 13 
AC/CC 26 23 14 
    
    
MCPH1_rs930557_rs2440416   
CC 37 41 14 
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CG/GG 24 22 12 
    
MCPH1_rs1057090_rs2912057   
AA/AG 36 39 17 
GG 23 23 10 
    
MCPH1_rs2912016_rs2959798   
CC/CT 35 37 14 
TT 26 26 12 
    
ASPM_rs3762271_rs1360558   
CC/CT 49 51 18 
TT 12 12 9 
    
SBNO1_rs7980687_rs12322888   
AA/AG 23 26 8 
GG 38 37 19 
    
HMGA2_rs1042725    
CC 19 17 12 
CT/TT 41 46 14 
    
CRHR1_rs11655470    
AA/AG 40 44 14 
GG 20 19 13 
    
NRG 221533    
CC/CT 63 70 41 
TT  37 43 18 
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NRG 241930    
GG 37 40 18 
GT/TT 58 64 31 
    
NRG 243177    
CC 32 33 19 
CT 56 53 29 
TT 21 10 15 
    
DTNBP1P1757    
AA/AG 31 44 14 
GG 45 58 29 
    
DTNBP1P1320 
rs760761 
   
CC 35 53 24 
CT/TT 28 33 15 
    
BDNF rs6265    
AA/AG 39 32 26 
GG 94 82 54 
    
COMT rs4680    
AA 37 24 23 
AG 62 58 39 
GG 32 30 17 
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Complimentay table 2: Genotype frequencies in patients and healthy 









Chi square- χ² (df,N), p 
value 
    
NRG 221533 100 59 χ²(df2,N=159)=4.23,p=.12 
CC  9 12  
CT  54 29  
TT  37 18  





GG 37 18  
GT 48 24  
TT 10 7  
    
NRG 243177 rs6994992 109 63 χ²(df2,N=172)=.633,p=.73 
CC 32 19  
CT 56 29  
TT 21 15  
    
DTNBP1P1757rs2005976 76 43 χ²(df2,N=119)=3.69,p=.16 
AA 6 0  
AG 25 14  
GG 45 29  
    
DTNBP1P1320 rs760761 63 39 χ²(df2,N=102)=3.94,p=.14 
CC 35 24  
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CT 22 15  
TT 6 0  
    
BDNF rs6265 133 80 χ²(df2,N=213)=.363,p=.83 
AA 4 2  
AG 35 24  
GG 94 54  
    
COMT rs4680 131 79 χ²(df2,N=210)=.234,p=.89 
AA 37 23  
AG 62 39  
GG 32 17  
    
DTNBP1_rs1047631   χ² (df2,N=87)=4.57,p=.10 
CC 0 2  
CT 13 5  
TT 48 20  
    
DTNBP1_rs6937379   χ² (df2,N=86)=.7.53,p=.02 
CC 29 20  
CT 23 6  
TT 9 0  
    
NTRK2_rs10868219   χ² (df2,N=84)=1.24,p=.54 
CC 7 2  
CT 25 9  
TT 27 15  
    
RELN_rs7341475   χ² (df2,N=87)=1.03,p=.60 
AA 1 0  
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AG 15 9  
GG 45 18  
    
OLIG2rs762178   χ² (df2,N=86)=1.37,p=.50 
CC 25 8  
CT 20 12  
TT 15 7  
    
MCPH1_rs2305022   χ² (df2,N=87)=3.85,p=.15 
AA 35 13  
AC 24 10  
CC 2 4  
    
MCPH1_rs2440416   χ² (df2,N=86)=4.07,p=.13 
CC 37 14  
CG 22 8  
GG 2 4  
    
MCPH1_ rs2912057   χ² (df2,N=85)=.47,p=.78 
AA 9 3  
AG 27 14  
GG 23 10  
    
MCPH1_ rs2959798   χ² (df2,N=86)=.08,p=.96 
CC 9 4  
CT 26 10  
TT 26 12  
    
ASPM_ rs1360558   χ² (df2,N=87)=1.92,p=.38 
CC 19 8  
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CT 30 10  
TT 12 9  
    
SBNO1_ rs12322888   χ² (df2,N=87)=1.17,p.555 
AA 3 2  
AG 20 6  
GG 38 19  
    
HMGA2_rs1042725   χ² (df2,N=86)=1.27,p=.53 
CC 19 12  
CT 26 9  
TT 15 5  
    
CRHR1_rs11655470   χ² (df2,N=87)=2.43,p=30 
AA 7 4  
AG 33 10  
GG 20 13  
 
